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See dying vegetables life sustain, 
See life dissolving vegetate again: 
All forms that perish other forms supply, 
(By turns we catch the vital breath, and die), 
Like bubbles on the sea of matter born, 
They rise, they break, and to that sea return. 
 
Alexander Pope, An Essay on Man (1733-34), Epistle III, lines 15-25 
 
 
 
 
 
 
 
 
 
Molecular illusion, going on to confuse our minds… 
…There reality is grey, with no hope or faith 
I start a journey to inside, waking my first term 
I'm just returning to my dream, where I'm coming from  
 
Eloy – Inside (1974) 
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Abstract	
 
Dietary restriction (DR) is a moderate reduction in nutrient intake that 
improves health and prolongs longevity across most species tested. The 
restriction of specific nutrients, rather than overall food intake, is particularly 
important in mediating the beneficial effects of DR. In flies dietary protein 
mediates DR-induced lifespan-extension, and imbalance of single amino 
acids (AAs) dictates longevity and fecundity. In a conserved fashion in mice 
and rats, restriction of protein or of single essential AAs (EAAs) also extends 
lifespan. However, the definition of what constitutes a limitation or excess in 
the intake of an AA can be dubious as many past attempts to determine a 
reliable measure for dietary AA requirements have had limited success. A 
possible general predictor of the AA requirement of an organism could be its 
genome, potentially allowing a rational design for a balanced dietary AA ratio. 
Here it is reported that the exome composition of an organism may provide a 
suitable template for its AA requirements. Matching the dietary AA supply of 
flies or mice to their exome promotes anabolic traits including growth and 
fecundity compared to amino acid profiles found in commonly used protein 
sources including yeast and casein. In flies, the presence of exome-defined 
limiting amino acids lowers the amount of bioavailable protein in the diet. 
However this response also depended on the identity of the limiting amino 
acid. Therefore the amino acid profile of a food source is an important factor 
when considering the usage of dietary nitrogen, anabolic traits, and lifespan. 																							
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Zusammenfassung		
 
Eine reduzierte Nahrungsaufnahme (dietary restriction, DR) verbessert die 
Gesundheit und erhöht die Lebensdauer der meisten untersuchten Spezies. 
Dabei ist die Verminderung spezifischer Nährstoffe, und nicht die reduzierte 
Nahrungsaufnahme wesentlich für die positiven Effekte von DR. In Fliegen ist 
der Proteinanteil der Nahrung für die DR-induzierte Verlängerung der 
Lebensspanne verantwortlich; ein Ungleichgewicht von einzelnen 
Aminosäuren bestimmt die Lebensdauer sowie Fertilität. In den 
Säugetiermodellen Maus und Ratte verlängert eine verminderte Aufnahme 
von Proteinen oder einzelnen essentiellen Aminosäuren ebenfalls die 
Lebensspanne. Jedoch ist immer noch unklar, was eine Limitierung oder ein 
Übermaß bei der Aufnahme von Aminosäuren darstellt, da frühere Versuche, 
ein verlässliches Maß für die erforderliche Menge an Aminosäuren zu finden, 
nicht besonders erfolgreich waren. Eine mögliche generelle Vorhersage des 
Aminosäurebedarfs eines Organismus könnte sich aus seinem Genom 
ergeben, das potentiell ein sinnvolles Design einer Diät mit einem 
ausgewogenen Aminosäurverhältnis erlauben könnte. In der vorliegenden 
Arbeit wird gezeigt, dass die Zusammensetzung des Exoms eines 
Organismus eine brauchbare Vorlage für die Berechnung des 
Aminosäurebedarfs des Organismus darstellt. Die Anpassung der 
Aminosäurezusammensetzung der Nahrung an das Exom von Fliegen und 
Mäusen begünstigt anabole Prozesse wie Wachstum und Fertilität im 
Vergleich zur Aminosäurezusammensetzung von herkömmlichen 
Proteinquellen für Nahrung wie Hefe oder Kasein. In Fliegen reduziert eine 
durch das Exom definierte limitierende Aminosäure die Menge des 
bioverfügbaren Proteins im Futter. Jedoch ist diese Reaktion auch von der Art 
der limitierenden Aminosäure abhängig. Deshalb ist die 
Aminosäurezusammensetzung der Nahrungsquelle ein wichtiger Faktor bei 
der Untersuchung der Lebensspanne, anaboler Prozesse oder der Nutzung 
des Stickstoffes der Nahrung. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	 8	
Contents	
 
DECLARATION 5 
ABSTRACT 6 
ZUSAMMENFASSUNG 7 
CONTENTS 8 
ACKNOWLEDGEMENTS 13 
ABBREVIATIONS-ACRONYMS 15 
PUBLICATIONS ARISING FROM THIS THESIS 16 
CHAPTER 1. INTRODUCTION: PROTEIN, METABOLISM, AND AGEING 17 
1.1 ABSTRACT 17 
1.2 INTRODUCTION 18 
1.2.1 DIET AND HEALTH 18 
1.2.2 DIETARY RESTRICTION 18 
1.2.3 DIETARY PROTEIN AND AMINO ACIDS 18 
1.3 DIETARY RESTRICTION, HEALTH, AND AGEING 19 
1.3.1 PROTECTIVE EFFECTS OF DIETARY RESTRICTION 19 
1.3.2 PROTEIN CONTENT AND AA IMBALANCE 20 
1.3.3 MULTIVARIATE COMPLEXITY OF DEFINING A DIETARY AA-IMBALANCE 20 
1.3.4 ANABOLIC TRAITS AND THEIR EXPERIMENTAL ASSESSMENT 21 
1.3.5 LINK BETWEEN ANABOLIC TRAITS AND LONG-TERM HEALTH? 21 
1.4 AMINO ACIDS: INGESTION, ABSORPTION, AND SYSTEMIC AVAILABILITY 22 
1.4.1 DIETARY PROTEIN AND AMINO ACID ABSORPTION 22 
1.4.2 DIETARY AAS AND THE MICROBIOTA 23 
1.4.3 THE SPLANCHNIC BED AND SYSTEMIC AA AVAILABILITY 24 
1.4.4 METABOLIC FATE OF INGESTED AMINO ACIDS 25 
1.5 DETECTION OF AA LIMITATIONS AND REGULATION OF METABOLISM AND HEALTH 27 
1.5.1 GCN2-DEPENDENT DETECTION OF AA LIMITATION 27 
1.5.2 GCN2-INDEPENDENT DETECTION OF AA LIMITATION 29 
1.5.3 EFFECTS OF AA LIMITATIONS ON AGEING 30 
1.5.4 TOR-DEPENDENT DETECTION OF AA ABUNDANCE 32 
	 9	
1.5.5 TOR-INDEPENDENT DETECTION OF AA ABUNDANCE 33 
1.5.6 RESPONSES TO AA SURPLUSES THAT AFFECT PHYSIOLOGY AND AGEING 35 
1.5.7 CONVERGENCE OF AA SENSING PATHWAYS 35 
1.5.8 FOOD AVERSION, PROTEIN LEVERAGE, AND GROWTH SIGNALING 36 
1.5.9 DISTINCT BIOENERGETIC AND METABOLIC ROLES OF AMINO ACIDS 37 
1.5.10 HEALTH BIOMARKERS OF SPECIFIC AA-IMBALANCES 37 
1.6 OPTIMAL AMINO ACID INTAKE 43 
1.6.1 VARIATION IN REQUIREMENT FOR AMINO ACIDS. 43 
1.7 CONCLUSIONS 45 
1.8 OUTSTANDING QUESTIONS ADDRESSED IN THE CURRENT THESIS 45 
1.9 SUMMARY POINTS LIST 46 
CHAPTER 2: MATERIALS AND METHODS 48 
2.1 MATERIALS AND METHODS FOR FLY EXPERIMENTS 48 
2.1.1 MEDIA AND FLIES 48 
2.1.2 AA RATIO CALCULATIONS AND DIET DESIGN 48 
2.1.3 SILAC PROTEOME AMINO ACID USAGE 49 
2.1.4 MEASURING DEVELOPMENT, BODY MASS, EGG LAYING AND LIFESPAN. 50 
2.1.5 FLY TISSUE DISSECTION 50 
2.1.6 FLY PROTEIN EXTRACTION 51 
2.1.7 BCA PROTEIN ASSAY 51 
2.1.8 WESTERN BLOT 51 
2.1.9 PROBOSCIS EXTENSION BEHAVIOUR (PEB) 52 
2.1.10 BLUE DYE ASSAY 52 
2.1.11 DIETARY PREFERENCE ASSAY 52 
2.1.12 TRIACYLGLYCERIDE 53 
2.1.13 S35-LABELLED METHIONINE INCORPORATION ASSAY 53 
2.1.14 PROTEOTOXIC STRESS ASSAY 53 
2.1.15 MITOCHONDRIAL RESPIRATION 54 
2.1.16 POLYRIBOSOME PROFILING 54 
2.1.17 PROTEASOME ACTIVITY ASSAY 54 
2.1.18 URIC ACID QUANTIFICATION 55 
2.1.19 STATISTICAL ANALYSES 55 
2.1.20 REPRODUCIBILITY AND EXPERIMENTAL DESIGN 55 
2.2 MATERIALS AND METHODS FOR MOUSE EXPERIMENTS 56 
2.2.1 MOUSE STRAIN SELECTION 56 
2.2.2 MOUSE HOUSING 56 
	 10	
2.2.3 MOUSE FOOD AND WATER INTAKE 56 
2.2.4 MOUSE DIET DESIGN 57 
2.2.5 BODY MASS 57 
2.2.6 MOUSE SILAC AMINO ACID USAGE 57 
2.2.7 FOOD INDICES 57 
2.2.8 PROTEIN EXTRACTION 58 
2.2.9 PROTEIN AND DNA EXTRACTION FROM THE SAME SAMPLES 58 
2.2.10 METABOLIC RATE, ENERGY EXPENDITURE, AND ACTIVITY 58 
2.2.11 BLOOD METABOLIC PROFILE 58 
2.2.12 GLUCOSE TOLERANCE TEST 59 
2.2.13 INSULIN TOLERANCE TEST 59 
2.2.14 FAT CONTENT CHARACTERISATION 59 
2.2.15 UREA EXCRETION AND NITROGEN BALANCE 59 
2.2.16 ORGAN MASS AND TISSUE HARVEST 60 
2.2.17 CHARACTERISATION OF SKELETAL GROWTH AND BONE MINERAL PARAMETERS BY 
µCT 60 
2.2.18 HISTOPATHOLOGY 61 
2.2.19 PORTAL VEIN PLASMA METABOLOMICS ANALYSIS 61 
2.2.20 POWER ANALYSIS 61 
CHAPTER 3: EXOME-MATCHING PREDICTS THE LIMITING EAA IN FLIES AND 
MICE 64 
3.1 ABSTRACT 64 
3.2 INTRODUCTION 65 
3.3 RESULTS 66 
3.3.1 EXOME-MATCHING PREDICTS THE LIMITING AA FOR DROSOPHILA FECUNDITY 66 
3.3.2 EXOME-MATCHING PREDICTS THE LIMITING AA FOR MOUSE GROWTH 71 
3.3.5 INDIVIDUAL EXONS AND THEIR DISSIMILARITY TO THE MEAN EXOME AA USAGE 74 
3.4 DISCUSSION 75 
CHAPTER 4: EXOME-MATCHING OF ESSENTIAL AMINO ACIDS IN THE FLY 
DIET MAXIMIZES ANABOLIC TRAITS 77 
4.1 ABSTRACT 77 
4.2 INTRODUCTION 78 
4.3 RESULTS 79 
4.3.1 FECUNDITY PREDICTIONS 79 
4.3.2 AMINO ACID SENSING AND PERCEPTION 88 
	 11	
4.3.3 DEVELOPMENT 91 
4.3.4 THE METABOLIC FATE OF INGESTED AAS 96 
4.3.5 NITROGEN LOSSES 96 
4.3.6 LIPID STORAGE AND STARVATION RESISTANCE 98 
4.3.7 ORGAN MASSES AND PROTEIN CONTENT 101 
4.3.8 MITOCHONDRIAL RESPIRATION 103 
4.3.9 GLUCOSE HOMEOSTASIS AND GLYCOGEN SYNTHESIS 103 
4.3.10 PROTEOSTASIS 106 
4.3.11 PROTEASOME ACTIVITY, BIOGENESIS, AND FECUNDITY 110 
4.3.12 EFFECTS OF EXOME-MATCHING ON EARLY ADULT VIABILITY 114 
4.3.13 EXOME-MATCHING VS. PROTEOME-MATCHING 115 
4.3.14 EFFECTS OF EXOME-DEFINED AA RESTRICTION OR DEPRIVATION UPON ADULT 
SURVIVAL 120 
4.3.15 EFFECTS OF LARVAL (L2) FREE AA-MATCHING 123 
4.4 DISCUSSION 125 
4.4.1 FLY DEVELOPMENT AND FECUNDITY 125 
4.4.2 FLY DIET PERCEPTION 126 
4.4.3 FLY BODY COMPOSITION 126 
4.4.4 FLY NITROGEN BALANCE 127 
4.4.5 FLY MITOCHONDRIA AND RESPIRATION 127 
4.4.6 FLY PROTEOSTASIS AND PROTEASOME ASSEMBLY 127 
4.4.7 EXOME-MATCHING VERSUS PROTEOME-MATCHING 128 
4.4.8 GENERAL CONCLUSIONS AND SUMMARY AND KEY POINTS 129 
CHAPTER 5: EXOME-MATCHING IN THE MOUSE DIET PROMOTES GROWTH 
AND DETERMINES INSULIN RESISTANCE 133 
5.1 ABSTRACT 133 
5.2 INTRODUCTION 134 
5.3 RESULTS 135 
5.3.1 GROWTH EFFECT OF EXOME-MATCHING AGAINST A CASEIN-MATCHED AA SUPPLY
 135 
5.3.2 GROWTH EFFECT OF EXOME-MATCHING AGAINST AN EXOME-MISMATCHED AA 
SUPPLY 144 
5.3.3 NITROGEN EXCRETION 147 
5.3.4 LIPID STORAGE AND BODY COMPOSITION 150 
5.3.5 NUTRIENT SENSING 154 
5.3.6 RESPIRATION 156 
	 12	
5.3.7 GLUCOSE HOMEOSTASIS AND GLYCOGEN SYNTHESIS 159 
5.3.8 PROTEOSTASIS 162 
5.3.9 ORGAN GROWTH AND BIOSYNTHESIS 165 
5.3.10 HISTOPATHOLOGICAL EFFECTS OF EXOME-MATCHING 169 
5.3.11 SKELETAL EFFECTS AND BONE QUALITY 172 
5.3.12 EXOME-MATCHING VS. PROTEOME-MATCHING AND BODY-MATCHING 174 
5.3.13 EXOME-MATCHED AGAINST NRC-MATCHED AA SUPPLY 176 
5.4 DISCUSSION 181 
5.4.1 MOUSE GROWTH 181 
5.4.2 MOUSE METABOLIC RATE 181 
5.4.3 MOUSE BODY COMPOSITION 182 
5.4.4 MOUSE GLUCOSE HOMEOSTASIS 184 
5.4.5 MOUSE PROTEOSTASIS 185 
5.4.6 MOUSE NITROGEN BALANCE 185 
5.4.7 MOUSE BONE QUALITY 186 
5.5 CONCLUSIONS 186 
CHAPTER 6: GENERAL DISCUSSION 189 
6.1 SUMMARY 189 
6.2 CONCLUSIONS 190 
REFERENCES 194 
CURRICULUM VITAE 205 																
	 13	
		
Acknowledgements		
First and foremost, I wish to thank Dame Professor Linda Partridge for giving 
me the opportunity to work in her lab, and for having faith in my ability - I’ll 
always be grateful for her support and influence. My thanks also go to Dr. 
Matthew Piper for having conceived the hypothesis tested by me and for 
providing ample support throughout my studies, and to Dr. Andrea Mesaros 
for having supported most of my mouse work, along with technical help from 
Martin Purrio and Andre Pahl. I also wish to thank the two students I had the 
pleasure to supervise, Nina Grisard and Hanna Salmonowicz, for helping 
push the project forwards in numerous ways. Much of my gratitude also goes 
to Ulrike Temp and Dr. Christine Lesch for their support along the way, as well 
as to the rest of the Biological Mechanisms of Ageing department for their 
help and collaboration at one point or another (too many names to list here!). I 
am also obliged to the in-house and external collaborators Dr. Ilian Atanassov 
(MPI for Biology of Ageing, Bioinformatics Core Facility), Dr. Annetter 
Schumacher (Ssniff Spezialdiäten GmbH), and Prof. Alain de Bruin and S.A. 
Youssef Hassan (Dutch Molecular Pathology Center): their work and input 
made possible many aspects of my thesis work. Finally I want to thank the 
two members of my PhD Progress Report Committee, Prof. Dr. Aleksandra 
Trifunovic and Prof. Dr. Mirka Uhlirova for their support, and Prof. Dr. Siegfrid 
Roth and Dr. Astrid Schauss for their help with my oral defence. At a more 
personal level, I want to thank Stanka Matic for her love, for teaching me 
patience and for supporting me whole-heartedly throughout my PhD. I also 
wish to thank my family for being supportive throughout my studies and for 
their love. Last but not least, I want to thank science communicators Carl 
Sagan, Brian Silver, Steve Jones, Matt Ridley, Stephen Hall, Richard 
Feynman, Michael West, and others, for kindling my love for science with their 
light and passion. 														
 		
	 14	
																																																	
	 15	
	
Abbreviations-Acronyms	
 
DR – dietary restriction 
AA – amino acid 
EAA – essential AA 
NEAA – non EAA 
BCAA – branched-chain AA 
IIS – insulin and insulin-like growth factor 1 (IGF1) signalling 
mTOR – mammalian target of rapamycin 
SB – splanchnic bed 
TCA cycle - tricarboxylic acid cycle 
TAGs – triacylglycerides 
ATF – activating transcription factor 
GCN2 - general control nonderepressible 2 
AMPK - denosine monophosphate-activated protein kinase 
AAR – amino acid response 
ASNS – asparagine synthetase 
CNS - central nervous system 
GAP activity - GTPase-activating protein (GAP) activity 
GEF activity - guanine nucleotide exchange factor (GEF) activity 
GPCR - G-protein-coupled receptor 
GLP-1 - Glucagon-like peptide-1 
PYY - peptide YY 
CCK – Cholecystokinin 
FOXO - transcription factor Forkhead box O  
BMI – body mass index 			
 
 
 
 
 
 
	 16	
Publications	arising	from	this	thesis		
1. Matthew D W Piper, Eric Blanc, Ricardo Leitão-Gonçalves, Mingyao 
Yang, Xiaoli He, Nancy J Linford, Matthew P Hoddinott, Corinna Hopfen, 
George A Soultoukis, Christine Niemeyer, Fiona Kerr, Scott D Pletcher, 
Carlos Ribeiro, and Linda Partridge. A holidic medium for Drosophila 
melanogaster. Nature Methods 11, 100–105 (2014). 	
2. George A. Soultoukis and Linda Partridge. Protein, Metabolism and 
Ageing. Annual Reviews of Biochemistry 85, xxx-xxx, (June 2016). 
																												
				
	 17	
Chapter	1.	Introduction:	Protein,	metabolism,	and	ageing	
 
 
1.1	Abstract	
 
Dietary restriction (DR), a moderate reduction in food intake, improves health 
during ageing and extends lifespan across multiple species. Specific nutrients, 
rather than overall calories, mediate the effects of DR, with protein and 
specific amino acids playing a key role. Modulation of single dietary amino 
acids affects traits including growth, reproduction, physiology, health, and 
longevity in animals. Epidemiological data in humans also link the quality and 
quantity of dietary proteins to long-term health. Intricate nutrient-sensing 
pathways fine-tune the metabolic responses to dietary amino acids in a highly 
conserved manner. In turn, these metabolic responses can affect the onset of 
insulin resistance, obesity, neurodegenerative disease, and other age-related 
diseases. Here it is discussed how amino acid requirements are shaped, how 
ingested amino acids regulate a spectrum of homeostatic processes, and 
finally how the use of related nutritional strategies provides a unique 
opportunity of using to improve human health during ageing. 
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1.2	Introduction	
 
1.2.1	Diet	and	health	
Obesity and its associated metabolic diseases are a global health problem, 
linked to reduced life expectancy. Both quantity and quality of food intake are 
clearly important in the development of obesity, with excess fat (1) and 
carbohydrate intake detrimental to health and lifespan in flies (2), mice (3), 
and humans (4). Clearly diets that promote obesity should be avoided, as 
should those that induce nutritional deficiencies. But what dietary 
compositions best promote health, and why? Does the optimal balance of 
macronutrients vary with age, gender, genotype or disease state? Defining 
the macronutrient composition of a healthy diet, and identifying the molecular 
and physiological mechanisms by which it promotes health, are important 
challenges. The introduction of this thesis focuses particularly on the roles of 
dietary protein. 
 
1.2.2	Dietary	restriction	
A nutritional intervention that has clear health benefits is dietary restriction 
(DR), a moderate reduction in food intake that protects against multiple 
ageing-related diseases and impairments, and extends lifespan in most 
animals tested. The severity of DR can range from ~10 to ~50% of ad libitum 
intake levels, and the lifespan increase can be as modest as a few percent or 
as high as three-fold (5) . In rodents and primates, DR protects against 
ageing-related loss of function and disease, including cardiovascular disease, 
obesity, multiple cancers, neurodegeneration, nephropathy, loss of sensory, 
motor and immune function, and diabetes (5, 6) . Short-term DR in humans 
also benefits glucose and energy homeostasis, increasing insulin sensitivity 
and reducing body fat (5) . However, DR is not a practical intervention for 
most humans because it is difficult to implement and sustain. Moreover, DR 
can decrease wound healing capacity and increase susceptibility to viral 
infections (5). Thus an important aim is to identify the nutrients that mediate 
the health benefits of DR. Understanding the physiological and molecular 
mechanisms by which these key nutrients exert their effects may pave the 
way to DR-mimicking diets, as well as pharmacological interventions to 
improve health during ageing with minimal side-effects.   
 
1.2.3	Dietary	protein	and	amino	acids	
Recent findings have increasingly pointed to a causal role of the protein 
component of the diet in promoting the health and lifespan benefits of DR. In 
the fruit fly Drosophila, restriction of dietary yeast, the fly’s usual protein 
source, but much less so of carbohydrate or total calories, extends lifespan 
(7), an effect attributable to the amino acids (AAs) (8) and the protein-to-
carbohydrate ratio of the diet (2). In mice (3) and rats (9), reducing dietary 
protein, thereby decreasing the diet’s protein-to-carbohydrate ratio, also 
increases healthspan and lifespan. The beneficial effects of protein restriction 
outweigh those of carbohydrate or fat restriction (3, 10, 11). Indeed, dietary 
carbohydrates and fats are largely interchangeable without detrimental effects 
in many species (1, 12). Moreover, specific AAs or their ratio can determine 
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health and ageing, because reduced intake of methionine in Drosophila (8), 
and of methionine or tryptophan in rodents (13, 14) results in improved health 
during ageing and increased lifespan. Additionally, increases in circulating 
branched-chain AAs (BCAAs) stimulate the target of rapamycin (TOR) and 
IGF/insulin signaling (IIS) pathways in rodents (3, 15), which may be 
detrimental for health, since suppression of TOR and IIS signaling is often 
beneficial for a healthy lifespan (5). The mechanisms by which individual 
dietary amino acids affect metabolism and health are starting to be 
understood, and are revealing potential targets for improvement of organismal 
health during ageing.  
 
1.3	Dietary	restriction,	health,	and	ageing	
 
1.3.1	Protective	effects	of	dietary	restriction		
The physiological, metabolic, and molecular changes through which DR 
extends healthspan and lifespan are becoming clearer, although a complete 
account is lacking for any organism. Reduction in nutrient intake triggers 
modulations in the activity of nutrient-sensing pathways, which stimulate 
protective mechanisms over most aspects of health during ageing. From flies 
to humans, the DR response is highly conserved and involves an extensive 
array of protective metabolic changes that include an increase in stress 
resistance, detoxification capacity, and genome stability, and promotion of 
proteostasis and energy homeostasis (5, 16). The IIS and TOR pathways are 
also conserved in humans, and so are their responses to DR (5). Long-term 
and short-term DR trials in humans result in marked reductions in IIS and 
TOR signaling, decreasing multiple risk factors such as obesity, insulin 
resistance, and cardiovascular disease (17). These evolutionarily conserved 
responses to DR present an opportunity for significant health-promoting 
applications in human nutrition (11). Apart from its effects on energy 
homeostasis, DR also reduces cancer propensity. A reduction in tumour 
incidence (lymphomas, pituitary, and thyroid neoplasms) accompanies DR 
treatment in mice (6). Furthermore, primate studies also implicate dietary 
protein in health during ageing. Two recent Rhesus monkey lifespan trials 
found conflicting results, with one (WNPRC), but not the other (NIA), reporting 
a lifespan extension as a response to DR (11), although both found multiple 
improvements in health in the DR animals. Among several experimental 
differences between the two trials, differences in the amount and type of 
dietary protein were prominent (5, 11). In humans too, DR reduces IGF-I and 
decreases the risk of cancer (17). However, DR in humans only lowers 
circulating IGF-I if protein intake is also restricted (5). Human trials also 
highlight a role for protein quality, because diets containing low, plant-based 
AAs promote multiple aspects of healthspan (18). Such findings emphasize a 
difference between protein sources, for example plant versus animal protein, 
discussed further below. Moreover, recent work suggests that increased 
activity of the transsulfuration pathway is required for the extension of lifespan 
by DR in Drosophila (19). Indeed, hydrogen sulfide production by the 
transsulfuration pathway is associated with extension of lifespan by DR in 
yeast, flies, and mice (20). 
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There is thus an emerging role of dietary protein, and of specific AAs, in 
modulating the health benefits of DR in humans, suggesting the potential of 
interventions in protein intake to improve human health. 
 
1.3.2	Protein	content	and	AA	imbalance	
In agreement to what is observed in DR animals, restriction of dietary protein 
or AAs reduces wound healing capacity and increases susceptibility to viral 
infections (21). Also in accord with what is seen in DR animals, protein-
restricted mice have protected cognitive function and live longer (3, 22). 
However, in contrast to DR animals, protein-restricted mice can show an 
increase in body fat and insulin resistance (3). Decreasing dietary protein also 
increases body fat in humans (23), but a high intake of dietary protein and 
AAs promotes insulin resistance and adversely perturbs glucose homeostasis 
(24). In consequence, only 10-15% of energy intake as protein is 
recommended for humans (25), although for weight loss management the 
absolute amount of protein consumption is of greater importance than the 
percentage of energy (23). 
 
The effective protein uptake depends on the efficiency of a protein’s usage. 
This is the result of the combined effects of (i) how much protein is ingested 
and metabolized, (ii) its essential to non-essential AA ratio (EAA:NEAA), and 
(iii) its precise AA composition (26). Adequate protein intakes can be achieved 
with lesser amounts of high quality protein than of low quality protein, where 
quality is determined by its efficiency for anabolic traits. The effects of a 
dietary AA imbalance are more severe when overall AA intake is low (27), as 
AA imbalances further decrease AA usage. A low EAA:NEAA can also be 
inefficient for anabolic traits at low AA intakes. Therefore, the protein content 
and effective macronutrient ratio of protein to carbohydrates and fats greatly 
depends on the AA proportions of the ingested protein. Consequently, the AA 
proportions of a diet are critical for health, both through effects on total protein 
usage, and through mechanisms mediated by specific AAs. We highlight the 
metabolic fate of AAs, from ingestion to effects upon metabolism and health, 
in the following sections. 	
 
1.3.3	Multivariate	complexity	of	defining	a	dietary	AA-imbalance	
Identifying a diet with a healthy mixture of nutrients is complicated by the 
multivariate nature of diets, which poses a challenge for experimentation, and 
by the synergistic effects of multiple essential macro- and micro-nutrients (2). 
Accordingly, complex interactions between individual AAs render phenotypic 
responses to different AA ratios hard to interpret. Moreover, an interaction of 
AAs with other nutrients such as vitamins can also modulate metabolism (28), 
which further increases the complexity of nutritional space and confounds 
biological interpretations. Consequently, defining a balanced AA intake is a 
challenge. 
 
To simplify the nutritional landscape, recent methods dissect nutritional 
interactions and their physiological effects in multidimensional space (2). Such 
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a representation of nutritional space, called the geometric framework, can 
better describe the responses of metabolic, lifespan, and other traits, and can 
reconcile apparently contradicting results (2). Multi-dimensional approaches 
are desirable but sometimes impractical, and progress can also be impeded 
due to the lack of standardized methods. In flies, the recent development of 
holidic diets enables the accurate analysis of the effects of single dietary AAs 
(29), and such tools would benefit work in other model organisms such as 
mice and rats. This kind of experimental standardization will aid the 
systematic analysis of multivariate AA interactions and their effects on health 
and ageing.  
 
It is difficult to discern the physiometabolic effects of subtle AA imbalances 
that occur under conditions of normal nutrition, which is usually characterized 
by the intake of varied dietary protein sources. Even in laboratory model 
organisms, with carefully controlled conditions using chemically defined diets, 
problems can persist. Autoclaving and irradiation, both common sterilization 
steps in laboratory rodent food preparation, can degrade certain AAs including 
lysine, methionine, and cysteine, as well as vitamins like A and B1 (28). In 
everyday human nutrition, food processing such as cooking may alter the AA 
contents of a protein source. Food texture can also have dramatic effects 
upon metabolism, as soft foods increase nutrient efficiency and adiposity. In 
humans, ageing also leads to anorexia and weight loss, largely due to the 
progressive functional decline of the digestive system (30), which also likely 
results in deceased AA absorption. All these factors render practical diet 
design challenging.  
 
1.3.4	Anabolic	traits	and	their	experimental	assessment	
Although health and lifespan responses to AA sources are sometimes 
evaluated, experimentally the balance of an AA source is typically defined by 
its ability to maximize production traits (28).  
 
With regards to the growth effect of single EAA limitations in vertebrates, the 
principle of the minimum is typically applied. The principle states that when all 
essential nutrients required for growth are abundant in a diet except for one, 
the limiting essential nutrient, incremental additions of this limiting essential 
nutrient only will increase growth (31). For EAAs, this has been repeatedly 
demonstrated experimentally in rodents (26). In addition, the principle is 
coupled to the law of diminishing returns, according to which each succeeding 
increment of the limiting essential nutrient will produce a smaller increment of 
growth than the preceding increment (31, 32). However, the nature of the link 
between anabolic traits and long-term health is complex and is discussed 
below with respect to protein and AA intakes. 
 
1.3.5	Link	between	anabolic	traits	and	long-term	health?	
Growth: Both DR and protein restriction can suppress growth and extend 
lifespan in rodents (3, 5, 26). The developmental theory of ageing holds that a 
prolonged lifespan is caused by retarded development, and this notion was 
quickly adopted as an explanation of the lifespan response to DR (33). In flies 
and mice, the reduced growth observed upon DR or protein restriction 
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respectively seems to be effected by a reduced cell number, implicating the 
suppression of IIS (34, 35). Life-extending tryptophan or methionine 
restrictions also reduce growth in mice and rats via reduction in circulating 
IGF-I (13, 14). Reduced IGF-I signaling modulates the negative correlation 
between body size and lifespan in mice (36) and dogs (37). Several rodent 
studies show a negative correlation between body size and longevity in both 
genders (36, 38), as do several genetic models of extended longevity under 
reduced IIS (39). All these observations together strongly suggest an inverse 
correlation between growth in body size and lifespan.  
 
However, growth depression is not a prerequisite for lifespan extension. Body 
growth has been uncoupled from longevity both in mice and in flies (39). 
Thus, manipulations of growth signaling can extend longevity with no effect on 
body growth. Moreover, although anabolic traits are often used in the 
nutritional evaluation of a dietary protein, such traits are not reliable predictors 
of health during ageing. In rodents, some AA imbalances that do not cause 
growth depression can be detrimental for health and cause fatty infiltration of 
the liver (26). Therefore, reduction in growth signals can cause growth 
suppression and lifespan extension, but the former is not a prerequisite for the 
latter. From this perspective it remains possible that specific dietary AA 
intakes could optimize anabolic traits and lifespan, avoiding trade-offs 
between them. 
 
Reproduction: Fecundity depends on nutrient utilization, and animal models 
are used to evaluate the link between fecundity and lifespan. In flies, DR 
reduces fecundity and increases lifespan (40). Fecund females allocate much 
of their ingested nutrients to reproductive processes, a proportion diminished 
in DR flies (41). In rodents, some long-lived models show a marked 
reproductive capacity reduction (40). Apart from extending rodent lifespan, 
protein restriction also suppresses fecundity (28). Reproductive output is also 
negatively associated with lifespan in dogs (42) and humans (43). However, in 
several fly models lifespan extension is not characterized by a lower 
reproductive output (40). Supplementing methionine in a methionine-restricted 
fly diet can rescue fecundity with no lifespan shortening (8), indicating that 
dietary modulation of AAs can promote longevity without impairing fecundity. 
Therefore, suppression of reproduction may not be indispensible for lifespan 
extension, and the design of diets that optimizes both traits is possible. 
 
 
1.4	Amino	acids:	ingestion,	absorption,	and	systemic	availability 
1.4.1	Dietary	protein	and	amino	acid	absorption		
The intake of AAs is achieved through the consumption of either whole protein 
or free AAs in the diet. Following their ingestion, the identity and amount of 
the AAs that become available to cells and tissues depends on AA absorption 
by epithelial enterocytes. The digestibility of whole dietary proteins is 
confounded by numerous factors (44), which makes it difficult to establish the 
identity and amount of bioavailable AAs after the ingestion of whole protein 
foods (45). Yet, whether derived from digested peptides or free AA diets, AAs 
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show substrate antagonism and other physicochemical properties that can 
complicate estimations of their availability (44-46). In contrast to whole protein 
diets, free AA diets avoid many of the confounding factors influencing whole 
protein digestion, and are more readily absorbable (29, 47). Moreover, in 
contrast to oligopeptide transporters, characterization of the free AA 
transporters in the human intestinal epithelium is comprehensive (46). 
Therefore, free AA diets are more suitable for the assessment of post-
absorptive effects of dietary AAs upon metabolism, health, and ageing. 
 
1.4.2	Dietary	AAs	and	the	microbiota		
The uptake of AAs is influenced by gut bacteria, and this can greatly affect the 
response to a dietary protein or AA source. Instead of epithelial enterocytes, 
free AAs in the gut’s lumen may first encounter gut microbes. Gut bacteria are 
both consumers and producers of AAs, but the net exchanges between host 
and microbiota of specific AAs, and the factors that influence this exchange, 
are not yet fully understood (48, 49). Nevertheless, many AA exchanges 
between the host and the microbiota have been characterized. Gut bacteria 
synthesize all essential AAs (EAAs), and contribute up to 10% of mammalian 
plasma metabolites, including the EAAs tryptophan, phenylalanine, and lysine 
(49, 50). Although such contributions for other EAAs are not yet described, 
they are likely to occur. In addition, during the host-colon nitrogen cycle, 
microbes further contribute towards AA re-absorption by the host (49). 
However, when rodents with a gut microbiota are fed single EAA-deficient 
diets, their health quickly deteriorates, which suggests that bacterial EAA 
contributions are modest (26). The effects of the deficiency also depend on 
the identity of the AA deprived (26), and on how much of each EAA gut 
bacteria can provide to the host. However, ruminants with a rumen microbial 
load able to synthesize all EAAs, still require an ample dietary AA supply to 
achieve high levels of growth or milk production (51). Therefore, the 
contribution of EAAs from gut bacteria to the host appears limited. In contrast, 
the microbiota consumes substantial amounts of AAs, with up to 50% of fecal 
nitrogen being of bacterial origin (1, 4). However, more work is needed to 
establish how much of each ingested AA can be used by gut bacteria (48). 
Therefore, the gut microbiota can shape AA availability to the host. This can 
be especially important in low protein diets, because small changes in AA 
availability can have a proportionally greater effect on the available AA profile. 
In turn, this can also influence the useable dietary protein and the 
macronutrient ratio, which shapes health and ageing.  
 
Changes in the microbiota are also associated with the risk for obesity, 
diabetes, and heart disease, and in mice DR enriches microbiota phylotypes 
associated with increased longevity (52). Gut bacteria adapt to ingested 
nutrients and can shift focus from dietary carbohydrate to dietary AA 
metabolism (53), while they also benefit from ample dietary fibre, which 
increases fecal nitrogen and decreases net AA uptake by the host (48). By 
adapting to macronutrients and metabolizing fibre, gut bacteria can stimulate 
the secretion of intestinal growth factors or satiety hormones (54, 55). Apart 
from the health risks of a chronically over-stimulated growth axis, such 
interactions also complicate estimations of efficiency of dietary AA sources 
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that rely on the evaluation of anabolic traits (growth) or behavioural traits (food 
intake). Also, the metabolism of AAs by gut bacteria may be influenced by 
circadian rhythms, or the host’s age and immune status. Due to such 
complications, quantifying the net AA exchanges between host and microbiota 
is easier in animals with a small number of gut bacteria species and 
chemically defined diets, such as fruit flies (29, 54). Understanding of the 
factors affecting AA usage by gut bacteria, the mechanisms by which gut 
microbes influence AA availability to the host and the health consequences, 
will be aided by approaches in which the amount or composition of the 
microbiome is experimentally manipulated. 
1.4.3	The	splanchnic	bed	and	systemic	AA	availability		
The amount of each AA that becomes systemically available is critical for 
metabolism, affecting health through AA-sensing mechanisms discussed in 
the following sections. However, this amount greatly depends on how many 
AAs are metabolized immediately after absorption in the gut. Once absorbed 
by enterocytes, free AAs enter into the splanchnic bed (SB), which comprises 
the gut, liver, spleen, and pancreas, where free AAs can be metabolized. In 
general, up to a third of all dietary AAs are metabolized by the SB (48), greatly 
shaping the AA profile that reaches circulation to become systemically 
available. Metabolism of AAs in the SB also depends on AA identity. Despite 
arterial supply of AAs, enterocytes greatly rely on dietary AAs (56), and a low 
AA intake may contribute to enteral atrophy. Enteral usage of threonine is 
particularly high, presumably for the synthesis of threonine-rich mucins (48, 
56). In the liver, methionine enters many transulfation, transmethylation, and 
folate metabolism reactions (56). Glutamate, valine, isoleucine, leucine, and 
phenylalanine are also largely used by the SB. For all these AAs, an 
estimated 35%-100% of dietary intake is used by the SB, never reaching 
systemic circulation (48, 56). In contrast, arginine, alanine, tyrosine, and 
proline undergo minimal usage by the SB (56). An AA’s conformation can also 
determine its SB usage. In flies, mice, and rats, D- and L-methionine are 
highly bioavailable, while in humans D-methionine is only ~30% bioactive (26, 
57, 58). In contrast, all other AAs are fully usable only in the L- form across 
the four species (26, 57). Thus, SB metabolism of free AAs substantially 
affects their systemic availability depending on the individual AA’s identity. 
 
Following their passage through the SB, free AAs pass into circulation, to 
become part of the free AA pool. Free AAs represent a very small fraction of a 
body’s total AA contents, but are metabolically significant as they form the 
systemically available AA profile. Indeed, free AAs are associated with 
lifespan across species. In flies low levels of glutamine, lysine, and alanine 
are linked to extended longevity (59). In mice, circulating metabolites including 
glutamine, methionine and proline decrease with age (60). This decrease is 
countered by acute DR, which increases circulating methionine, glutamine, 
alanine, and valine indicating a shift towards gluconeogenesis and energy 
conservation (61). However, an opposite metabolic shift has been suggested 
in dogs, where lower levels of isoleucine, leucine, phenylalanine, and valine 
are associated with the health benefits induced by DR (62). The same 
association has been made in humans too, where a plasma decrease in 
isoleucine, leucine, valine, lysine, phenylalanine, and histidine was linked to a 
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reduced carbohydrate metabolism and an increased AA catabolism (63). 
Moreover, depleted levels of circulating methionine and BCAAs have been 
observed in long-lived IIS mutant mice (64). Finally, in mice elevated 
circulating BCAAs stimulate their catabolism in the liver (15). Thus, it is 
currently difficult to interpret the mechanisms involved in plasma AA changes 
with age or with DR, or the consequences of these changes for health. Some 
possible mechanisms linking such free AA modulations to lifespan are 
discussed in more detail in following sections. 
 
From circulation, free AAs can enter interstitial fluids and cells, to become part 
of tissue intracellular pools. Although the circulated free AA pool is available 
to all tissues reached by circulation, cell-specific AA availability depends on 
AA transporters whose abundance can vary between cell types (65, 66). 
Abundance of transporters is well characterized for enterocytes, hepatocytes, 
pancreocytes, nephrocytes, and in the brain, as is substrate antagonism 
between AAs for transporters (46, 66, 67). Thus, despite equilibrium between 
circulatory and intracellular pools for most free AAs, substantial differences in 
concentrations between the two pools are seen in some cases. In humans, 
glycine, glutamate, and glutamine are 10-50 times more concentrated in 
intracellular pools (4). And it is also noteworthy that the free AAs in a tissue do 
not match the AA composition of the tissue’s proteome. In rat muscle, 
compared to protein-bound AAs, there are depleted levels of phenylalanine, 
methionine, and BCAAs (4). Therefore, circulating, intracellular, and protein-
bound AA profiles differ significantly, but circulating and intracellular AAs 
fluctuate more dynamically and play a prominent metabolic role.  
 
The dynamics between transporter abundance and tissue-specific AA 
availability need more clarification, as do the effects of bidirectional transport 
between specific AAs, such as glutamine and leucine (68) upon AA tissue 
specific AA availability. Nonetheless, some physiological effects of AA 
antagonisms are clear. Antagonisms between the BCAAs can result in growth 
depression upon supplementation of one of these three AAs in the diet (26). 
Similarly, antagonisms between lysine and arginine can suppress growth 
upon addition of lysine or arginine only in the diet (26). Excess leucine or 
methionine deppress rat growth independently of food intake, with excess 
leucine increasing the growth requirement for tryptophan (26). However, there 
is a lack of long-term studies, and the effects of an AA imbalance-induced 
decrease in growth signaling upon health and lifespan await further study.  
 
1.4.4	Metabolic	fate	of	ingested	amino	acids	
The metabolic fate of intracellular AAs is important in determining the effects 
of AA intake upon health and ageing. An outline of AA metabolism is given in 
Figure 1.1. Once in the splanchnic bed, free AAs can be used for protein 
biosynthesis (e.g. in liver or intestinal muscle cells), or can be broken down to 
their carbon skeleton and amine groups. Amine groups are typically excreted, 
but carbon skeletons can have a diverse fate. They can be used in the 
biosynthesis of acetyl-coenzyme A (acetyl-CoA) or acetoacetyl-CoA, the main 
precursors of fatty acids, which are in turn stored as triacylglycerides (TAGs)  	
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Figure 1.1 
 
The metabolic fate of ingested amino acids. Modified from Berg et al. 2006 (69) 
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in adipose tissue. Alternatively carbon skeletons can be used to synthesize 
pyruvate and oxaloacetate, the precursors of glucose (stored as glycogen) 
fueling the tricarboxylic acid (TCA) cycle. Finally catabolism of the carbon 
skeleton can also be used for cellular respiration and energy production in the 
form of ATP. Those AAs not metabolized in the splanchnic bed can enter 
circulation, from where they can be absorbed by cells and tissues. 
Consequently, the proportion of AAs in the diet can affect many of these 
metabolic pathways. This aspect is discussed separately for AA limitations 
and excesses in the following sections.  
 
1.5	Detection	of	AA	limitations	and	regulation	of	metabolism	and	health 
 
The sensing of both circulating and intracellular free AAs occurs through 
various mechanisms, at both the cellular and systemic levels. These two 
modes of AA-sensing determine many of the metabolic and physiological 
responses to fluctuations in AA availability.  
1.5.1	GCN2-dependent	detection	of	AA	limitation		
A metabolic response to limited AAs can only occur after their limitation is 
detected. In flies, nutrient perception involves chemosensory sensila, 
enteroendocrine, and gustatory signals (70). The consequences of the fly’s 
nutrient sensing can be uncoupled from its actual food intake, because 
stimulating odorant receptors can reverse the benefits of DR upon lifespan 
independently of food or protein intake (71). The fly’s selection of an AA 
source is partly mediated by the serine/threonine-protein kinase general 
control nonderepressible 2 (GCN2) acting in dopaminergic neurons in the 
brain (72). The mammalian central chemosensor detecting decreased 
circulating essential AAs is found in the brain’s anterior prepiryform cortex 
(APC) (73). Here, low levels of EAAs stimulate GCN2, which suppresses 
anabolism and promotes catabolism through the AA response (AAR) pathway 
(73-75) (Figure 1.2). This GCN2 activation is independent of the AA’s identity, 
because GCN2 senses the AA deficiency by binding non-specifically to any 
uncharged transfer RNA (73, 76). However, branched chain AAs, and in 
particular leucine, the most abundantly used AA in mammalian proteomes, 
appear to play a predominant role (77). Upon binding an uncharged tRNA, 
GCN2 changes its conformation to promote inhibitory phosphorylation of its 
primary downstream translation activator, the eukaryotic initiator factor 2 
alpha (eIF2α) (73). This leads to global down-regulation of transcription and 
translation through changes in mRNA levels or mRNA stabilization, growth 
arrest and reductions in lipid and carbohydrate anabolism, activation of AA 
transporters (e.g. asparaginase synthetase ASNS), and changes in neuronal 
glutamatergic activity, intracellular calcium and GABAergic signaling (65, 73, 
74, 78). A common downstream effector of GCN2 activation upon methionine 
or leucine restriction is fibroblast growth factor 21 (FGF21), which represses 
liver fatty acid synthesis and increases fatty acid mobilization (13, 79).  
Although GCN2 is a key modulator of the systemic response to decreased 
levels of circulating AAs, it is also expressed across tissues and may also act 
in a cell-autonomous manner (73). In rodents, three isoforms of GCN2 are 
found: α, β, and γ. The α and γ isoforms have no functional GI (GCN2/Impact)  
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Figure 1.2 
 
GCN2-dependent sensing of AA limitations. Extracellular amino acids (AAs) can activate their 
cognate tRNA, which is now available for ribosomal protein synthesis (LS=large subunit, 
SS=small subunit). In contrast, uncharged tRNAs bind to and activate by phosphorylation 
GCN2, which in turn phosphorylates eIF2α. This activates the eIF2 complex to stimulate 
ATF4, which induces FGF21 to trigger the amino acid response (AAR), which inhibits 
anabolic processes, and promotes catabolism (see main text). 
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domain to bind GCN2 to its activator GCN1, and are expressed tissue-
specifically, while β has a functional GI domain and is expressed similarly 
across tissues (76). However, mice lacking GCN2 specifically in the brain fail 
to show the normal aversive behaviour towards AA-imbalanced diets. AA 
sensing in the APC thus overrides peripheral GCN2 activity with regards to 
feeding behaviour (74). Therefore, low circulating AAs result in stimulation of 
the AAR pathway through the activation of GCN2, which orchestrates cell-
autonomous and non-cell autonomous effects to promote catabolism, 
suppress anabolism, and thereby induce a metabolic maintenance mode. 	
 
1.5.2	GCN2-independent	detection	of	AA	limitation		
Although much evidence supports a role for GCN2 in the sensing of ingested 
AAs, some studies cast doubt over its significance in the physiological and 
behavioural responses to AA-deficient foods. Recently, GCN2 has been 
shown to have no effect on the detection of AA-deficient diets in mice (80). In 
addition, sensing of AAs such as alanine or glycine in hypothalamic neurons 
also occurs via excitatory signals that are modulated within seconds from the 
moment an AA is supplied (81). Such response mechanisms are GCN2-
independent, as transcriptional changes modulated by GCN2 would likely 
require a longer time period. Indeed, some preliminary findings in GCN2 
knockout mice indicate that the response to methionine restriction is not 
dependent on GCN2 (13). Therefore, given the central role of the 
hypothalamus in modulating feeding behavior, obesity, and metabolism (82), it 
will be interesting to see how different ingested AAs give rise to an organism’s 
hypothalamic and consequent metabolic response to ingested AAs.  
Dietary AA restriction also regulates gene expression via multiple GCN2-
independent pathways, including transcriptional (e.g. Cxcl10) or post-
transcriptional (e.g. Dusp16) responses (74, 83). Although the molecular 
mechanisms behind the activation of such responses by low AAs are not 
known, such changes are able to increase catabolic processes and metabolic 
efficiency independently of the GCN2-mediated AAR response. For example, 
efficiency of AA uptake is increased by up-regulation of asparagine 
synthetase ASNS, or of plasma membrane AA transporters such as the 
neutral AA transporters SNAT2 and LAT-1 and the cationic AA transporter 
CAT-1 (65, 74, 84). Other GCN2-independent responses can include 
transcription factor adjustments (ATF2-5, C/EBP and other ATF/CREB TFs), 
and changes in ribosomal proteins that affect translation (65, 74, 84). 
Although GCN2 is the only kinase exclusively responsive to AA deprivation, 
phosphorylation of eIF2α can also be effected by other kinases including 
heme-regulated inhibitor kinase (HRI), double-stranded RNA-activated protein 
kinase (PKR), and PKR-like endoplasmic reticulum-resident kinase (PERK), 
and considerable overlap has emerged in the activation of downstream 
effectors between PERK and GCN2 upon methionine restriction in mouse 
liver (78). Moreover, internal ribosomal entry sites (IRESs), such as that in the 
CAT-1 mRNA, allow preferential translation by phosphorylated eIF2α, and the 
role of such IRESs in PERK or GCN2 activation also requires further 
characterization (78). Another GCN2-independent mechanism may involve 
the AMP-activated protein kinase AMPK, which senses low-energy states by 
detecting high AMP levels (85). AMPK functions both cell-autonomously and 
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non-cell-autonomously and is also activated upon low AA status (85, 86). 
Importantly, increased AMPK activation extends worm and fly lifespan (85). 
 
The dynamics of GCN2-independent responses can vary. As mentioned, 
sensing of supplied AAs by hypothalamic neurons can occur within seconds, 
thereby comprising a rapid response (81). In contrast, other modulators can 
vary across a wide range of time. For ASNS, a translational surge upon AA 
limitation is followed by a more sustained transcriptional activation (65). 
Moreover, plasma AA responses to dietary AA limitations indicate that the 
limited AA drops in the plasma initially, but after several days its levels are 
restored (87). As a response to an AA-imbalanced diet, growth and food 
intake depression also subside after several days (88), perhaps through 
reconstitution of hormonal homeostasis (discussed below). In contrast, short-
term responses relying on GCN2 do not require hormonal adjustments (73). 
However, some AA-sensing mechanisms require further elucidation. For 
example, eukaryotes detect misloaded tRNAs with different efficiencies 
depending on the identity of the AA (89). A domain in glutaminyl-tRNA 
synthetases allows the accurate sensing of loaded tRNAsGln to glutamine (89), 
but the metabolic or proteostatic causes and effects of such differential 
accuracies in correct tRNA loading, as well as related non-GCN2 signaling 
effects, are unclear. Thus, although several GCN2-independent responses to 
limited AAs have emerged, further clarification of the molecular mechanisms 
and characterization of the short- versus long-term responses is needed. 
 
1.5.3	Effects	of	AA	limitations	on	ageing		
All limitations or excesses of dietary AAs are sensed in a way that modulates 
anabolic and catabolic processes and, ultimately, homeostasis. Suppression 
of anabolism and growth signaling can extend lifespan and is induced by AA 
limitations. The identity of essential AAs is conserved between rodents and 
humans, and human cell culture work on AA limitations shows consistent 
results to murine cell systems implying conserved molecular mechanisms 
(90). In rodents, methionine and tryptophan limitations suppress anabolism 
and translation, and promote catabolic processes (13). Glucose, insulin, 
thyroid hormones, and IGF-I levels are also reduced in methionine-restricted 
mice. Yet, generally, low levels of circulating AAs reduce IGF-I function largely 
independently of their identity (91). Lack of the AA building blocks for anabolic 
traits also results in induction of apoptosis by IGF-I, which activates the 
apoptosis inducer CHOP (65). Stimulation of apoptosis aids the recycling of 
molecular building blocks, including AAs. Therefore, AA limitations deplete 
growth signaling and can thus induce a maintenance mode that benefits long-
term health. 
 
By increasing catabolism, methionine or tryptophan restrictions also reduce 
fat storage in rodents (13, 14). However, although across multiple organisms 
and humans DR results in leanness or rescue from obesity to confer multiple 
metabolic advantages that favour longevity, the role of fat loss per se in 
promoting health is not clear. For instance, diets low in protein increase 
adiposity in mice because of increased food intake, but these mice are as  
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Figure 1.3 
 
TOR-dependent sensing of AAs. Intracellular AAs activate TORC1 through multiple TOR-
associated factors (see main text for details). GAP - GTPase-activating protein; GEF - 
guanine nucleotide exchange factor (GEF) 
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healthy as DR mice (2, 3). Additionally, the ability of animals to maintain their 
adiposity despite DR appears to mediate the beneficial effects of DR (92). The 
decline of mTOR expression with age in rat white adipose tissue is also 
prevented by DR (93). Therefore, as the role of fat deposition in DR is 
unclear, and given that different types of fat affect health differently, the role of 
fat deposition in mediating the health benefits of protein or single AA 
restriction requires further investigation. 
 
1.5.4	TOR-dependent	detection	of	AA	abundance	
In mammals, the cell-autonomous AA response upon excess of AAs relies 
primarily on the mammalian target of rapamycin (mTOR), which occurs in two 
complexes, mTORC1 (rapamycin/nutrient sensitive) and mTORC2 
(rapamycin/nutrient insensitive). Absence of AAs results in the TORC1-
inhibitory recruitment of the tuberous sclerosis protein TSC2 onto the 
lysosomal membrane (94). Mechanisms of activation of mTORC1 in the 
presence of AAs are shown in Figure 1.3. Sensing involves a complex 
interplay between numerous molecules recruited in or around the lysosome, 
which is a key site of AA recycling, and intracellular/intravacuolar AA sensing 
(77, 95). Intracellular AAs prevent the inhibitory association of Sestrins with 
the GATOR2 complex (96, 97). This lowers GATOR1’s GAP activity upon Rag 
A/B, which is bound to Rag C/D and is important for the activation and 
translocation of TORC1 onto the lysosomal membrane (96). Intracellular AAs 
are taken into the lysosome by transporters such as SLC38A9, which has a 
particularly high affinity for arginine(98). This transport induces conformational 
changes in the endolysosomal V-ATPase, which dissociates from the 
Ragulator/Rag complex (98). The Ragulator then enables the activation of 
Rag A/B through its guanine nucleotide exchange factor activity (98)(88). 
Intracellular AAs can also promote the GTPase activity of the folliculin 
complex FLCN/FNIP (99), which results in the RagC/D complex being loaded 
with GDP, and stimulates Arf1 and Rab5, which are involved in intracellular 
trafficking inducing TORC1 activation (100).  
 
The identity of the AA also determines how it is sensed by TORC1. Leucine 
activates Rag A/B through Sestrin 2 (97), glutamine sensing involves Arf1 and 
the V-ATPase, but not Rag A/B, and arginine sensing involves SLC38A9 
(101). Other factors involved in TORC1 activation by AAs may involve the 
kinase Vps34 and SH3BP4 (95). Importantly, inhibition of mammalian TORC1 
activation extends lifespan and, although activated TOR is critical in regulating 
adiposity by inducing lipid synthesis (95), insulin resistance is effected 
primarily by mTORC2 (102). The interplay between TOR and AMPK in 
sensing AAs also requires further characterization. Inhibition of rat muscle 
mTORC1 with rapamycin has no effect on AMPK, but activation of AMPK 
suppresses mTOR signaling and insulin resistance (103). Accordingly, 
reduced AMPK activity precedes mTOR activation by glucose or leucine, 
leading to insulin resistance (103).  
 
As discussed for GCN2, not all AAs stimulate mTORC1 equally. In rodents 
leucine is a particularly strong activator (77). It has been reported that 
intracellular leucine is uniquely sensed by leucyl-tRNA synthetase (LeuRS), 
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which activates the mTORC1 complex (Figure 1.3) (104). Nonetheless, it is 
now known that Sestrin2 possesses a leucine pocket to bind to, and sense, 
cytoplasmic leucine levels (105). Some obese animal models deplete their 
circulating glucogenic AAs, leaving higher circulating sulphur (106) and 
BCAAs including leucine (15)), which can result in chronic TOR activation. In 
contrast, a low protein diet decreases circulating BCAAs and mTOR activation 
(3) and sensitizes animals to AA imbalances (26). Importantly, TOR activation 
can stimulate the secretion of hunger or satiety hormones in the GI tract and 
brain, such as ghrelin and leptin, respectively (24), and recent evidence 
suggests TOR is a mediator of the enteroendocrine hormonal responses to 
dietary proteins and AAs (107). Therefore a regularly high dietary intake of 
AAs induces chronic mTOR activation, which is detrimental to health and 
lifespan, whereas AA imbalances or limitations can inhibit TOR. However, 
TOR activation with respect to single AA modulations requires further 
elucidation both in invertebrates and vertebrates. 
 
1.5.5	TOR-independent	detection	of	AA	abundance	
Multicellular organisms have both intracellular and extracellular AA sensors, 
as well as neural sensors that respond to the intake of nutrients. Although 
TORC1 senses endocellular AAs and can stimulate satiety signals, in the GI 
tract extracellular AA sensors also play a prominent role. At least some 
mammalian G-protein-coupled receptors (GPCRs) are transceptors. 
Transceptors are transmembane transporters of nutrients, including AAs, that 
also act as receptors involved in inducing endocellular signaling. In mammals, 
GPCR receptors of the T1R family are activated mostly by L-AAs in the 
digestive tract (108), and even modulate TOR signaling independently of 
intracellular AA levels (66). Transmembrane GPCRs in enteroendocrine cells 
can stimulate the release of appetite-regulating incretins or decretins (104, 
109). Specifically, high luminal AA concentrations increase secretion of satiety 
incretin hormone GLP-1 by enterocytes (110). Additionally, in response to 
food or AA intake, density-, stretch-, and other chemo-receptors in the GI tract 
release neural signals of satiety to the CNS (55, 111). Cholecystokinin (CCK) 
is secreted in response to luminal AAs, and CCK receptors stimulate vagal 
afferent signals to the nucleus of the tractus solitaries (NTS) of the brainstem, 
which relays signals to the hypothalamus (111). Other secreted peptides by 
the GI tract or along the splanchnic bed include leptin, insulin, and peptide YY 
(PYY), which suppress appetite in response to bulk food intake or protein 
intake, while ghrelin increases it (111) (Figure 1.4). Furthermore, recent 
evidence strongly supports unique ingested amino acid-specific signaling to 
the CNS, involving vagal afferents and the area postrema (112). All the above 
responses have some degree of conservation between invertebrates and 
vertebrates as similar mechanisms are involved in the fly’s intestinal nutrient 
sensing (70). Thus, neural and hormonal modulations in the gut can function 
independently of intacellular AA sensing by TOR. In this way, ingested AAs 
trigger the release of hormones to regulate homeostatic processes in the 
whole organism (Figure 1.4).  
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Figure 1.4 
 
Sensing of dietary proteins and AAs along the gastrointestinal (GI) tract. Ingested AAs 
activate transceptors (e.g. GPCRs) that relay hormonal and neural signals of satiety to the 
brain. Protein or amino acid intake can also stimulate the secretion of a range of appetite 
suppressors including PYY, CCK, and GLP-1 (see main text). Such hormonal signals are 
targeted to the hypothalamus, which regulates a range of systemic and metabolic processes 
that are associated with homeostasis and health during ageing. 
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1.5.6	Responses	to	AA	surpluses	that	affect	physiology	and	ageing	
High protein diets increase satiety and decrease food intake in many 
organisms, including flies (29), mice (2), and humans (23), an effect referred 
to as ‘protein leverage’ (2), with the main driver of appetite a target protein 
intake. Therefore the reduced obesity and insulin resistance of animals and 
humans fed a high protein diet ad libitum can be explained by their decreased 
food intake (24). However, dietary AA-induced chronic stimulation of the 
IIS/TOR pathways is detrimental for health (3, 24, 86, 95, 113). In yeast and 
worms, AA restrictions can inhibit TOR and extend lifespan (5, 114, 115). 
Inhibition of TOR by rapamycin or of S6 kinase (S6K), a downstream effector 
of TOR, also extends fly and rodent lifespan (113). Another main effector of 
mTOR is the translation repressor 4E-BP, which is activated upon TOR 
inhibition by DR in flies (113) or methionine-restriction in rodents (116). In 
humans, high levels of protein or AA intake also result in TOR activation (24) 
and insulin secretion (23), while excess acidifying AAs or sulphur AAs also 
raise blood pressure (23). With ageing, mTOR activity in mouse hypothalamic 
neurons increases, silencing anorexic neurons and contributing to age-related 
obesity (16). Moreover, TOR function can affect diverse systemic processes, 
including cell and tissue growth signaling, immune function, proteostasis, 
neurodegeneration and cognitive function, tissue and stem cell physiology, 
and others (95, 113). Thus, activation of TOR by high AA intakes can in the 
long-term be detrimental for health, promoting age-related disease such as 
neurodegeneration (117).  
 
Although AAs promote growth signaling and TOR, excess AAs can also 
suppress growth, and therefore growth signaling, through antagonistic 
interactions. Mechanistically, this may occur if an AA is ingested in amounts 
that saturate specific AA transporters due to the AA’s higher abundance, 
substrate affinity, or kinetics. In this case, it is possible that in some tissues 
intracellular levels of out-competed AAs become limited, thereby triggering the 
AAR to inhibit anabolic processes. Specific examples of moderate additions of 
AAs inhibiting growth in rodents were discussed earlier. Unpublished data in 
our laboratory also indicate that moderate additions of AAs can inhibit growth 
or growth signaling in both flies and mice. Importantly, such inhibitions of 
growth signaling may also affect health and longevity. In worms, addition of 
some AAs extends lifespan significantly through TOR inhibition (114). 
However, the identity of the AA is important, as addition of some AAs in the 
worm’s diet had no effect, or even decreased lifespan drastically (114). In 
rats, an excess of threonine can be well tolerated but a similar excess of 
tyrosine can cause pathological lesions (26). Therefore the identity of the AA 
ingested in excess determines its effects upon health. More life-long studies 
will further clarify these interactions upon long-term health and ageing. 
 
1.5.7	Convergence	of	AA	sensing	pathways	
There are many interactions between the multiple nutrient and AA sensing 
pathways discussed above (83). Phosphorylation of some translation initiation 
factors by TOR changes their conformation to allow accessibility by other 
kinases or phosphatases (including GCN2 downstream effectors) (118). 
Protein synthesis inhibition by GCN2/eIF2α stimulation occurs in conjunction 
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with mTOR inhibition, and some cancer drugs deplete circulating AAs and 
trigger GCN2 to decrease mTORC1 signaling (119). In yeast, the AAR 
pathway is most responsive when mTORC1 is inhibited by rapamycin (76). In 
worms, there is also a convergence of GCN2 and TOR upon AA limitation 
towards inhibition of global translation and down-regulation of FOXO 
transcription factors (120). Stimulation of FOXO transcription factors 
modulates the life-extending effect of IIS downregulation across species (5, 
16). Therefore, the orchestration of these two nutrient sensing pathways (TOR 
and GCN2) modulates AA sensing, although a detailed characterization of this 
interaction, especially with respect to individual AAs, remains to be 
established. 
 
1.5.8	Food	aversion,	protein	leverage,	and	growth	signaling		
Because imbalanced protein sources prevent the usage of excess and 
therefore total AAs, adequate protein intakes can be achieved with lesser 
amounts of high quality protein than of low quality protein. In order to achieve 
the target AA intake as driven by protein leverage, a less usable protein will 
therefore be consumed in greater amounts than a highly usable protein. For 
instance, whey promotes growth more than does casein, and also induces a 
higher satiating effect in humans (121, 122). However, imbalanced AA 
sources can result in deficiencies for specific essential AAs, and so animals 
must also have protective aversive responses to direct them to alternative, 
balanced AA sources (27). Thus the motive for increasing the intake of an 
imbalanced AA diet to achieve a target protein consumption may conflict with 
the motive to avoid a detrimentally imbalanced AA intake. The thresholds 
distinguishing between such conflicting motives are unclear, as is the impact 
of the imbalanced AA’s identity on such effects.  
 
Rodents are more sensitive to limited than they are to excess AAs. Very small 
AA limitations are detectable by rats, representing a 0.009% w/w change in 
the diet (73). Such limitations are not reflected in the plasma, but are seen in 
the APC region within 15 minutes of feeding on the imbalanced diet, resulting 
in loss of appetite (73). In contrast, growth suppression is detectable upon 
changes that represent >0.1% w/w of the limiting AA in the diet (26). In 
addition, ad libitum fed rodents on severely AA-limited diets decrease their 
food intake and growth but, if the animals are made to eat equal amounts, 
growth returns to normal (26). Therefore, appetite is more malleable in 
response to ingested AAs than is growth signaling. Moreover, responses to 
ingested AAs also depend on the identity of the imbalanced AA. Restriction of 
specific AAs (lysine, threonine, or isoleucine) alters food preference but not 
food intake in rats (73) . In mice, excess consumption of some AAs (e.g. 
methionine, tryptophan) suppresses food intake and growth more than does 
excess intake of others (e.g. threonine) (26). Therefore, the response to an 
imbalanced AA ingestion depends on the AA identity and on the physiological 
(e.g. growth) or behavioural (e.g. appetite, food choice) trait assessed. Further 
understanding of these aspects and interactions will be important in 
elucidating how AA modulations regulate metabolism and ageing, and in 
designing nutritional applications for humans. 
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1.5.9	Distinct	bioenergetic	and	metabolic	roles	of	amino	acids		
Because of their different molecular structures, free AAs are broken down 
through distinct biochemical reactions. According to their catabolism, AAs can 
be glucogenic (all AAs except lysine and leucine), leading to the generation of 
glucose, or ketogenic (lysine, leucine), resulting in ketone bodies, although 
some AAs can be both (isoleucine, threonine, phenylalanine, tyrosine, and 
tryptophan). Glucose and ketones are the body’s main energy sources, and 
cellular energy production from AA catabolism can represent 10-15% of total 
energy production (23). Importantly, the energy density of glucose is typically 
lower than that of ketones. Moreover, the energy expenditure for the 
metabolism of different AAs varies. Glutamate is the most energetically 
efficient AA (123), which may explain the central role of glutamate in providing 
TCA cycle precursors (67). Each AA also has a different metabolic efficiency 
for anaplerotic reactions, i.e. reactions that produce TCA cycle intermediates 
from precursors including AAs. Therefore, the metabolism of specific AA can 
uniquely affect energy homeostasis, which may impact on ageing. In worms, 
dietary supplementation with the ketogenic beta hydroxybutyrate (114), the 
ketone derivative α-ketoglutate (124), or with several TCA cycle metabolites 
extends lifespan (114). This longevity gain in worms is thought to be mediated 
by anaplerotic reactions (114, 124). The energy sensor AMPK senses and 
modulates the metabolic and energy homeostasis changes of these long-lived 
worms, and the DAF-16/FOXO pathway is also activated by higher levels of 
TCA cycle intermediates (114).  
 
The ketogenic or glucogenic potential of ingested AAs may also affect long-
term health and ageing in rodents and humans. In mice, highly ketogenic diets 
reduce the catabolism of ketogenic AAs to prevent further ketogenesis, but do 
not alter lifespan (12). However, a modest increase in the intake of ketogenic 
compounds may be beneficial for mouse lifespan. Increasing the intake of the 
ketogenic AA leucine contributes to the mouse lifespan extension by BCAA 
supplementation (125), while in a mouse cancer model two different ketogenic 
compounds, butanediol and ketone ester, significantly increased survival 
independently of DR (126). In humans, ketogenic or leucine-supplemented 
diets may decrease food intake, adiposity, insulin resistance, sarcopenia, and 
cognitive deterioration with age (127-130). However, the TCA cycle is 
amphibolic, i.e. it is both anaplerotic and cataplerotic. This makes it difficult to 
quantify its bioenergetic modulations upon intake of different AAs. Therefore 
ketogenesis, TCA metabolite levels, and energy flux are coordinated by 
different AA ingestions to induce health and longevity gains across species. 
However, more investigations are needed to further elucidate how AA 
catabolism impacts on health and ageing through such modulations. 
 
1.5.10	Health	biomarkers	of	specific	AA-imbalances	
The AA profile of a dietary protein is generally the primary determinant of the 
protein’s nutritional value. Several studies have identified effects of different 
dietary proteins with distinct AA profiles upon health and ageing. Soy and 
whey proteins improve a range of health markers and longevity, including 
increased insulin sensitivity and reduced adiposity (Table 1.1). In contrast, 
milk or casein proteins increase circulating IGF-I, insulin, and satiety 
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hormones compared to other protein sources, and such chronic IIS over-
stimulation can be detrimental for ageing (Table 1.1). The molecular 
mechanisms mediating the effects of such different protein sources implicate 
their AA contents. Soy (Figure 1.5A) and whey (Figure 1.5B) proteins are low 
in methionine and tryptophan content (1, 131), while casein has a higher 
methionine content than soy protein (Figure 1.5C). Tryptophan (132) and 
methionine (13) promote growth hormone (GH) secretion, so diets with lower 
levels of these AAs decrease IGF-I, thereby promoting long-term health (131). 
Whey protein is also high in the BCAAs leucine and isoleucine (Figure 1.5B), 
which may explain its growth-promoting and appetite-suppressing effects in 
animals (122), and its prevention of muscle loss in older humans (129). Egg 
protein is a high-quality protein for growth (122), but is not necessarily optimal 
for long-term health as it causes high postprandial levels of circulating glucose 
accompanied by a low appetite suppression effect (121). Therefore specific 
protein sources with distinct AA profiles can down-regulate IIS and increase 
healthspan and longevity.  
 
Other endocrine modulations involve thyroid hormones, with soy protein 
lowering parathyroid (PTH) hormone secretion (Table 1.1), which in humans 
is linked to BMI and mortality, at least under some pathological conditions. 
Along with growth hormones, secretion of thyroid hormones is also reduced 
by DR (6) and tryptophan restriction (14). In mice, increased plasma levels of 
BCAAs are associated with decreased lifespan (3), but high dietary BCAAs 
have also extended lifespan presumably through different protective 
mechanisms (125) that require more detailed investigation. In humans, 
increased plasma BCAAs are linked to insulin resistance and type 2 diabetes 
(133).  	
Fish protein is also linked to human health benefits, including increased 
insulin sensitivity and reduced circulating low-density lipoproteins (Table 1.1) 
(23, 24). A comparison of the AA content in >10 fish species shows that the 
two most limiting AAs in fish are tryptophan and methionine (Figure 1.5d), with 
cysteine as the most limiting non-EAA. Some long-lived human populations, 
like Okinawans, Sardinians, or Ikarians (134) are located in areas were fish is 
a predominant protein source (135, 136). Thus it is tempting to draw a link 
between the reduced sulphur AAs and tryptophan and the insulin sensitivity 
and lifespan-extension observed in these populations.  	
In humans, several cohort studies show that high intakes of animal protein, 
which is typically methionine-rich, are positively associated with chronic and 
age-related disease, and this association is abolished when the dietary 
protein source is plant-based (11). However, the age of an individual also 
determines the health response to the ingested protein (11), as discussed 
below. 	
The bioenergetics of different AA sources may also contribute to health 
effects. The metabolic efficiency of different dietary proteins integrates their 
AA composition and the energy used in the catabolism of each AA to produce 
one ATP molecule (123). A comparison of the metabolic efficiency of different		
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Table	1.1	
 
List of findings relating dietary protein sources to healthspan and lifespan, including effects 
upon the IIS and TOR pathways, and on circulating metabolites linked to health-related 
parameters(23, 24, 30, 121, 130-132, 137-144).  			
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Figure 1.5 
 
A) Four published soy EAA profiles show considerable batch-to-batch variability and low 
levels of tryptophan and methionine. Molar proportions are shown. 
 
B) The essential AA proportional representation in three published whey profiles. Five of 
the essential AAs, including methionine and tryptophan, are particularly low, but leucine is 
higher than in soy, fish, or casein proteins. 
 
C) Six bovine casein EAA profiles indicate differences between casein sources within 
the same species (Bos taurus), low contents of tryptophan, and higher levels of methionine 
compared to whey or soy proteins. 
 
D) An analysis of the AA profile of ten teleost fish species indicates limitations in 
tryptophan, histidine, and methionine. However, due to the severe limitation in cysteine, the 
limitation of methionine likely surpasses that of histidine, making methionine the second most 
limiting AA. Also, a lower leucine level is seen compared to soy, whey, or casein proteins. 
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dietary proteins shows that proteins linked to beneficial effects for healthspan 
and lifespan in animals and humans (Table 1.1) tend to have an essential AA 
profile that has a higher metabolic efficiency (Figure 1.6a). The calculated % 
energy efficiency is lower for lactalbumin, egg, and casein, and higher for soy 
and fish proteins. Therefore it is possible, although not yet established, that a 
link between metabolic efficiency of AA catabolic reactions and health exists.  
 
Interestingly, in the two recent DR primate studies, the WNPRC diet had 
higher contents of tryptophan and BCAAs (lactalbumin) than the NIA diet 
(fish-soybean-wheat-corn-alfalfa) (Figure 1.6b). Milk and dairy proteins such 
as lactalbumin can induce TOR activation and insulin resistance in humans 
(24, 132). Thus, AA intake differences between the two studies could 
contribute to differences in mortality and cancer incidence, as a higher intake 
of BCAAs and tryptophan could have lead to a chronically higher TOR/IIS 
stimulation (5).  
 
In conclusion, a number of observations suggests an important role of dietary 
AA intake upon health and ageing in humans.  
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Figure 1.6 
 
A) The calculated % energy expenditure for the production of one ATP molecule based 
on non-integral P/O ratios (Milgen 2002), shown for the essential AA composition of five 
common types of dietary protein: lactalbumin, egg, casein, soy, and fish. Differences are due 
to the range of carbon chain and cofactors that result from essential AA catabolism. Some 
protein sources associated with health benefits (Table 1.1) appear to have a proportionally 
higher metabolic efficiency than proteins associated with detrimental effects. 
 
 
B) Comparison of the mean EAA content (from published data) of the six protein 
sources used in the two primate studies (see main text for discussion). Lactalbumin has a 
particularly high content in tryptophan and isoleucine, as well as leucine. 
 
 
 
 
 
 
 
 
 
 
	 43	
1.6	Optimal	amino	acid	intake	
 
1.6.1	Variation	in	requirement	for	amino	acids.	
The AA needs of individuals, populations, and species, are influenced 
dynamically by internal state and environmental factors. The main sources 
leading to variation in AA requirements are discussed here. 
 
Although not much studied beyond inborn errors of metabolism, genetic 
background across and within species impacts greatly on the response to AA 
consumption. Inter-strain variability for the requirement of some AAs (e.g. 
glycine) has been shown to be significant in Drosophila (145). In rodents and 
humans, genetic background profoundly affects body size, AA requirements, 
and food intake (4, 28). Wild strains of worms and flies live longer upon DR 
(146), and mice of different strains respond diversely to a single DR regime 
(147). The genetic background may also contribute to differences in the DR 
response observed in the recent primate studies (5). Single DR regimes do 
not indicate the response of a mouse strain across different restriction levels 
(2), but do suggest that genetic constitution profoundly impacts on the 
response to reduced intake of nutrients including AAs. Some recent 
approaches assess single nucleotide polymorphisms (SNPs) to identify 
specific genes and to explain how genetic variation in inbred mouse 
populations determines traits of interest (148). Similar approaches could be 
employed to evaluate the role of genetic determinants in the DR response, 
both in rodents and in humans. Such information will inform our understanding 
of how natural genetic variation predisposes the DR response both in model 
organisms and in humans, and even aid the design of individualized 
nutritional interventions. 
 
All growing or reproducing mammals, including humans, have higher AA 
requirements than adults (25, 28). Consequently young children are more 
susceptible to protein malnutrition and related diseases such as Kwashiorkor. 
For laboratory animals there is a clear distinction between diets optimized for 
breeding or growth stages versus diets optimized for long-term maintenance 
(28). Adjusting the dietary protein supply to match AA requirements with age 
promotes health and longevity. Providing high dietary protein to young 
animals and lower to mature ones extends lifespan in rats (9, 149) and mice 
(6). In rodents, protein absorption reduces with age as older rats show a 
decreased ability to digest proteins and AAs (150). Moreover, mature rodents 
fail to show some of the adverse effects of ingesting AA-imbalanced diets (26, 
27). Accordingly, BCAA stimulation of the IIS/TOR pathways is greater in 
younger, not older, animals (84). Therefore it is not surprising that early onset 
DR extends rodent lifespan significantly (151), but late onset DR is less 
effective (6). The protein source during early life also impacts on health during 
ageing. Although milk protein can chronically over-stimulate IIS and contribute 
to insulin resistance (Table 1.1), restriction of milk-protein during weaning only 
can significantly increase mouse lifespan (152). Requirements for AAs may 
also change qualitatively as an animal physically matures. Some evidence in 
mice suggest subtle changes in the body’s AA composition with development 
(153). In humans, a low protein intake appears to benefit groups of 50-65 
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years of age, but may be detrimental when applied to older ages (11). 
Therefore, it is clear that age and life stage can affect both the requirement for 
AAs, and the response to AA intakes. 
 
The EAA requirements of individual cells or tissues can vary depending on 
tissue-specific AA metabolism. For example, enterocytes secrete threonine-
rich proteins, so require a higher threonine intake than other cells (48, 56). 
Hepatocytes require high levels of methionine to serve many transulfation, 
transmethylation, and folate metabolism reactions (56). The type and 
abundance of AA transporters also determines which AAs enter readily into 
which cells. These aspects require further study in conjunction with more 
systematic analysis of tissue-specific usage of individual AAs. 
 
In humans, gender defines AA requirements as males require more AAs than 
non-pregnant females, which reflects body size differences to an extent (4, 
25). Beyond inborn errors of metabolism, the maintenance of health requires 
adequate AA supply, as multiple immunological processes depend on AAs, 
and an imbalanced AA intake can suppress the immune system (21). Indeed, 
the efficiency of the immune response declines and the susceptibility to 
infections increases upon low AA intake (4). Thus, it is possible that infectious 
or disease conditions that increase the function of immunological processes 
may raise dietary AA requirements (21). In the future, more work is required to 
understand how specific disease states increase the requirement for specific 
AAs. 
 
In addition, healthy physical activity increases the metabolic rate and 
promotes protein degradation, AA oxidation, and depression of protein 
synthesis in humans, thereby increasing AA requirements (4). The metabolic 
rate of individuals can also be modulated by environmental conditions, as 
lower temperatures can increase the metabolic rate in endothermic animals 
(4). Similarly, seasonal increases in day cycle duration can promote physical 
activity, thereby increasing the metabolic rate particularly at younger ages (4). 
Such increases in metabolic rate also translate in increases in AA 
requirements.  
 
In summary, numerous findings from different branches of nutritional research 
clearly indicate that both environmental and internal state factors must be 
considered when estimating of AA requirements. 
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1.7	Conclusions	
 
Identifying beneficial AA intakes can lead to improvements in human nutrition. 
In human populations, health benefits for older age groups mirror most 
mortality gains, and late life dietary interventions based on AA intake are 
beneficial (11). As AA intakes are critical to the DR response, dietary AAs 
provide a powerful intervention strategy for human health. Indeed, recent 
evidence shows that a fasting mimicking diet based on a limited plant-based 
AA intake benefits human health (18). Such dietary manipulations comprise a 
drug-free way of intervening towards healthy ageing. Moreover, nutritional 
efficiency can have diverse applications within our societies, as it can help to 
end starvation, to devise tools against obesity and disease, to enhance 
produce yield in the food industry, and to assist patients in numerous clinical 
applications including cancer.  
 
 
1.8	Outstanding	questions	addressed	in	the	current	thesis	
 
The work described in this thesis addresses some of the unresolved issues in 
the field of dietary protein and amino acids, metabolism, and ageing. More 
specifically, the following questions are addressed: 
 
1. What defines dietary AA requirements - can they be approximated by 
the organism’s exome AA usage? To answer this question several 
anabolic traits were assessed in flies and mice including developmental 
rate and viability, growth rate, fecundity, and lean mass accretion 
(Chapters 3 & 4).  
 
2. Is the exome a better measure of AA requirements than other, 
commonly used measures of estimating AA needs, than commonly 
used AA sources, or than the weighted whole body proteome? A 
comparison of several historically accepted measures of defining AA 
requirements, as well as a direct comparison of the exome versus the 
weighted proteome AA profiles, was carried out focusing on anabolic 
traits both in flies and mice (Chapters 3 & 4). 
 
3. Can the exome AA supply be used to quantitatively predict 
physiometabolic phenotypes? To address this point, models were 
designed for the prediction of the limiting dietary AA in exome-
mismatched diets, and their accuracy in predicting an anabolic trait 
response (notably a fecundity response in flies) was examined 
(Chapters 3 & 4). 
 
4. What are the behavioural and physiometabolic consequences of 
matching the dietary AA supply to the exome, against commonly used 
(exome-mismatched) dietary AA supplies? To address this point, 
several bahavioural, physiological and biochemical aspects were 
assessed in both flies and mice. These included food preference, food 
intake, fat metabolism, nutrient sensing, proteostasis, respiration rate, 
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glucose and glycogen homeostasis, nitrogen balance, bone mineral 
density, and others (Chapters 3 & 4). 
 
5. Do any physiometabolic effects of an exome-matched AA supply affect 
ageing? To address this point, survival analyses were carried out in 
flies comparing the exome-matched diet to a range of exome-
mismatched diets (Chapter 3). 
 
 
1.9	Summary	points	list	
 
1. Even with adequate intake of macronutrients, the protein and amino 
acid content of the diet are critical for health during ageing 
 
2. An imbalanced supply of amino acids occurs when the requirement for 
dietary amino acids, usually determined by their effects on anabolic 
traits, is not matched by their intake 
 
3. This requirement is affected by multiple factors including genetic 
diversity, gender, age, and health status 
 
4. Amino acid absorption and availability is determined by the gut 
microbiota, the amino acid’s identity, and first pass metabolism 
 
5. Ingested and systemically available AAs are sensed by various 
mechanisms, involving TOR, GCN2, GPCRs, and other sensors 
 
6. Excess intakes of amino acids can over-stimulate growth signaling, 
which can be chronically detrimental and decrease longevity 
 
7. Limiting or imbalanced intakes of amino acids can down-regulate 
growth signaling, inducing a maintenance mode 
 
8. Experimental animal models can inform human nutrition, increasing our 
understanding of how AA intakes affect human health and ageing 
 
9. This thesis addresses several unresolved questions around dietary AA 
requirements, and the effect of a diet upon behavior, physiology, 
metabolism, and ageing 
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Chapter	2:	Materials	and	Methods	
2.1	Materials	and	methods	for	fly	experiments	
2.1.1	Media	and	flies	
In all experiments except otherwise indicated, we used our laboratory stock of 
outbred wild-type D. melanogaster, Dahomey. Flies were maintained in large 
population cages or in multiple glass bottles with overlapping generations at 
25 °C with a 12 h:12 h light:dark cycle. Flies wDah; Df(3L)ilp2-31, ilp5 deletion 
mutants (lacking (ilp2, ilp3 and ilp5) and Wolbachia-positive white Dahomey 
(wDah) controls are those previously reported (154). Dilp flies were 
backcrossed into the genetic background of their control for at least six 
generations prior to experiments. 
For all experiments using adult flies, other than specified development 
assays, flies were reared on sugar, yeast food (155). Holidic media were 
prepared as previously described (156). 
To generate age-synchronized adult flies, larvae were allowed to develop on 
SY food at standard density, transferred to fresh SY food upon emerging as 
adults and allowed 48 h to mate. Under light CO2 anesthesia, females were 
separated from males and allocated to treatment vials at a density of ten flies 
per vial. Flies were transferred to fresh vials three times per week at which 
point deaths and censors were scored. Egg-laying was scored after flies 
occupied vials for ~18 h, and the value was expressed as the number of eggs 
per vial per female. 
 
2.1.2	AA	ratio	calculations	and	diet	design	
We account for deficiencies in the conditionally EAAs, tyrosine and cysteine, 
by reducing the molar availability of their precursor essential amino acids, 
phenylalanine and methionine respectively, by one mole per mole of amino 
acid required. Methionine (M) is typically limiting in casein, however the batch 
used in our analysis was particularly limiting in tryptophan (W), another 
common limiting EAA in casein (157), thus making W as limiting as M in this 
ratio, when accounting for casein’s cysteine deficiency using our above 
conversion. The soy protein composition was calculated from several reported 
soy protein compositions (158-161). 
In flies, the whole larval body ratio was adopted from previously published 
data (162). The second instar larval ratio (L2AA) was selected for this 
comparison rather than the third instar larval ratio as the later was more 
limiting for tryptophan (rW(min)=0.026) than the former (rW(min)=0.031). 
To enable comparisons, all diets were isocaloric, with constant micro- and 
macro- nutrient compositions (except for AAs), isonitrogenous, and with 
constant total mass and total moles of amino acids. Moreover, as under 
normal conditions in eukaryotes AA catabolism accounts for 10-15% of total 
energy production in the cell, we also considered that each AA’s utilization 
towards ATP formation requires greatly different energy expenditures due to 
the variety of intermediate metabolic steps for each AA’s catabolism (23). 
Thus we also ensured equal metabolic efficiency values across all tested 
ratios on the basis of recent biochemical data on energy expenditure of 
nonintegral P/O ratios (123). Therefore MouseAA is 1% less energetically 
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efficient than mSILACAA, and 2% less efficient than the mMMAA and the 
NRCAA, while it is 1% more efficient than CaseiAA. 
To predict the most limiting essential amino acid in a diet, the proportion of 
amino acids in the food was divided by the proportional representation of 
amino acids in the translated exome of the consumer. The essential amino 
acid with the lowest value after this transformation was considered limiting. If 
the requirement for either of the conditionally essential amino acids tyrosine or 
cysteine exceeded the available supply, their requirement was met by 
subtracting a mole of phenylalanine or methionine, respectively, for each mole 
of amino acid to be synthesised. To design MMAA, the Euclidian distance 
from HuntAA to FlyAA in 20 dimensional space (1 dimension per amino acid) 
was determined. Another point, MMAA, that the found that was equidistant 
from FlyAA as HuntAA, but as far away as possible from HuntAA. 
 
2.1.3	SILAC	proteome	amino	acid	usage	
Using the weighted amino acid composition of set of proteins expressed in a 
tissue or organism (the proteome) would provide a better approximation of its 
amino acid content and provide more data for diet optimization. In this line, we 
used published mass spectrometry based proteomic data (163) in order to 
calculate protein copy numbers and the corresponding weighted amino acid 
composition.  In order to calculate the protein copy numbers we used the 
Total Protein Approach, a label free quantification method which relies on the 
proportionality between protein abundance and its mass spectrometric signal 
(164). This method was initially developed for the quantitative analysis of 
cancer tissues and was shown to perform well in the calculation of protein 
copy numbers of label free or stable isotope labeled standard proteins (165).  
The raw data from published proteomic studies on fly (163) and mouse (166) 
was reanalyzed. Protein identification was carried out using MaxQuant (167) 
version 1.4.1.2 using the integrated Andromeda search engine (168). For fly, 
the raw data were searched against the gene translations fasta database 
(release FB2008_05), downloaded from Flybase, 
ftp://ftp.flybase.net/releases/FB2008_05/dmel_r5.8/fasta/dmel-all-translation-
r5.8.fasta.gz, 21,070 entries. For mouse, the gene translations fasta database 
(release 54) was downloaded from Ensembl, 
ftp://ftp.ensembl.org/pub/release-
54/fasta/mus_musculus/pep/Mus_musculus.NCBIM37.54.pep.all.fa.gz, 40732 
entries. For the protein identification from the raw proteomics data, the fasta 
databases were automatically complemented with sequences of 
contaminating proteins by MaxQuant. For peptide identification, cysteine 
carbamidomethylation was set to “fixed” and methionine oxidation and protein 
N-terminal acetylation as “variable” modifications. For in silico digestion the 
enzyme was set to “LysC/P” allowing for cleavage after lysine, also when 
followed by proline with a maximum of two missed cleavages. The minimum 
number of peptides and razor peptides for protein identification was 1; the 
minimum number of unique peptides was 0. Protein and peptide identification 
was performed false discovery rate (FDR) of 0.01. The “second peptide” 
option was on allowing for the identification of co-fragmented peptides. In 
order to transfer identifications to non-sequenced or non-identified peptides in 
the separate raw files, the option “Match between runs” was turned on using a 
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“Match time window” of 1 min and “Alignment time window” of 20 min. Protein 
copy numbers per 1g of total protein were derived using the label free 
quantification based total protein approach (TPA) (164, 165). Protein copy 
numbers were calculated from the protein intensity data from MaxQuant’s 
ProteinGroups.txt output file. As MaxQuant reports identified proteins in 
groups when the presence of individual protein sequences cannot be 
unambiguously inferred, only the first protein ID in a protein group was used. 
For each mouse tissue or whole fly experiment only proteins that had 
recorded mass spectrometric intensity more than zero were used for analysis. 
For the whole fly data, the combined (heavy and the light SILAC) signal from 
the proteins was used. For the mouse data, only the light SILAC signal was 
used. Protein copy numbers (per 1g of total protein) were calculated by 
dividing the protein intensity values by the total intensity of all identified 
proteins. This value, which corresponds to protein concentration measured in 
mol per gram total protein, was divided by the protein MW arriving at protein 
copy numbers per 1g of total protein. Next, the protein copy number was 
multiplied by the number of each of the 20 amino acids arriving at the total 
amino acid numbers for each protein (data not shown). These latter values 
were used to calculate the total amino acid quantities for a mouse tissue or a 
whole fly and the respective weighted amino acid proportions (data not 
shown).  
 
2.1.4	Measuring	development,	body	mass,	egg	laying	and	lifespan.	
For development assays, young age-matched flies were allowed to lay eggs 
on grape juice plates overnight. 24 h later, first instar larvae were picked onto 
holidic media, pre-warmed at 25 °C. The eclosion time of adults was scored 
daily at 24-hour intervals, and viability was calculated at the end of the 
experiment as the % of larvae eclosing. Approximately 50% of all eclosions 
were male and 50% female. For the body mass measurement in flies, 
approximately 20 pairs of 10-day old flies per treatment were allocated into 
0,5ml Eppendorf tubes. Body mass was measured with the use of a 
microscale (Sartorius ME235S genius balance). Developmental viability was 
defined as the proportion of picked eggs eclosing successfully. 
For lifespan assays, we generated age-synchronized adult flies: larvae were 
allowed to develop on SY food at standard density, transferred to fresh SY 
food upon emerging as adults and allowed 48 h to mate. Under light CO2 
anesthesia, females were separated from males and allocated to treatment 
vials at a density of ten flies per vial. Flies were transferred to fresh vials three 
times per week at which point deaths and censors were scored. Egg-laying 
was scored after flies occupied vials for ~18 h, and the value was expressed 
as the number of eggs per vial per female. For mortality analyses, 1000 flies 
were allocated into 10 bottles of 100 flies each, and flies were transferred into 
fresh bottles three times per week as for vials. 
2.1.5	Fly	tissue	dissection	
Flies treated in the respective diets were immobilized on ice after 8 days of 
treatment (10 days of adult age) unless otherwise stated. Head and thorax, 
abdomen, fat body and digestive tracts of Drosophila were manually dissected 
in PBS with the use of fine forceps.  
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2.1.6	Fly	protein	extraction		
10-day old flies treated in the respective diets were homogenized in 300 µl of 
RIPA buffer (50 mM Tris-HCl, pH 7.4, 1% NP-40, 0.5% Na-deoxycholate, 
0.1% SDS, 150 mM NaCl, 2 mM EDTA, 50 mM NaF) and centrifuged for 5 
min at 13,000 rpm (4°C). The supernatant was collected as the protein 
fraction. 
2.1.7	BCA	Protein	Assay	
The bicinchoninic acid (BCA) assay (Thermo Scientific, PierceTM BCA 
Protein Assay Kit 23225) was used for protein measurements. 25µl of fly 
homogenate (the number of flies/tissues used for each experiment indicated 
in captions) as well as 8 dillutions (0, 125, 1250, 500, 750, 1000, 1500 and 
2000µg/ml) of protein standard (BSA) to plot the standard curve were 
transferred to a 96-well plate. Absorbance was measured at 562nm. 
2.1.8	Western	blot	
Extracted protein was subjected to Tris/Glycine/SDS polyacrylamide 
electrophoresis and transferred to nitrocellulose membranes using a 
criterionTM blotter (Bio-Rad) for 1 h at 100 V. After blocking with TBST milk 
(50 mM Tris, 150 mM NaCl, 0.05% Tween20, 5% milk powder) the membrane 
was incubated with primary and subsequently secondary antibodies. The list 
of utilized primary and secondary antibodies indicated in the table below. An 
ECL (Enhanced Chemi-Luminescence) reaction was performed using 
Amersham ECL Select Western Blotting Detection Reagent (RPN2235, GE 
Healthcare Life Sciences). Imaging was performed using the ChemiDoc MP 
System, Biorad. 
 
Table	2.1:	list	of	primary	and	secondary	antibodies	used	in	this	study 
 
Antibody name Company, product nr. Origin Concentration
Atg8 Custom-made Rabbit 1:1 000
eEF2 CST 2332S Rabbit 1:1 000
P-eEF2 CST 2331S Rabbit 1:1 000
nonP-4E-BP1 CST 4923 Rabbit 1:1 000
P-4E-BP1 CST 2855S Rabbit 1:1 000
LC3 MBL PM036 Rabbit 1:1 000
20S alpha proteasome subunit Santa Cruz Biotech sc-65755 Mouse 1:1 000
Ref2P Abcam ab178440 Rabbit 1:1 000
K48-linkage Specific Polyubiquitin CST 4289 Rabbit 1:1 000
Alpha Tubulin Sigma T9026 Mouse 1:1 000
VDAC Merck Millipore MABN504 Mouse 1:1 000
anti-Mouse IgG (H+L) Secondary 
Antibody, HRP conjugate G21040, Life Technologies Goat 1:10 000
anti-Rabbit IgG (H+L) Secondary 
Antibody, HRP conjugate G21234, Life Technologies Goat 1: 10 000
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2.1.9	Proboscis	Extension	Behaviour	(PEB)		
PEB assays were set up with 5-10 females per vial, for 10 vials (50-100 flies) 
per treatment, as previously reported (11). The flies were observed on several 
days for a period of 90 minutes, with feeding events recorded every 10 mins. 
Each assay was repeated >3 times on mated females every 2-3 days from 
day 3 to day 10 of age. The assay was carried out in a standard conditions 
behavior assay chamber (25°C / 65% humidity). Data points shown represent 
distinct biological replicates, each representing the mean of more than three 
90-minute average values per treament at ages 3-10 days. 
 
2.1.10	Blue	dye	assay	
Food intake across the dietary AA ratios was quantified using blue-stained 
holidic media as previously described (169). For each assay, 50 mated female 
flies were placed in vials of 5-10 flies for each treatment. PEB assays were 
carried out, and at 10 days of age, following 2 days mating in 1SY media and 
8 days on the respective holidic diet, the PEB-flies were used in the Blue Dye 
Assay. Flies were transferred into fresh vials containing Erioglaucine disodium 
salt (EDS) blue dye for exactly 30 minutes. Flies were then frozen and 
homogenized, and absorbance of the homogenate was measured at 629 nm 
along standards as previously described (169). Data points shown represent 
distinct biological replicates, each representing the mean of a trial of 50-100 
flies per treament, at age 10 days. 
 
2.1.11	Dietary	preference	assay	
The apparatus used for the dietary preference assays is a modified version of 
that described in (170), which enables the experimental flies to choose 
between 4 vials containing a medium. We used a prototype scaled-down 
version of the chamber for 40 flies (we thank Wilfried Haider from the Max 
Planck Institute for Metabolic Research, who designed and constructed the 
chambers), and tested diet preference, population effects and time-monitoring 
to determine the experimentally optimal conditions. To avoid side-bias, the 
chamber was enclosed in a polysterene container, which only allowed diffuse 
light to enter the chamber, precluding light-dependent behaviour and 
eliminating spatial or other environmental cues (including temperature 
variations), while experiments were also reproduced with the chamber rotated 
hourly by 90°. Each assay differentiated between two diets only, each set 
placed diagonally. All the media used for the food choice assay were 
prepared according to recently described holidic medium recipies (156). All 
media contained the same quantities of all other nutrients (sugar, cholesterol, 
vitamins, ions, nucleic acids, etc. (156). 
The dietary preference assay was carried out in female flies only. Drosophila 
undergoes a dietary switch after mating leading to increased preference for 
protein-enriched diets (171). Therefore, after emergence, females were mated 
for two days and were then treated with a diet lacking all AAs (0N) for 3 days. 
Following this, 5 day-old females were used for assessing dietary preference. 
Flies were sorted under light CO2 anesthesia, and were placed in the 
apparatus. Each assay used 40 females, and flies where acclimatized in the 
chamber and allowed time to settle on the diet of their choice overnight for 
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approximately 14 hours before the start of preference measurements. This 
amount of time (14 hours) was previously found to be adequate for the 
detection of dietary preferences in females in this set up (unpublished data). 
To avoid any disturbances in the feeding behavior, measurements started in 
the morning and readings were taken hourly for ~8 hours. A strong positive 
correlation has been established in our set-up between the number of flies in 
a food surface and the number of flies feeding (as determined by proboscis 
extension behavior, data not shown). The feeding rate was quantified as the 
number of flies having a direct contact with the food surface as follows: DPI = 
(nr. of flies on surface of food A – nr. of flies on surface of food B) / (nr. of flies 
on surface of food A + nr. of flies on surface of food B). The DPI was 
calculated at each of the ~8 time points, and the mean DPI was calculated as 
the mean of these 8 values (the proportion of flies feeding at each time point 
remained constant; data not shown). We took the mean DPI to represent one 
biological replicate, and this value was combined to the mean DPIs of 5-10 
independent assays, representing 5-10 biological replicates, for each 
experiment. 
2.1.12	Triacylglyceride	
Flies (25 flies per diet) were anesthetized using CO2, homogenized (5 flies per 
MP Biomedical Lysing Matrix D tube) in 1 ml 0.05% Tween 20 lysis solution, 
heated at 70°C for 5 min, and centrifuged at 14,000 rpm for 5 min. 
Supernatant (50 µl) from each sample was then transferred to a 96-well plate, 
and 200 µl of Thermo Infinity Triglyceride solution (pre-warmed at 37°C) was 
added to each well. Samples were incubated away from light for 5 mins, and 
absorbance was measured at 540 nm. Whole-body TAG levels were 
measured in adult flies (10 days age / 8 days treatment) and normalized to 
total protein levels (25 flies per group). 
2.1.13	S35-labelled	methionine	incorporation	assay	
Heads and thoraxes (5 tissues/sample) were dissected in DMEM medium 
(Ginco 41965-039). The medium was removed and tissues were washed with 
methionine- and cysteine- free DMEM, and subsequently incubated in 
methionine- and cysteine- free medium for 30 min to deplete intracellular 
methionine. 40µl/ml 35S-methionine/cysteine was added to 200µl of 
methionine/cysteine-free DMEM. After 30 min incubation on a slow shaker, 
tissues were washed with PBS, centrifuged for 2 min at 13,000rpm and lysed 
in 24µl RIPA buffer (50 mM Tris-HCl, pH 7.4, 1% NP-40, 0.5% 
Nadeoxycholate, 0.1% SDS, 150 mM NaCl, 2 mM EDTA, 50 mM NaF) with 
addition of protease inhibitor for 15 min on ice. Samples were centrifuged at 
13,000rpm for 10 min. Protein concentration was determined with the use of 
BCA assay. Subsequently, samples were subjected to Tris/Glycine/SDS 
electrophoresis as described for Western blots. The gel was stained in 
Coomassie Blue for 30 min, incubated in 40% MeOH, 10% glacial acetic acid 
for 40 min, dried and exposed to film. 
 
2.1.14	Proteotoxic	stress	assay	
At least 80 female flies (at lest 8 replicates, 10 flies each allocated into glass 
vials) were sorted to the respective diets after mating for 2 days in 1SY bottles 
following emergence. Flies were pre-treated for 8 days with holidic diets of the 
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respective AA ratios, and then transferred to the same diet supplemented with 
Bortezomib 15 µM (PS-341; S1013 Selleckchem), proteasome inhibitor. 
Stress resistance was quantified by regularly scoring dead flies and plotted as 
survival curve for each treatment. 
 
2.1.15	Mitochondrial	Respiration	
Female flies (10 days old) were dissected in PBS and tissues were collected 
(n=2, 8, 15 and 20 per replicate for thoraces, fat bodies, heads and guts, 
respectively). Tissues were resuspended in the respiration buffer (20 mM 
sucrose, 50 mM KCl, 20 mM Tris-HCl, 4 mM KH2PO4, 2 mM MgCl2, 1 mM 
EGTA, 0.05% BSA, 0.01% digitonin, pH 7.2). Oxygen flux was measured at 
25°C using a high-resolution respirometry device called OROBOROS 
Oxygraph 2K. Complex-I driven respiration (PGMP3) was measured by 
adding substrates Pyruvate (10mM), Glutamate (5mM), Malate (5mM) and 
Proline (10mM), along with ADP (1.25mM) (state 3). Un-phosphorylated state 
(PGMP4) of respiration was measured by inhibiting complex-V activity using 
Oligomycin. The respiration (state PGMPc) was uncoupled using CCCP 
(0.3uM). Maximum flux (Max. flux) was measured by adding complex-II 
substrates Glycerol-3 phosphate (5mM) and Succinate (10mM). Rotenone 
sensitive flux (RS) was measured in presence of 3uM rotenone. Finally, dry 
weights of tissues were determined and normalized to the oxygen 
consumption flux. 
 
2.1.16	Polyribosome	profiling	
Gradients of 17–50% sucrose (11 ml) in gradient buffer (110 mM KAc, 20 mM 
MgAc2 and 10 mM HEPES pH 7.6) were prepared in thin-walled, 13.2 ml, 
polyallomer 14 × 89 mm centrifuge tubes (Beckman-Coulter, USA). Heads 
and thoraxes were lysed in 500 µl polysome lysis buffer (gradient buffer 
containing 100 mM KCl, 10 mM MgCl2, 0.1% NP-40, 2 mM DTT and 40 U/ml 
RNasin; Promega, Leiden, Netherlands) using a dounce homogenizer. 
Samples were centrifuged at 1200 g for 10 min and protein concentration was 
measured with a BCA assay. Samples corresponding to 3µg of total protein 
were loaded on the top of the sucrose gradients. Samples were 
ultracentrifuged for 2 h at  40,000rpm in a SW41Ti rotor (Beckman-Coulter, 
USA) in the Optima XPN-100 ultracentrifuge (Beckman-Coulter, USA). 
Gradients were passed through an UA6 absorbance reader (Teledyne ISCO, 
USA) using a syringe pump (Brandel, USA) containing 60% sucrose. 
Absorbance was recorded at an OD of 254 nm. 
 
2.1.17	Proteasome	activity	assay	
Flies were homogenized in homogenization buffer (25 mM Tris-CL, pH 7.5) 
and centrifuged for 5 min at 13,000rpm at 4°C. Protein concentrations were 
determined by BCA assay. 20ug of fly protein was incubated at 37 °C with 
fluorigenic substrates Succinyl-Leu-Leu-Val-Tyr-7-Aminocoumarin (Suc-
LLVY-AMC; Enzo BML-P802-005) and Leu-Leu-Glu-7-Aminocoumarin 
(LLEAMC; Enzo BML-ZW9345-0005) for 30 min and the release of free 
fluorescent AMC was measured every 2 min using a microplate fluorescence 
spectrophotometer (Infinite M200, Tecan), at excitation/emission wavelengths 
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of 360/460 nm. Reactions were carried out in black 96-well plates. 20S activity 
was calculated by the slope of free AMC release over time and expressed as 
pmoles of substrate degraded per minute and mg protein (pmol/min/mg 
protein).  
Mouse proteasome activity assays were performed similar to the fly assay 
using a different homogenization buffer (172) (50mM Tris, 150mM NaCl, 5mM 
MgCl2, 1mM EDTA, 1mM DTT, pH 7.5). Proteasome activity was assessed 
on flash-frozen livers, muscles, guts and brains. 
 
2.1.18	Uric	acid	quantification	
Uric acid excretion was quantified separately in ad-libitum and in fasting 
regimes. For the ad libitum regime, after 8 days of treatment, mated 10-day 
old females were placed in fresh vials containing the respective holidic diet. 
Flies were maintained for 16 hours at 25 °C and 65% humidity standard 
conditions. Following this period, flies and media were removed from the vial, 
and the uric acid content of the vials was dissolved in 2 ml of 0.1 M sodium 
glycinate buffer (pH 9.2) and quantified spectrophotometrically (585 nm) using 
the conversion of uric acid to resorufin (Amplex Life Technologies kit A22181). 
For the fasting regime, after 8 days of treatment, mated 10-day old females 
were placed in empty vials and were maintained for 16 hours at 25 °C and 
65% humidity standard conditions. After this time, flies were removed and uric 
acid was quantified as above. 
 
2.1.19	Statistical	analyses	
All statistical analyses were performed using Prism software (V9). The 
nonparametric Wilcoxon rank-sum test was chosen to avoid assumptions of 
data normality. The log-rank test, a nonparametric test for survival analysis, 
was used to assess survival distributions of treatments, and Cox proportional 
hazard was used for survival experiments with more than one explanatory 
variable. Student's t-test and analysis of variance (ANOVA) were used where 
previous experimental data has conformed to the assumptions about 
normality and variance equality. Student's t-test was used for Western blot 
analysis, one-way analysis of variance (ANOVA) with Dunnet post hoc was 
used for proteasome activity assay analysis.  
 
2.1.20	Reproducibility	and	experimental	design	
Sample sizes are at least, and in many cases beyond, what is required to give 
confidence in the results. These are consistent with established norms for 
research on Drosophila and aging. For lifespan and egg-laying assays, 
individuals that developed in the same vessels were assigned evenly and 
systematically between experimental treatments. Except for the dietary 
preference assay, none of the assays required scoring blindly. Moreover, the 
current mouse study was designed to meet rigorous criteria for ageing 
research as described recently (173).  
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2.2	Materials	and	methods	for	mouse	experiments		
2.2.1	Mouse	strain	selection	
For each mouse experiment shown, twenty C3B6F1/J females per treatment 
were used. Our parental mice are two inbred strains. C57BL/6J and C3H. 
C57BL/6J is a sub-strain of C57BL/6, bred for F=227 generations at the 
Jackson laboratory; it is one of the most commonly used inbred strains and 
the first strain to have its genome sequenced. The N strain was separated at 
F=50 from the original inbreedings that generated the J strain. A recent report 
is in favour of 4-way cross hybrid animals (produced from the cross of two F1 
hybrids derived from four genetically distinct parents, so that the F2 
generation have four different grandparents), which it claims are preferable to 
2-way cross hybrids for reasons of greater genetic diversity, heterozygosity, 
and elimination of genetic background effects (174). However recent findings 
suggest that the body size variability in such F2 hybrids is high (with adult BW 
often ranging from 25 to 60 grams), which renders such strains less 
appropriate for the accurate assessment of growth rates. Moreover, even 
though heterozygosity issues may be bypassed, the genetic variability in such 
hybrids is not as diverse as would be desired to eradicate genetic background 
effects.  
	
2.2.2	Mouse	housing	
Mice were kept at a temperature range of 20-24°C (mostly 21-22°C). 
Individually housed mice weigh more, show more cancers, and a greater 
variance in body mass compared to group housed mice (175, 176). We 
therefore housed mice under SPF conditions in groups of 5 per cage to 
achieve a lower variance in growth rates.  
 
2.2.3	Mouse	food	and	water	intake	
Except for ad libitum fed animals, a pair-feeding regime was applied to ensure 
identical food intakes. Pair feeding is a method by which food intake in a 
control group is measured, and then applied on the next day to other animals 
to ensure equal cumulative feeding (177). To determine the food intake of the 
pair-fed groups, the mass of pellets consumed daily by the food-restricted 
group consuming the least amount of food was supplied to the rest of the 
groups at the following time point(s), until cumulative food consumption was 
equalized between all pair-fed groups.  
For the ad-libitum-fed groups, food intake was measured for each cage 
separately (dry matter mass consumed during the feeding period) twice per 
week, and the mean of a treatment was calculated as the average of all 4 
cages (N = 4 per treatment per timepoint).  
Water intake for all treatments was also measured for each cage separately 
twice per week, and the mean of a treatment was calculated as the average of 
all 4 cages (N = 4 per treatment per timepoint).  
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2.2.4	Mouse	diet	design 
Dietary nitrogen, energy, protein retention efficiency (PRE) and protein 
efficiency ratio (PER) are more efficient in the lower-protein diets, with a 
balanced NEAA:EAA (178). Moreover, low protein diets enable the detection 
of physiometabolic effects of dietary AA imbalance (26), therefore all our 
mouse diets were designed to have a low crude protein (CP) content of 6-8%.  
 
2.2.5	Body	mass	
Body mass may be a good predictor for mouse lifespan at early ages (peaking 
at 5 months), but maximum weight is not a good predictor (36). We therefore 
measured mouse body mass twice per week, as reported previously for 
studies focused on the effect of AA limitation on growth (179), post-weaningly 
for a period of 20 weeks (until age 23 weeks of age). The linear growth curve 
portion (from 3.0 to 6.4 weeks) was used to estimate growth rates and dietary 
efficiency (180).  
 
	
2.2.6	Mouse	SILAC	amino	acid	usage	
For the calculation of AA usage in the whole mouse and in specific mouse 
organs, we employed the same method as described for flies, and used 
published mass spectrometry based proteomic data (166) in order to calculate 
protein copy numbers and the corresponding weighted amino acid 
composition in C57BL/6 mice. We expressed AA abundance in the proteomic 
profiles of both whole mice (mouse SILAC AA, referred to as mSILACAA) and 
of tissue-specific proteins (tissue-specific mouse SILAC AA, referred to as 
tsmSILACAA).  
 
2.2.7	Food	indices	
Mice are coprophagic, with approximately one-third of their dietary intake 
being faeces (181), which is a good source for a range of nutrients but 
primarily for vitamins B and K (177). However as murine faeces is composed 
of ~1% protein (177) and protein is the limiting macronutrient in our diets, the 
effects of coprophagy on our food and protein index evaluation are considered 
negligible. Therefore, the Food Efficiency Ratio (FER) was defined as 
previously reported (182): FER = 100*cumulative body mass gain / cumulative 
protein intake). Protein Efficiency Ratio (PER) was also defined as previously 
reported (51): PER = cumulative body mass gain / cumulative protein intake). 
Both were calculated after 20 weeks of post-weaning diet treatment (N = 20).  
Net protein utilization (NPU) was defined as the ratio of utilized to supplied 
nitrogen: NPU = 2 x amount of nitrogen utilized in 24 hours (mg) / amount of 
nitrogen excreted in 24 hours (mg). NPU can be affected by proteostatic 
processes (e.g. protein turnover), but is primarily determined by the level of 
limiting amino acids in a diet (26). As a value, NPU can range from 1 to 0, with 
a value of 1 indicating 100% utilization of dietary nitrogen as protein and a 
value of 0 indicating that none of the ingested nitrogen was converted to 
protein. 
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2.2.8	Protein	extraction		
Protein was extracted from females treated in the respective diets for 20 
weeks (approximately 23-24 weeks of age). Harvested and flash-frozen 15-
20mg mouse liver pieces were homogenized in 2ml of the RIPA buffer with 
use of IKA T10 basic ULTRA-TURRAX homogenizer and centrifuged for 1h at 
13,000 rpm (4°C). The supernatant was collected as the protein fraction. 
 
2.2.9	Protein	and	DNA	extraction	from	the	same	samples	
To obtain the protein:DNA ratio, a single tissue sample was utilized for protein 
and DNA extraction with the use of AllPrep DNA/RNA/Protein Mini Kit 
(Qiagen, 80004). Subsequently, the BCA assay and DNA concentration 
measurement (Nanodrop 2000 Spectrophotometer) were performed. 
 
2.2.10	Metabolic	rate,	energy	expenditure,	and	activity		
Eight animals per group were used to measure 
energy homeostasis in metabolic cages 
(PhenoMaster, TSE Systems). For the 
metabolic measurements, the mice were 
housed singly and supplied with a constant 
flow of air. Due to their metabolism, mice 
consume O2 and produce CO2.During indirect 
calorimetry, the difference of O2 and CO2 
content of the air before entering the cage and 
after leaving the cage is measured. With this 
measured difference, the O2 consumption, CO2 
production, the respiratory exchange ratio and 
the basal energy rate were calculated. 
Moreover, the activity of the mice was 
recorded by laser-beam obstruction. During 
the monitoring of mice in metabolic cages, 
food and water intake were also measured 
with automatic food and water sensors.  
Before starting the measurements, mice were 
trained in training cages. During this time the mice were acclimatized to single 
housing, hanging water bottles, special drinking nipples, and hanging food 
baskets. Mice were intensively checked for their drinking and eating behavior 
to ensure they accepted the new drinking and feeding system. After the time 
in the training cages, the mice are acclimatized for 24 hours in the metabolic 
cages. Data was collected for 48 hours.  
Body surface temperature was assessed by infra-red (IR) thermometry 
applied on the ear canal at 23 weeks of age (20 weeks of treatment) using a 
standard infrared thermometer (Thermoscan, Braun). IR thermometry is a 
clinically reliable indicator of body core temperature due to its location near 
the hypothalamus (the body's temperature regulator) and is typically applied 
to mice. 
2.2.11	Blood	metabolic	profile		
Blood glucose and insulin levels were monitored at week 23. All animals were 
fasted for 3 hours and blood samples were collected after this fasting period. 
	
Figure 2.1: metabolic cage (Phenomaster, 
TSE Systems) 
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Blood was extracted from tail-tip clippings and used to determine blood 
glucose levels, as well as insulin levels. Each clipping aimed to collect ~5µl of 
blood for the glucose measurement and ~5µl of blood for the insulin 
measurement. Blood insulin and leptin levels were determined using 
commercially available enzyme-linked immunosorbent assays (ELISA) 
ALPCO 80-INSMSU-E01, E10 (insulin) and 22-LEPMS-E01 (leptin). 
For the ketone assay, mice were fasted over night, blood was collected by tail 
clippings, and β-hydroxybutyrate was quantified using Precision Xtra ® test 
strips. 
2.2.12	Glucose	tolerance	test	
To analyze glucose homeostasis, glucose tolerance tests (GTT) were 
performed at 23 weeks of age. GTT analyzes how efficiently the body 
metabolizes glucose. After an approximately 16 hour-fasting period (GTT 
mice were not fed a morning 1g food aliquot, unlike mice subjected to insulin 
tests, see below) with free access to drinking water mice were 
intraperitoneally injected with 2 g of glucose per kg body weight. The injected 
volume of glucose solution is 10 µl per g body weight. Blood glucose was 
measured before, 15, 30, 60 and 120 minutes after glucose injection.  
2.2.13	Insulin	tolerance	test	
The insulin tolerance test (ITT) measures the acute reaction to exogenous-
applied insulin and the resulting blood glucose-lowering effect. The decline of 
blood glucose after insulin application is a direct measurement of insulin 
sensitivity and a standardized method for the analysis of glucose homeostasis 
in mice. ITT was performed at 24 weeks of age. Mice were intraperitoneally 
injected with 0.75 units of insulin (in 0.9% NaCl) per kg body weight. The 
injected volume of insulin solution was 10 µl per g body weight. Blood glucose 
was measured before, 15, 30 and 60 minutes after insulin injection. ITT mice 
were fed a small meal of 1 gram per mouse approximately 2 hours prior to 
being tested.  
 
2.2.14	Fat	content	characterisation		
Body fat content was determined by in vivo magnetic resonance tomography 
imaging (time domain nuclear magnetic resonance or TD-NMR) at weeks 3, 
13 and 23 of age (0, 10, and 20 weeks of treatment respectively). This non-
invasive procedure was applied to all 20 animals/group to measure the effects 
of dietary amino acid nutrition upon fat deposition and fat metabolism. The fat 
content measured by TD-NMR included all types of fat in the body and the 
lean content included all kind of muscle tissue and free fluids in the body (e.g. 
water in the ankles and in the brain; but not blood). Typically, the fat, lean and 
free fluid content amounted to ~92-96% of the total body mass. Absolute fat 
and lean mass (g) were calculated by: 
Fat mass (g) = fat % x total body mass 
Lean mass (g) = lean % x total body mass 
2.2.15	Urea	excretion	and	nitrogen	balance	
When protein is metabolized, about 90% of the protein nitrogen is excreted in 
the urine in the form of urea, uric acid, creatinine and other nitrogen end-
products, allowing the accurate characterisation of nitrogen-balance. The 
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remaining 10% of the nitrogen is eliminated in faeces. The total nitrogen 
excreted is compared to the total N content consumed, to estimate nitrogen 
balance. To establish nitrogen losses, urine urea concentration was 
determined by a coupled enzyme reaction (phenylalanine assay) at 570 nm 
using a commercial kit (Sigma-Aldrich MAK006). Urine samples were 
collected following 4 hours of starvation and normalized to body mass and 
urine loss rate (N=10).  
In addition, nitrogen balance studies were carried out singly-housed animals 
(N=6) in specifically designed metabolic cages (Tecniplast, see Figure 2.2) 
that eliminate the possibility of coprophagy, collect all excreta (solids and 
fluids), and contain custom-made feeding inserts to accurately measure feed 
intake. Animals were first acclimatised for 24 hours in these cages, with the 
measurement spanning an additional 24 hours approximately at 23 weeks of 
age. Within these cages, food is supplied as powder in a container that 
ensures no food losses. It should be noted that non-solid pellet foods in 
rodents can exacerbate obesity and weight gain due to less work required for 
the digestion of the food (183). 
 
 
Figure 2.2: Tecniplast metabolic cages for excreta collection used in N-balance assessment. 
 
2.2.16	Organ	mass	and	tissue	harvest	
After the end of the 20-week treatment period (age 23 weeks), all mice were 
euthanised by gassing CO2 (spinal displacement inappropriate due to skeletal 
size measurement) and organs were harvested. Wet organ masses were 
recorded immediately, including: brain, right quadricep, fat pads, kidney, liver, 
heart, spleen, thymus, and thyroid. All organs were then flash-frozen. All mice 
were fed a small meal of 1 gram per mouse approximately 2 hours prior to 
their euthanisation – tissues were harvested immediately after this. 
 
2.2.17	Characterisation	of	skeletal	growth	and	bone	mineral	parameters	by	µCT	
The C57BL/6J strain is an ideal model for assessing BMD effects (184). The 
age at which bone parameters were assessed (23 weeks) is close to the peak 
of bone mass accretion after development (around 18-20 weeks), so any 
effects of dietary nutrients upon bone tissue development should be 
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detectable at this age (185). After the end-point of the study (week 23), seven 
right femur bones from seven animals of each group were harvested, placed 
in 10% PBS saline solution, and stored at -80°C. Before scanning, samples 
were thawed and hydrated overnight in a saline solution at 5°C. Femurs were 
scanned with a high resolution µCT scanner (SkyScan 1176, Bruker, Belgium) 
with an isotropic voxel size of 8.8 µm3. The x-ray settings for each scan were 
50 kV and 500 µA using a 0.5 mm aluminum filter. All scans were performed 
over 360 degrees with a rotation step of 0.3 degrees and a frame averaging of 
1. Images were reconstructed and analyzed using NRecon and CTAn 
software, respectively (Bruker, Belgium). Trabecular and cortical bone regions 
of distal femurs were selected with reference to the growth plate (0.44-2.2 and 
2.2-2.64 mm from growth plate for group 1, respectively. Size and position of 
bone regions were adjusted for the other groups depending on femur length). 
Bone mineral density was determined based on calibration with two phantoms 
of known density (Bruker, Belgium), which were scanned under the same 
conditions as the bone samples. Skeletal growth was also analysed by 
manually measuring the height (skeletal length) of all 120 main cohort mice 
(from nose tip to tail base) immediately after mice were killed. 
 
2.2.18	Histopathology	
Formalin-fixed specimens from the liver, kidneys, skeletal muscles, skin, 
adipose tissue, sternum and intestines of 80 mice were used for 
histopathologic evaluation. Tissues were trimmed, processed, blocked, 
sectioned, stained with H&E and examined microscopically. All slides were 
examined unbiased for the presence of histopathologic lesions. Severity score 
of all recorded lesions was semi-quantitatively assessed in all organs on a 
scale of 0 to 5 with 0.5 interval. Scores were given as absent (0), subtle (1), 
mild (2), moderate (3), severe (4), and marked (5) for each criteria. 
Representative digital images to the recorded lesions were taken for each 
analysis. The histopathologic examination was done unbiased without 
previous information to the sample examined. Total skin thickness (including 
epidermis, dermis, subcutaneous fat, and panniculus carnosus) and thickness 
of subcutaneous fat were measured using arbitrary line option of the 
LabSense 1.1 image analysis software (Olympus soft imaging solutions).  
2.2.19	Portal	vein	plasma	metabolomics	analysis	
Portal vein blood samples were harvested from pair-fed female C3B6F1/J 
mice at 23 weeks of age. Each animal was fed a 1 g meal approximately 1 
hour prior to sample harvest. Mice were euthanized by CO2 gassing, 
dissected, and portal vein blood collected in EDTA tubes, and span for 15 
minutes at 1,200 rpm (4oC). Isolated plasma samples were flash-frozen in 
liquid nitrogen and thawed once for an LC-MS-based metabolomics analysis 
performed by the Finnish Institute for Molecular Medicine (FIMM). 
2.2.20	Power	analysis	
To determine the number of animals used in our mouse growth analysis, a 
power analysis was carried out. This analysis was based on data obtained 
from our collaborator, Professor Stephen Simpson (University of Sydney, 
Australia). The growth data (body mass in grams) for the first 10 weeks in 
these diets are shown on Table 2.2:  
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Table	2.2: Body mass data (in grams) for 5% crude protein diets.  
 
 
 
* Growth rate at week 10.1 is taken as the difference in body mass between weeks 10.1 and 
0, divided by the number of weeks (10.1). 
 
 
Previous data from our lab (by Dr. Sebastian Groenke) were used to 
determine standard deviation (S.D.) in 5 randomly selected female C3B6F1/J 
animals (F1 hybrid annotation) for the same time point (13 weeks of age). 
These are shown in Table 2.3, below. 
 
Table	2.3: Body mass data for 5 randomly selected animals, with cage number, ear 
annotation, and body mass (in grams).  
 
 
From these two data sets (week 10 growth data of Prof. Simpson’s 5%P diets, 
and week 10 standard deviation data from Dr. Groenke’s study) we performed 
a standard power analysis. In the basis of this power analysis we projected 
the numbers needed at week 20 to give an 80% power to detect a difference 
of 1.19 grams for n=15: 
- a maximum difference of 5.84g between the groups, (Mean growth 
rate, Table 2.2) 
- a power of 80%  
- a SD of 1.12 (STDEV) 
- 15 animals per group required to detect a minimum mass difference of 
1.19 grams between groups in a statistically significant manner for the 
first 12 weeks post-weaning. 
To account for the event of smaller statistical differences and to ensure a high 
resolution to further secure the detection of any growth depression effects, we 
used 20 animals per group. We determined this number satisfactory to detect 
statistical differences in our mouse growth experiments.  
As the phenotypes (excluding lifespan and food consumption) tested in the 
lifespan experiment compare mice across a wider range of ages (from 0 to 24 
months of age), the statistical difference across those time-points and 
Post-weaning week 0 2 6 10 Growth rate
DIET 1 (5% protein) 11,94 13,72 15,91 18 0,6
DIET 3 (5% protein) 12,79 13,52 16 17,8 0,5
DIET 6 (5% protein) 12,28 13,77 16,78 18,73 0,64
Mean 12,34 13,67 16,23 18,18 0,58
Body mass (grams)
Post wean age Week 10
Ad libitum fed group Animal age Week 13
Cage number Ear number Body mass (grams)
988 22 27.6
214 19 29.7
1004 56 27.4
201 39 27.3
996 27 26.8
Mean 27.8
STDEV (range of values) STDEV 1.12
SQRT (square Root of the population size, number) SQRT 2.24
SEM (STDEV/SQRT) 0.50
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between the groups were projected to be more significant for all the tested 
phenotypes. 
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Chapter	3:	Exome-matching	predicts	the	limiting	EAA	in	flies	
and	mice	
 
 
 
3.1	Abstract	 	
Defining the identity and degree of a limitation or excess in the intake of an 
AA is dubious as many past attempts to determine a reliable measure for 
dietary AA requirements have had limited success. A possible general 
predictor of the AA requirement of an organism could be its genome, 
potentially allowing a rational design for a balanced dietary AA ratio. Here it is 
shown that exome-matching correctly predicts the identity of the limiting EAA 
for female fly fecundity, and that it can be used to accurately estimate the 
degree of that limitation. Moreover, dietary manipulations in the amount of the 
limiting EAA in the fly diet result in predictable modulations of the fly’s 
fecundity. In mice, a comparison of EAA-limiting diets to the mouse exome AA 
usage also reveals that exome-matching is a valid measure for the prediction 
of the identity of the limiting EAA. Therefore, these results suggest that the 
exome composition of an organism may provide a suitable template for its AA 
requirements for at least some anabolic traits. 
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3.2	Introduction	
 
Historically, many approaches have been used to approximate dietary AA 
requirements. Qualitative and quantitative determinations of the metabolic fate 
of dietary nitrogen (186), or of stable AA isotopes of carbon (187), hydrogen 
(56), or sulphur (188), can indicate the relative AA requirements of an 
organism by revealing how ingested AAs are utilized. The response of plasma 
AAs to the intake of different AA sources can also be used to estimate AA 
needs (4). Alternatively, the body AA approach is based on the assumption 
that an organism requires AAs in a proportion that reflects the accrued whole 
body AA profile (187). The method has been used in mice (153), rats (189), 
pigs (190), cows (191), sheep (192), fish (193), and humans (187, 191). For 
growing mammals, the AA composition of maternal milk is also thought to 
match AA requirements (47, 191, 193). However, there are severe limitations 
in each of these approaches, discussed elsewhere in detail (4, 25, 186, 187, 
194-197).  
 
A hypothesis that was developed before I joined the laboratory by Dr. 
Matthew D. Piper relied on the assumption that an alternative possible 
general predictor of the AA requirement of a healthy organism could be its 
genome, potentially allowing a rational design for a balanced dietary AA ratio. 
Therefore, using flies and mice we asked if the biological demand of an 
organism for AAs is best reflected by its exome. We translated all predicted 
protein-coding genes in silico and derived a proportional representation of 
each AA in the predicted exome. We thus tested our hypothesis by designing 
diets that contain AAs in the proportions defined by the exome, for both flies 
and mice, and then assessing both production traits and ageing.  
 
Drosophila melanogaster is a particularly useful model in studying how dietary 
manipulations impact on production traits and ageing. Recently, we reported 
the development of a chemically defined medium for Drosophila, which 
supports development, fecundity, and long-term maintenance (29). This 
holidic medium was first used to define the identity of the limiting EAA in 
various diets with different AA compositions, and then to make quantitative 
predictions on the effects of limiting EAAs upon production traits. Preliminary 
results showed that the exome composition of an organism may provide a 
suitable template for its AA requirements. Exome-matched supply of dietary 
AAs promoted egg production in flies and did so in a manner that successfully 
identified the identity of the limiting EAA. Moreover, several rodent studies 
were identified in the literature where the identity of the limiting EAA in diets 
with specific AA compositions has been experimentally verified. We therefore 
tested the accuracy of using the exome-matched AA profile in predicting the 
identity of the limiting EAA in those diets. These preliminary results showed 
that exome-matching is a reliable measure for predicting the identity of the 
limiting EAA in a range of rodent diets, each with different limiting EAAs. 
Moreover, other previous measures or estimating EAA requirements failed to 
correctly identify the limiting EAA. Thus, our preliminary results suggested that 
exome-matching can allow modeling of the requirement for all EAAs. 
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3.3	Results	
 
3.3.1	Exome-matching	predicts	the	limiting	AA	for	Drosophila	fecundity	
 
It was hypothesized that the EAA requirements of an organism for anabolic 
traits match the mean AA usage by its exome. Thus, to predict the 
requirement of the fruit fly Drosophila melanogaster for EAAs, we translated in 
silico the 19,736 predicted protein-coding genes from the whole genome 
sequence, and calculated the proportional representation of each amino acid 
(FlyAA) (Figure 3.1A). If FlyAA accurately predicts the requirement of the fly 
for EAAs, then we can identify the limiting EAA in any diet as the one with 
value r, where r = mini, di/ei (for EAAi, mini is the minimum, di and ei are the 
relative concentration in the diet and in the exome respectively). This 
methodology is based on the chemical score calculation for different protein 
sources(198). Restricting dietary protein reduces fly fecundity (2) but for flies 
kept on a laboratory yeast-based diet the limiting EAA for egg-laying is 
methionine (8). Compared to the yeast proportional AA composition (YAA), 
FlyAA shows several differences (Figure 3.1B), but correctly predicts the 
limiting EAA in YAA as methionine (Figure 3.1C, left panel).  
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Figure 3.1 		
a. Overview of exome matching in Mus Musculus and Drosophila melanogaster. The entire 
mouse genome (2.7 Gb) or fly genome (122 Mb) (left panel) are trimmed to their respective 
gene-coding exome sequence (second panel). This sequence is then translated in silico (third 
panel), and the genome-wide proportional representation of each amino acid is defined as the 
proportional amino acid usage in the exome (fourth panel). This amino acid profile is then 
added to chemically defined diets for flies and mice respectively (right panels). 
 
b. Comparison of dietary AA ratios used in our Drosophila melanogaster experiments. 
The EAA proportions in the fly exome ratio (FlyAA) are compared against those in HuntAA, 
MMAA, and YAA. Each bar represents the molar proportion for each EAA in each ratio, and 
isonitrogenous amounts of total EAAs are compared between ratios. FlyAA, HuntAA, and 
MMAA data by Dr. Matthew D. Piper and Dr. Eric Blanc. 
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c. Calculation of the most limiting dietary EAA(s) for each exome-mismatched ratio compared 
to the fly exome ratio (FlyAA) using r = mini, di/ei (for EAAi, mini is the minimum, di and ei are 
the relative concentration in the diet and in the exome respectively). Arginine (R) is the most 
limiting EAA in HuntAA (aR (min) = 0.27, or 27% of the proportional exome requirement for 
R), while methionine (M) is the most limiting EAA in Yaa (aM (min) = 0.55, or 55% of the 
proportional exome requirement for M). All EAAs above the solid red diagonal (vectors 1,1) 
are predicted to be in excess in the exome-mismatched ratios compared to the exome ratio. 
FlyAA, HuntAA, and MMAA data by Dr. Matthew D. Piper and Dr. Eric Blanc. 
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HuntAA (Figure 3.1B), an AA ratio previously reported to be adequate for 
Drosophila growth and development (199), was recently used to develop a 
holidic food medium that supports multi-generational development, adequate 
fecundity, and a healthy lifespan (29). FlyAA is substantially different from 
HuntAA, with arginine (R), an EAA in Drosophila (57), predicted to be the 
limiting EAA in HuntAA, and leucine (L) the next most limiting (Figure 3.1C, 
middle panel). In our equation, because r will predict the limiting EAA for egg 
laying on the current diet (diet 1), the proportional change in egg laying when 
flies feed on a diet with a different amino acid ratio (diet 2) should also be 
predictable according to r1/r2. We therefore determined whether exome-
matching could quantitatively predict the response of female egg-laying on 
HuntAA to alterations in arginine or leucine contents, using the same holidic 
medium. Increasing or reducing arginine concentration alone in HuntAA 
caused egg-production to increase or to decrease to the same extent as when 
all amino acids were altered by the same amount (Figure 3.2A). Considering 
the second most limiting EAA in HuntAA, methionine, we predicted that 
restoring arginine by 50% would increase fecundity by the same degree 
(~50%), but restoring arginine to the exome-required proportion (by increasing 
by 270%) would roughly double egg-laying (rR(min)/rM = 0.58). Indeed the 
results confirmed this prediction accurately (Figure 3.2B).  
 
The effect of the dietary EAA ratio on egg-laying could be attributable to one 
or more of the EAAs acting as a signal, rather than to the efficiency of their 
use in anabolism. To probe this possibility, we used another EAA ratio also 
predicted to be MisMatched (MMAA) to FlyAA but with a different proportion 
of all 20 AAs (Figure 3.1B) and with isoleucine predicted to be the limiting 
EAA (Figure 3.1C, right panel). Confirming this prediction, increasing or 
reducing isoleucine concentration alone in MMAA by 50% caused egg-
production to increase or to decrease to the same extent as when all amino 
acids were altered by the same amount (Figure 3.2C). Considering the 
second most limiting EAA in MMAA, tryptophan, we correctly predicted that 
restoring isoleucine to the exome-required dietary proportion would not 
significantly raise fecundity compared to MMAA + 50% I (Figure 3.2C).  
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Figure 3.2 
 
a. Egg laying prediction in Drosophila females fed HuntAA diets. Observed egg laying for 
increase in total AAs increases or decreases in the same proportion as when adjusting 
Arginine in the medium (Arginine addition or reduction by 50%). Each bar represents 2-9 
trials, each trial using (per treatment) 6 biological replicates of 10 flies. Error bars represent 
SD, letters indicate statistically significant differences (p<0.05) between pair-wise 
comparisons (Student’s t-test). 
 
b. Observed egg laying (grey bars) increases or decreases by arginine adjustment in the 
medium (arginine addition or reduction), matching the predicted response (red bars) based on 
the identification of arginine as the limiting EAA, and methionine the second most limiting 
EAA, in HuntAA compared to the exome ratio (FlyAA). Restoring arginine to the exome-
required proportion (by increasing it by 270% on its original HuntAA level so that rR = 1) 
roughly doubles egg-laying as predicted from rR(min)/rM = 0.58. Thus exome-matching 
accurately predicts the fecundity effects from adjustments in the limiting amino acid, Arginine, 
the next most limiting EAA (methionine). Each bar represents 2-9 trials, each trial using 6 
biological replicates of 10 flies per treatment. Error bars represent SD, letters indicate 
statistically significant differences (p<0.05) between pair-wise comparisons (Student’s t-test). 
 
c. Observed egg laying (grey bars) increases or decreases by isoleucine adjustment in 
MMAA (isoleucine addition or reduction), matching the predicted response (red bars) based 
on the identification of isoleucine as the limiting EAA, and tryptophan the second most limiting 
EAA, in MMAA compared to the exome ratio (FlyAA). Considering the second most limiting 
EAA in MMAA, tryptophan, we predicted that restoring isoleucine to the exome-required 
dietary proportion by increasing it by 176% on its original MMAA level (so that rI = 1) would 
not significantly raise fecundity compared to MMAA + 50% I. When leucine is added to this 
diet (100N MMAA + 176% isoleucine), egg laying is further increased to a level predicted by 
the next limiting EAA, tryptophan (W). Each bar represents 2-9 trials, each trial using 6 
biological replicates of 10 flies per treatment. Error bars represent SD, letters indicate 
statistically significant differences (p<0.05) between pair-wise comparisons (Student’s t-test). 
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3.3.2	Exome-matching	predicts	the	limiting	AA	for	mouse	growth	
 
Because exome-matching is a genome-based approach, it can be applicable 
to any organism whose genome sequence is known. Indeed, we found 
several published mammalian diets designed to be limiting for single EAAs, 
with the identity of the limiting EAA verified experimentally. In each case, the 
exome successfully identified the growth-limiting amino acid: threonine (T) for 
rats fed a threonine-basal diet (200) (Figure 3.3A), leucine (L) for rats fed a 
leucine-basal diet (201) (Figure 3.3B), arginine (R) for rats fed an arginine-
limited diet, (Figure 3.3C) (202) and methionine (M) for mice fed a 0.15% Met 
diet (203) (Figure 3.3D). In contrast, we found instances where other 
measures of dietary AA requirement, such as the body AA composition, fail to 
correctly predict the limiting AA (Figure 3.3E). (Data for Figure 3.s 3A-B and D 
by Dr. Matthew D. Piper and Dr. Eric Blanc). 
 
The AA profile of dietary proteins has long been implicated in healthspan and 
lifespan. A good example of this is plant proteins such as soy protein, which 
has been reported to be beneficial for a range of physiometabolic parameters 
in rodents and humans (23, 24, 138, 204). A comparison of the AA profile of 
soy protein showed that its proportional EAA composition is highly similar to 
MouseAA (rT (min) = 0.75 ; Figure 3.3F) and to the human exome profile 
(HumanAA; rT (min) = 0.77 ; Figure 3.3G). Thus the AA profile of a dietary 
protein source reported to be beneficial across mammalian species highly 
resembles the exome-predicted requirement. Moreover, compared to the 
human or mouse exome, the two most limiting AAs in soy protein are 
methionine and leucine (Figure 3.s 3F-G). Interestingly, both AAs are 
implicated in lifespan modulation, as methionine restriction extends lifespan, 
while leucine activates the TOR pathway, whose down-regulation is also 
linked to lifespan extension (113). Moreover, the human exome requirement 
also appears enriched in tryptophan, an AA whose restriction also extends 
lifespan, when compared to the AA profile recommended by the WHO (25) 
(Figure 3.3I). More experimental work will firmly establish whether a link exists 
between such single AA differences in these protein sources and the 
modulation of anabolic traits and lifespan. Therefore in light of all these 
observations the exome-matching approach appears as a potentially useful 
tool in resolving some of the issues around AA ingestion, anabolic traits, and 
life history traits. 
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Figure 3.3 
 
a. The exome AA usage of rats (RatAA) correctly identified threonine as the limiting AA in a 
diet previously shown experimentally to be threonine-restricted (TRAA) (rT(min) = 0.33). See 
text for more details. (Data by Dr. Matthew D. Piper). 
 
b. The exome AA usage of rats (RatAA) correctly identified leucine as the limiting AA in a diet 
previously shown experimentally to be leucine-restricted (LRAA) (rL(min) = 0.42) (53)(201). See 
text for more details. (Data by Dr. Matthew D. Piper). 
 
c. The exome AA usage of rats (RatAA) correctly identified arginine as the limiting AA in a 
diet previously shown experimentally to be arginine-restricted (RRAA) (rL(min) = 0.42). See text 
for more details. 
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d. The exome AA usage of mice (MouseAA) correctly identified methionine as the limiting AA 
in a diet previously shown experimentally to be methionine-restricted (MRAA) (rM(min) = 0.40). 
See text for more details. (MouseAA data by Dr. Eric Blanc). 
 
e. The body AA composition of rats (BodyAA; Kremen et al. 2003) incorrectly identified 
phenyalanine as the limiting AA in a diet previously shown experimentally to be leucine-
limiting (rF(min) = 0.58).  
 
f.  The exome AA usage of mice (MouseAA) identifies threonine as the limiting AA in an AA 
profile reflecting soy protein (SoyAA). However, the degree limitation of the most limiting AA 
in soy (rT(min) = 0.75) is only 25%, indicating that SoyAA shares a high degree of AA contents 
to MouseAA. 
 
g.  The exome AA usage of Homo Sapiens (HumanAA) identifies threonine as the limiting AA 
in an AA profile reflecting soy protein (SoyAA). However, the degree limitation of the most 
limiting AA in soy (rT(min) = 0.77) is only 23%, indicating that SoyAA shares a high degree of 
AA contents to HumanAA. (HumanAA data by Dr. Eric Blanc). 
 
h. The exome AA usage of Homo Sapiens (HumanAA) identifies arginine as the limiting AA in 
an AA profile reflecting Maximuscle protein supplement (MPAA). Thus, the exome AA usage 
can potentially be used to improve the design of AA supplementation for anabolic traits, 
avoiding adverse effects of imbalanced AA ingestion. 
 
i. Comparison of the AA profile recommended by the World Health Organization compared to 
the human exome AA requirement. The WHO recommendation provides 55% of the exome 
requirement, although is very close to the exome requirement for most other EAAs. 
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3.3.5	Individual	exons	and	their	dissimilarity	to	the	mean	exome	AA	usage	
 
Individual exons (especially oligo-peptides) can be dissimilar to the whole-
exome AA usage, as highly non-random AA sequences are abundant in living 
systems (205). Thus, an averaged exome or proteome AA profile may not 
equally facilitate the transcription and translation of all exons, which can have 
complex and unforeseeable metabolic consequences depending on what 
exons are affected most. In this respect, it was hypothesized that larger 
proteins, consisting of a greater number of AAs, would be less likely to be 
dissimilar to the mean exome AA usage. Indeed, analysis of the log2 distance 
(wd2) of each exon to the mean exome AA usage revealed a strong negative 
correlation (R2 = 0.55) of this measure to the exon length (Figure 3.4). This 
finding supported the logical assumption that longer exons are less likely to be 
highly dissimilar to the mean exome AA usage (FlyAA) while, in contrast, 
shorter protein-coding exons are more likely to be dissimilar to the mean 
exome AA usage (FlyAA). Thus, the synthesis of large macromolecular 
structures consisting of long peptides appears to be constrained towards 
employing an AA sequence that resembles the mean AA usage of the entire 
exome.  
 
 
 
 
 
 
Figure 3.4 
 
a. Analysis of the log2 distance (wd2) of each of the 19,736 predicted protein-coding exons to 
the mean exome AA usage (FlyAA) reveals a strong negative correlation (R2 = 0.55) of this 
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measure to the exon length (log2 of the number of AAs). See text for more details. (Data by 
Dr. Ilian Atanassov). 
 
 
 
 
 
3.4	Discussion	
 
Despite the complexity of the multitude of factors that can alter AA usage, 
nutrigenomics may be the most promising approach for defining AA 
requirements. The genetic composition of a species may affect the response 
to ingested AAs and contribute to the diversity of protein sources consumed 
across species. In humans, recent nutrigenomics methods employ the use of 
genetic information on inborn errors of metabolism to direct the use of dietary 
AAs in clinical research (206). Yet, the advance of multiple –omics 
technologies has opened the possibility of evaluating dietary AA requirements 
across species through novel approaches. Here, a genome-based technique 
for designing an enhanced quality protein was tested. The preliminary results 
herein showed that the exome is a powerful measure for defining AA 
requirements in vertebrates and invertebrates. Because this model is driven 
by the genome sequence of the organism in question, the principle can be 
applied to any organism whose genome sequence is known. 
 
The preliminary results presented in this chapter strongly suggested that 
exome-matching can be used to successfully predict the identity of the limiting 
EAA. The principle of the minimum poses that the most limiting nutrient in a 
diet can prevent successful utilization of other, non-limiting nutrients that are, 
as a result, acquired in excess (31). Accordingly, it is shown here that exome-
defined limiting EAAs prevent the usage of non-limiting EAAs for egg-laying in 
a predictable manner. These observations provided supporting evidence to 
the proposed exome-based approach for designing enhanced protein quality 
in fly diets by improving female fecundity. Therefore it was decided to further 
test exome-matching by focusing on other anabolic and physiometabolic traits 
in Drosophila. This work is described in the following chapter. 
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Chapter	4:	Exome-matching	of	essential	amino	acids	in	the	fly	
diet	maximizes	anabolic	traits		
 
4.1	Abstract	
 
In the previous chapter, it was shown that exome-matching can accurately 
predict the identity of the limiting EAA in various dietary AA sources in both 
flies and mice. In this chapter a comprehensive analysis of how dietary AA 
imbalances, rather than limitations, affect fly metabolism is carried out. 
Exome-matching is found to promote anabolic traits including growth and 
fecundity more than do amino acid profiles found in commonly used protein 
sources including yeast. The metabolic fate of ingested AAs is characterized 
and exome-matching is shown to promote anabolism by increasing dietary 
nitrogen utilization. Moreover exome-matching reduces lipid storage, whilst 
increasing respiration in the fat body. Such biological responses to ingested 
AA profiles may be critical in the determination of healthspan and lifespan. 
Therefore the amino acid profile of a food source is an important factor when 
considering the usage of dietary nitrogen, anabolic traits, and health. Finally, 
exome-matching is compared to proteome-matching, and the role of the 
identity of individual limiting AAs is also highlighted. 
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4.2	Introduction	
 
Across species, dietary AAs modulate key life history traits such as growth, 
reproduction, and lifespan (5, 26). Consequently dietary protein sources with 
distinct AA proportions can largely affect growth signaling. A balanced dietary 
AA ratio is typically considered to reflect the organism’s AA requirements, 
thereby promoting growth. In contrast, imbalanced AAs subtly (imbalance) or 
grossly (restriction, deficiency, or toxicity) misrepresent an organism’s AA 
requirements (26). The preliminary results described in the previous chapter 
suggest that the exome can be a reliable predictor of key life history traits 
including fecundity in flies, as well as growth in mice (26). Yet, the molecular 
mechanisms mediating the responses to the ingestion of exome-matched AAs 
are as yet uncharacterized. Thus, work in this chapter aims to further 
characterize such physiometabolic responses by focusing on flies. Drosophila 
melanogaster is a particularly useful model in studying how dietary 
manipulations impact on production traits and ageing. Recently, the 
development of a chemically defined medium for Drosophila, which supports 
development, fecundity, and long-term maintenance (29), enabled the study 
of individual dietary AA modulations. Here this holidic medium is used to 
define the identity of the limiting EAA in various diets with different AA 
compositions, and to make quantitative predictions on the effects of limiting 
EAAs upon production traits. 
 
The effects of ingesting exome-imbalanced AA profiles are assessed through 
several physiometabolic responses. Dietary amino acids modulate key life 
history traits including development, fecundity, and lifespan. Restriction of 
individual essential amino acids (EAAs), or an imbalanced proportion between 
some EAAs, also affects lifespan. In this chapter, it is shown that an exome-
matched supply of dietary AAs promotes production traits in flies more than 
do other commonly used dietary AA sources, including AAs provided in the 
proportion found in yeast. Furthermore, a comprehensive phenotypic 
characterization is carried out focusing on fecundity, development, lipostasis, 
proteostasis, nitrogen utilization, feeding behavior, AA bioavailability and 
sensing, glucose homeostasis, energy homeostasis, and ageing. Results 
show that exome-matching promotes fecundity and development, decreases 
fat storage, mitochondrial activity, and starvation resistance, increases 
proteasomal activity and nitrogen utilization, diminishes nitrogen losses, and 
defines feeding behaviour. These findings in Drosophila suggest that the 
exome composition of an organism may provide a suitable template for its AA 
requirements. Furthermore, dietary AA balance appears critical for the 
modulation of key life history traits, including growth, reproduction, and 
ageing.  
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4.3	Results	
 
4.3.1	Fecundity	predictions	
 
After establishing the identity of the limiting EAA in HuntAA and MMAA 
(Chapter 3), a direct comparison of the fecundity of flies on HuntAA, MMAA 
and FlyAA showed that exome-matching quantitatively predicted egg-laying 
(Figure 4.1A), suggesting that the nutritional, rather than signaling, properties 
of the EAAs are important in determining their effect on egg production. The 
effect persisted in 65 day old females, where the three-fold increase of FlyAA 
over MMAA was preserved (Figure 4.1B). To test if the arginine limitation in 
HuntAA affects fecundity independently of dietary nitrogen levels we repeated 
fecundity tests on diets with arginine modulations across various dietary N 
levels (25N-300N). Interestingly, although predictions were accurately 
confirmed at lower dietary nitrogen levels (Figure 4.1C), this was not the case 
at higher dietary N levels (300N), where the observed responses of dietary 
arginine modulations were less severe than the predicted ones (Figure 4.1D). 
Further analysis of the relationship between observed vs. predicted fecundity 
across dietary nitrogen levels showed that the exome-predicted response 
overestimated the observed response at nitrogen levels of >100N against 
both HuntAA and MMAA (Figure 4.1E). Examination of the interaction 
between dietary nitrogen and the AA ratio showed that increases in fecundity 
were linearly correlated to the dietary nitrogen content (expressed as mM of 
N) for HuntAA and MMAA, but this was not the case for FlyAA, which was 
instead best described by a logarithmic fit (Figure 4.1F). This implied that the 
physiological limit for egg production is approximated by FlyAA when dietary 
N levels are high. Indeed, although increasing dietary yeast, the fly’s protein 
source in a common sugar-yeast diet, increases fecundity (Figure 4.1G) flies 
fed a high nitrogen FlyAA diet were no more fecund than flies fed live yeast, 
which maximizes egg laying (Figure 4.1H-I). Therefore, the difference 
between the predicted and observed values in high nitrogen diets (Figure 
4.1E) is the result of the divergence of the linear (HuntAA and MMAA) vs. 
logarithmic (FlyAA) fecundity increases as dietary nitrogen is raised (Figure 
4.1F). Combined these observations indicate that exome-matching increases 
the utilization of dietary AAs to maximize egg-laying, and that increasing 
dietary nitrogen alleviates the fecundity-reducing effect of a limiting EAA in the 
diet. Therefore the response of fecundity depends on the dietary nitrogen 
levels, with fecundity modulations accurately predicted at low but not high 
levels.  
 
The finding that exome information, unweighted by transcriptional or 
translational information, is such an accurate predictor of egg laying was 
unexpected, so the ovarian accrued proteome was analyzed to see whether 
its AA abundance is uniquely identical to the mean AA usage in the exome. 
However, this was not the case as AA usage did not vary considerably 
between the fly ovarian and other tissue-specific proteomes (Figure 4.2A; 
data by Dr. Ilian Atanassov). Thus, the possibility that the ovarian expressed 
transcriptome uses AAs in a manner that is representative of the whole 
genome was investigated. To do this, all in-silico translated genes were 
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ranked on the basis of how similar their predicted AA usage is compared with 
that of the median usage for the whole exome. From the most predominantly 
abundant egg proteins, the three highly-expressed yolk proteins ranked in the 
top 25% of genes most similar to the exome ratio (Figure 4.2B; data by Dr. 
Matthew D. Piper, Dr. Eric Blanc, and Dr. Ilian Atanassov), while the average 
ranking of the ovarian-expressed transcripts (207)  was smaller than expected 
by chance when compared with randomly selected gene lists of the same size 
(P=0.09, CATMAP (208); Figure 4.2C; data by Dr. Matthew D. Piper, Dr. Eric 
Blanc), which was not the case for other tissues. Thus, the ovarian 
transcriptome appears constrained towards encoding AAs in exome-like 
proportions to maximize future biomass production.  
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Figure 4.1 
 
a. Egg laying predictions for Drosophila females fed MMAA and HuntAA diets at 100N dietary 
nitrogen (N) levels. Observed egg laying (grey bars) for both MMAA and HuntAA supplied at 
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100N dietary nitrogen levels matches the predictions made by exome matching (red bars) for 
each ratio. N = 6-14 trials per treatment, with each trial using (per treatment) 6 biological 
replicates of 10 flies. Error bars represent SD, letters indicate statistically significant 
differences (p<0.05) between pair-wise comparisons (Student’s t-test). 	
b. The predicted fecundity differences between FlyAA and MMAA match the observed 
fecundity responses even at older ages (65 day-old females). Each bar represents 3 trials, 
each trial using 6 biological replicates of 10 flies per treatment. Error bars represent SD, 
letters indicate statistically significant differences (p<0.05) between pair-wise comparisons 
(Student’s t-test). 	
c. Day 8 fecundity for dahomey females across dietary nitrogen levels, expressed as mM 
concentration of biologically available nitrogen in the diet. Modulations include changes in 
total AAs (25N-300N) or changes in the limiting AA arginine (+/- R). Each bar represents >2 
trials, each trial using 60 flies per treatment. Error bars represent SD (1-way ANOVA analysis 
with Dunnet posthoc test, F ratio = 10.48; P value < 0.0001 for multiple comparisons to 25N 
HuntAA control treatment).  
 
d. Effect of high dietary nitrogen on single EAA manipulations at high dietary nitrogen levels. 
The observed fecundity response to increases or decreases in Arginine is less potent than 
the predicted predicted response when dietary nitrogen is at the higher level of 300N. At this 
level, both the increase or decrease of fecundity as a response to dietary Arginine adjustment 
reach approximately half of the predicted extent. Each bar represents 2-7 trials, each trial 
using (per treatment) 6 biological replicates of 10 flies. Error bars represent SD (1-way 
ANOVA analysis with Dunnet posthoc test, F ratio = 0.8700; P value = 0.4884).  	
e. Observed versus predicted fecundity for HuntAA and MMAA across dietary nitrogen (N) 
levels. The red diagonal starting from the origin of (x,y) indicates the predicted relationship 
between dietary N and fecundity when fecundity is independent of dietary N. However the 
observed values indicate that the accuracy of fecundity predictions depends on dietary N 
levels as the predicted response overestimates the observed response for both HuntAA and 
MMAA at >100N levels, where the exome-based predictions gradually start to fail. At 300N, a 
reduction of 33% Arginine reduced fecundity by only 20%, while a reduction of dietary 
Arginine by 50% reduced fecundity by 34%. Moreover, an increase of 50% Arginine increases 
fecundity only by 25%. Each bar represents 4-16 trials, each trial using (per treatment) 6 
biological replicates of 10 flies. Error bars represent SD. 
 
f. Observed fecundity for FlyAA, HuntAA, and MMAA across dietary nitrogen levels (25N-
300N). The fecundity increases for HuntAA and MMAA are linearly correlated to the 
increasing intake of nitrogen (in the form or amino acids) and are best described by a liner fit 
(R2 values for HuntAA and MMAA are 0.998 and 0.986 respectively). In contrast, the 
fecundity increase for FlyAA shows a negative acceleration phase, so the curve is best 
described by a logarithmic fit (R2 = 0.993). Each bar represents 4-16 trials, each trial using 
(per treatment) 6 biological replicates of 10 flies. Error bars represent SEM (2-way ANOVA 
analysis with Bonferonni posthoc test, HuntAA vs. FlyAA F ratio = 1.099; MMAA vs. FlyAA F 
ratio = 1.172; for both comparisons, N level-AA ratio interaction P value > 0.05, and both N 
level and AA ratio P value < 0,0001).  	
g. Observed fecundity for a range of sugar-yeast diets across a range of yeast dilutions. Each 
bar represents (per treatment) 6 biological replicates of 10 flies. Error bars represent SEM, 
letters indicate statistically significant differences (p<0.05) between pair-wise comparisons 
(Student’s t-test). 
 
h/i. Day 8 fecundity for dahomey females fed the exome-matched diet (FlyAA) at high dietary 
nitrogen levels (300N) compared with females fed (d) a high sugar-yeast diets (2SY) 
supplemented with live yeast (LY), or (e) a 300N/FlyAA diet supplemented with LY. Each bar 
represents >3 trials, each trial using 60 flies per treatment. Error bars represent SD. Statistical 
analysis uses Student’s T-test for pair-wise comparisons. 
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Figure 4.2 
 
a. Proportional AA usage in the tissue-specific proteome in Wdah flies, as determined by 
SILAC protein quantification. The AA content of ovaries is within the 95% CI of the mean AA 
usage from all other tissues, indicating that it is very similar in AA usage to other tissues. The 
AA usage of w1118 flies is also similar to that of Wdah flies, indicating the genetic 
background differences between the two strains has no effect upon AA usage. Data provided 
by Dr. Ilian Atanassov. 
 
b. Ovarian expressed genes use amino acids in a ratio representative of that of the whole 
exome. All in silico translated genes were ranked by how similar their proportional amino acid 
usage is compared with that of the mean AA usage for all genes in the predicted fly exome. 
Genes were ranked from most to least similar according to a distance measure: wd2 = sqrt 
(sum over all amino acids of((ratio in protein – mean ratio in proteome)/sd ratio in exome)^2). 
The three yolk proteins (YP) ranked in the top 25% of genes. Data by Dr. Matthew D. Piper, 
Dr. Eric Blanc, and Dr. Ilian Atanassov. 
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c. We interrogated how likely it is that the average rank of tissue-specific subsets of genes, 
identified in FlyAtlas (207), could be found by chance. This revealed that the ovarian 
expressed genes may have been specifically constrained towards using amino acids in the 
same proportion as that of the whole genome (P=0.09, CATMAP). Data by Dr. Matthew D. 
Piper and Dr. Eric Blanc. 
 
To check if the effects of MMAA and HuntAA on fecundity depended on 
insulin signaling, the fecundity response of females that do not secrete insulin-
like peptides 2-3, and 5 due to a knock-out mutation (dilp2-3,5) (154) was 
tested. Although dilp2-3,5 knock-out females showed much lower levels of 
fecundity than dahomey females in the holidic medium, the fecundity 
differences observed between AA ratios in dahomey flies were also seen in 
dilp2-3,5 flies (Figure 4.3A). This suggested that the effects of MMAA and 
HuntAA on fecundity were at least partially independent of the presence of 
dILPs 2-3,5. Similarly, to establish if the effects of HuntAA on fecundity 
depended on regulation of the target of rapamycin (TOR), the fecundity levels 
of females on HuntAA and FlyAA upon inhibition of TOR by rapamycin was 
determined. Rapamycin decreased fecundity regardless of the dietary AA 
ratio, but fecundity differences between the two ratios were still preserved 
(Figure 4.3B). These observations suggest that the effects of exome-predicted 
limiting dietary AAs upon fecundity are partially independent of suppression in 
IIS or TOR signaling.  
 
However, despite the fact that the observed fecundity effects were very close 
to the predicted values (Figure 4.1A), some discrepancies between the 
observed and predicted fecundity effects were also seen. Therefore, MMAA 
had a marginally lower mean fecundity than that predicted, while an HuntAA 
had a marginally higher mean fecundity than that predicted (Figure 4.1A). To 
establish whether this discrepancy may reflect a biological effect stemming 
from the identity of the limiting EAA in these exome-mismatched dietary AA 
profiles, the fecundity of females fed the exome AA profile (FlyAA) but with an 
80% reduction in individual EAAs was assessed. Restricting individual AAs 
had a diverse effect on fecundity, with isoleucine restriction reducing day 8 
egg-laying more than did arginine, histidine, or methionine restriction (Figure 
4.3C). Moreover, an 80% restriction of histidine or methionine resulted in a 
negligible suppression of fecundity across dietary nitrogen levels, whereas 
80% restriction of all other EAAs significantly suppressed fecundity (Figure 
4.3D). In addition, upon deprivation of each single EAA in a high nitrogen diet 
(300N HuntAAA), only histidine and methionine deprivations failed to 
immediately suppress fecundity (Figure 4.3E), resulting in significantly higher 
levels of lifetime fecundity (Figure 4.3F).  
 
As discussed in Chapter 3 (Figure 4.s 1A-B), yeast, the common protein 
source of laboratory flies, is methionine-limiting (8). Therefore it was tested 
whether exome-based fecundity predictions are accurate upon a dietary AA 
profile matching that of yeast (YAA). The observed day 8 fecundity for flies fed 
YAA grossly surpassed the predicted value and matched that observed in flies 
fed FlyAA (Figure 4.3G), suggesting that the exome-based fecundity 
prediction is not accurate when the limiting EAA is methionine. Moreover, 
there where no significant differences between YAA and FlyAA across dietary 
nitrogen levels (Figure 4.3H), but when the prediction was adjusted to the next 
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most limiting EAA (leucine) it accurately reflected the observed values (Figure 
4.3I). Similarly in the HuntAA ratio, considering the second predicted most 
limiting EAA methionine was a less accurate predictor of fecundity that 
considering the third predicted most limiting EAA leucine (Figure 4.3J). All 
these observations supported a replenishable role of methionine for 
Drosophila fecundity. 
 
 
 
Figure 4.3 
 
a. Day 8 fecundity for dahomey females and knock-out females lacking dILPs 2-3,5. The 
effects of dietary AA ratios on fecundity appear to be at least partially independent of the 
presence of dILPs 2-3,5 as the fecundity differences observed across AA ratios in dahomey 
females were also seen in flies lacking dILPs 2-3,5. Each bar represents two trials, each trial 
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using 60 flies per treatment. Error bars represent SD (1-way ANOVA analysis with Dunnet 
posthoc test, F ratio = 4.276; P value = 0.0097).  
 
b. Day 8 fecundity for dahomey females with and without rapamycin (5µM). The effects of 
dietary AA ratios on fecundity appear to be at least partially independent of the presence of 
dILPs 2-3,5 as the fecundity differences observed across AA ratios in dahomey females were 
also seen in flies lacking dILPs 2-3,5. Each bar represents two trials, each trial using 60 flies 
per treatment. Error bars represent SD (1-way ANOVA analysis with Dunnet posthoc test, F 
ratio = 3.571; P value = 0.0036).  
 
c. Observed and predicted fecundity responses for a range of 80% restrictions of selected 
EAAs (100N). Each bar represents (per treatment) three experiments, each with 6 biological 
replicates of 10 flies. Error bars represent SEM. Letters indicate statistically significant 
differences (P value < 0.05) for pair-wise comparisons (Student’s t-test).   
 
d. Observed fecundity for a range of 80% restrictions of all EAAs, and across a range of 
dietary nitrogen (100N, 200N, 300N for the top, middle, and bottom panels respectively). 
Each bar represents (per treatment) 6 biological replicates of 10 flies. Error bars represent 
SEM. Letters indicate statistically significant differences (P value < 0.05) for pair-wise 
comparisons (Student’s t-test).   
 
e-f. Observed fecundity for complete EAA deprivations in a HuntAA 300N diet. Except for the 
EAA noted as deprived with a minus sign, all others are at the concentration found in the 
HuntAA 300N diet. Each bar represents (per treatment) 6 biological replicates of 10 flies. 
Error bars represent SEM. Letters indicate statistically significant differences (P value < 0.05) 
for pair-wise comparisons (Student’s t-test).   
 
g. Observed and predicted fecundity responses for YAA and FlyAA at 100N. Each bar 
represents 6 or more trials, each using (per treatment) 6 biological replicates of 10 flies. Error 
bars represent SEM. (1-way ANOVA analysis with Dunnet posthoc test, F ratio = 1.036; P 
value > 0.05). 
 
h. Observed fecundity for YAA and FlyAA across dietary nitrogen levels (25-200N). Each bar 
represents 3 or more trials, each using (per treatment) 6 biological replicates of 10 flies. Error 
bars represent SEM. (2-way ANOVA analysis with Bonferonni posthoc test, P value = 0.0376 
for the N level-AA ratio interaction, F ratio = 2.683; N-level factor P value < 0,0001, AA ratio P 
value = 0.2427).  
 
i. Observed versus predicted fecundity for YAA and FlyAA across dietary nitrogen levels (25-
200N). Each bar represents 3 or more trials, each using (per treatment) 6 biological replicates 
of 10 flies. Error bars represent SEM. Letters indicate statistically significant differences (P 
value < 0.05) for pair-wise comparisons (Student’s t-test).   
 
j. Observed versus predicted fecundity for HuntAA with additions of the most limiting EAA 
(arginine), the second most limiting EAA (leucine), and the third most limiting EAA 
(methionine). Each bar represents 2 or more trials, each using (per treatment) 6 biological 
replicates of 10 flies. Error bars represent SEM. Letters indicate statistically significant 
differences (P value < 0.05) for pair-wise comparisons (Student’s t-test).   
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4.3.2	Amino	acid	sensing	and	perception	
 
As FlyAA promoted key production traits in flies including fecundity, and fly 
fecundity is known to be modulated by the fly’s fat body, sensing of the 
different AA sources could involve changes in AA-sensing pathways. A key 
protein involved in satiety induced by protein consumption is the target or 
rapamycin (TOR), which mediates AA sensing (77). S6K is one of the main 
downstream effectors of the target of rapamycin (TOR), which in turn is critical 
for AA sensing (77) and whose inhibition extends fly and rodent lifespan 
(113). Upon assessing S6K levels and activation in exome-matched and 
exome-mismatched diets, an increase in S6K activation in the heads of 
females fed the exome-matched (FlyAA) diet was observed, compared to 
exome-mismatched diets (HuntAA, MMAA) (Figure 4.4A).  
 
To test if an exome-matched diet is perceived by flies as a more potent 
source of protein the feeding rates and food intake of flies kept at the different 
diets was quantified. Surprisingly, similar feeding rates and food intake across 
ratios and nitrogen levels were observed (Figure 4.s 4B-C). Perception of 
satiety by looking at food choice behavior was also tested. A feeding assay 
was developed to investigate the food preference behavior of Drosophila, 
whose method is described in detail in Chapter 2 (Methods). Flies were 
maintained for 3 days on holidic media lacking all AAs (0N), and then were 
presented with a choice of FlyAA or an exome-mismatched diet to assess 
their preference for HuntAA, MMAA, or FlyAA. Flies starved of all AAs for 3 
days consistently showed a dietary preference for FlyAA over HuntAA or 
MMAA, but no preference for FlyAA against FlyAA, a trend that persisted 
across dietary nitrogen levels (Figure 4.4D). Combined, these data are 
consistent with exome-matching defining a perceptibly enhanced quality of 
protein to the adult fly.  
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Figure 4.4 
 
a. S6 kinase (S6K) protein and phosphorylation (T389) levels in the heads of 10-day old 
females across different dietary AA profiles. For quantification, each bar shown represents 4-
5 biological replicates, each replicate using a protein extract from 20 heads per treatment. 
Error bars represent SEM. 
 
b. Effects of dietary AA ratio on food intake. Food intake across the dietary AA ratios was 
quantified using blue-stained holidic media as previously described (169). For each assay, 50 
mated female flies at 10 days of age (following 2 days mating in 1SY media and 8 days on 
the respective holidic diet) were placed in vials of 10 flies for each treatment. Each data point 
represents the mean of 5 trials (N=5), and error bars represent inter-trial SEM (2-way ANOVA 
analysis with Bonferonni posthoc test, P value > 0.05). 
 
c. Proboscis Extension Behaviour (PEB) shows the feeding response of dahomey females to 
each ratio as previously described (169). Assays recorded the proportion of 2-day-mated 
females extending their proboscis to the medium at 3-10 days of age (3-4 every-other-day 
measurements per trial). Each trial used 5 or 10 females per vial, and 10 replicate vials per 
treatment (i.e. 50-100 flies per treatment per trial). For 50N and 100N treatments 5 trials were 
carried out (N = 5), while 3 trials were performed for 200N treatments (N = 3). Error bars 
represent inter-trial SD (2-way ANOVA analysis with Bonferonni posthoc test, P value > 0.05). 
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d. Dietary preference index. Colour of box indicates the AA profile offered to flies against 
FlyAA in a two-choice assay (see methods). Pre-starving flies of amino acids flies for 3 days 
resulted in an increased dietary preference for FlyAA over HuntAA or MMAA, but not over 
FlyAA, confirming flies perceived the exome ratio as a more attractive dietary AA source. 
Each bar represents 5-10 biological replicates, with 40 females per replicate. Error bars 
represent SD, letters indicate statistically significant differences (P value < 0.05) for pair-wise 
comparisons (Student’s t-test).  Data for Figure 4.4D by Hanna Salmonowicz and George 
Soultoukis. 
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4.3.3	Development	
 
Development time is a valid indicator of Drosophila’s dietary AA requirements 
as the proportion of dietary AAs greatly impacts upon development rates (57). 
Moreover, protein-restricted diets also delay or inhibit growth both in flies 
(Figure 4.5A) and in rodents (28). As exome matching improves dietary AA 
utilization for fecundity, it was next tested whether the exome also defines 
diets to enhance development, because a large proportion of the genome is 
likely to be involved in the egg’s transformation to an adult. Drosophila larvae 
were reared on each of the three AA ratios and measured egg to eclosion 
time. Confirming expectations, FlyAA supported faster development than 
either HuntAA or MMAA, especially at lower dietary nitrogen levels (Figure 
4.5B). Interestingly, we observed the same trends for developmental survival, 
as larvae reared on FlyAA showed a significantly enhanced viability compared 
to larvae reared on HuntAA or MMAA, an effect that was more significant at 
lower levels of dietary nitrogen (Figure 4.5C). We also assessed the 
possibility that total biomass synthesis during development is affected by an 
exome-balanced dietary AA ratio supply. Comparison of female adult body 
masses upon eclosion showed a significantly increased body mass when 
dietary AAs were exome-matched, again more prominently at lower dietary 
nitrogen levels (Figure 4.5D). This effect was consistent in male flies (Figure 
4.5E), indicating that AA usage for anabolic processes is not strictly affecting 
egg-production or ovarian-related processes, but is rather linked to how 
utilizable an EAA profile is towards whole-body biomass synthesis. Combined, 
these observations indicate that matching the dietary AA supply to the exome 
requirement enhances AA utilization for biomass synthesis, both in developing 
larvae and adult flies, especially at lower dietary nitrogen levels. 
 
The endosymbiont bacterium Wolbachia can be essential for insect growth 
and development due to its provision of cofactors including B vitamins to the 
host (209), while in some cases endosymbionts may even produce and 
supply AAs to the host and accelerate development (210). Therefore it was 
tested whether the presence of Wolbachia affects development in the same 
conditions. The effects of dietary AA ratios on development time, viability, and 
body mass were independent of the presence of Wolbachia in both genders, 
as well as of fly strain (Figure 4.6A-D). In addition, the effects of dietary AA 
ratios on developmental time and viability were at least partially independent 
of the presence of dILPs 2,3-5 as differences for both traits observed across 
AA ratios in dahomey flies were also seen in flies lacking dILPs 2,3-5 (Figure 
4.6E-F). Thus the developmental effects of FlyAA were independent of 
Wolbachia status or of the secretion of dILPs 2,3-5. 
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Figure 4.5 
 
a. Development time as a function of dietary yeast concentration. Development is delayed 
when the supply of dietary yeast, the only protein source in the standard SY diet, is 
decreased. Each date point represents a trial using (per treatment) 5 biological replicates of 
20 flies. Error bars represent SEM. 
 
b. Effects of dietary AA ratio on developmental time across dietary nitrogen levels. 
Developmental delay for both male and female flies, seen as prolonged egg-to-eclosion time 
(days), occurred in both exome-mismatched ratios (HuntAA and MMAA) compared to the 
exome-balanced ratio (FlyAA). However, the effect is prominent at low dietary N levels 
(<200N) and dissipates as dietary N increases. Error bars shown represent SD between 
trials, N = 5-10 trials per treatment, with 125 eggs per trial per treatment (2-way ANOVA 
analysis with Bonferonni posthoc test, HuntAA vs. FlyAA P value = 0.0153 for the time-AA 
ratio interaction, F ratio = 3.567; MMaa vs. FlyAA P value = 0.0231 for the time-AA ratio 
interaction, F ratio = 2.3565; for both comparisons, both viability and AA ratio P value < 
0,0001).  
 
c. Effects of dietary AA ratio on developmental viability across dietary nitrogen levels. 
Developmental survival, seen as proportion of eggs eclosing, is decreased in both exome-
mismatched ratios (HuntAA and MMAA) compared to the exome-matched ratio (FlyAA). 
However, as for developmental timing, the effect is clear at low dietary N levels (<200N) but 
wanes as dietary N increases. Error bars shown represent SD between trials, N = 5-10 trials 
per treatment, with 125 eggs per trial per treatment (2-way ANOVA analysis with Bonferonni 
posthoc test, HuntAA vs. FlyAA P value < 0.0001 for the viability-AA ratio interaction, F ratio = 
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10.28; MMaa vs. FlyAA P value < 0.0001 for the viability-AA ratio interaction, F ratio = 17.54; 
for both comparisons, both viability and AA ratio P value < 0,0001). 
 
d. Female body mass upon eclosion across dietary AA ratios and dietary nitrogen (N) levels. 
Upon eclosion (day 1) female body mass is decreased for flies reared in HuntAA or MMAA 
compared to flies reared in the exome ratio (FlyAA). However, as for developmental timing, 
the effect is strong at low dietary N levels (<200N) but less so as dietary N increases. Error 
bars represent SD between trials, N = 5-10 trials per treatment, with 125 eggs per trial per 
treatment (2-way ANOVA analysis with Bonferonni posthoc test, HuntAA vs. FlyAA P value < 
0.0001 for the mass-AA ratio interaction, F ratio = 15.31; MMaa vs. FlyAA P value = 0.0057 
for the mass-AA ratio interaction, F ratio = 5.24; for both comparisons, both mass and AA 
ratio P value < 0,0001). 
 
e. Male body mass upon eclosion across dietary AA ratios and dietary nitrogen (N) levels. 
Upon eclosion (day 1) male body mass is decreased for flies reared in HuntAA or MMAA 
compared to flies reared in the exome ratio (FlyAA). However, as for developmental timing, 
the effect is strong at low dietary N levels (<200N) but less so as dietary N increases. Error 
bars represent SD between trials, N = 5-10 trials per treatment, with 125 eggs per trial per 
treatment (2-way ANOVA analysis with Bonferonni posthoc test, HuntAA vs. FlyAA P value < 
0.0001 for the mass-AA ratio interaction, F ratio = 14.93; MMaa vs. FlyAA P value < 0.0001 
for the mass-AA ratio interaction, F ratio = 29.44; for both comparisons, both mass and AA 
ratio P value < 0,0001). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	 94	
 
 
 
Figure 4.6 
 
a/b. Female (a) and male (b) body mass upon eclosion across dietary AA ratios and dietary 
nitrogen (N) levels of dahomey (Wolbachia +), and white dahomey (Wolbachia+ or 
Wolbachia-). Upon eclosion (day 1) both female and male body mass is decreased for flies 
reared in HuntAA or MMAA compared to flies reared in the exome ratio (FlyAA), and this is 
independent of the presence of Wolbachia (+ vs. -) or the fly strain (dahomey vs. white 
dahomey). Moreover, the effect is strong at low dietary N levels (<200N) but less so as 
dietary nitrogen (N) increases. Error bars shown represent SD, while N = 5 biological 
replicates of 25 eggs per treatment (2-way ANOVA analysis with Bonferonni posthoc test, 
HuntAA vs. FlyAA P value < 0.05 for the N level-AA ratio interaction, F ratio = 3.12; MMaa vs. 
FlyAA P value < 0.05 for the N level-AA ratio interaction, F ratio = 2.67; for both comparisons, 
both N level and AA ratio P value < 0,0001). 
 
c. Effects of dietary AA ratio on developmental time across dietary nitrogen levels of dahomey 
(Wolbachia +), and white dahomey (Wolbachia+ or Wolbachia-). Developmental delay for 
both male and female flies, seen as prolonged egg-to-eclosion time (days), occurred in both 
exome-mismatched ratios (HuntAA and MMAA) compared to the exome-balanced ratio 
(FlyAA) and this is independent of the presence of Wolbachia (+ vs. -) or the fly strain 
(dahomey vs. white dahomey). However, the effect is prominent at low dietary N levels 
(<200N) and dissipates as dietary N increases. Error bars shown represent SD, while N = 5 
biological replicates of 25 eggs per treatment (2-way ANOVA analysis with Bonferonni 
posthoc test, HuntAA vs. FlyAA P value < 0.05 for the N level-AA ratio interaction, F ratio = 
8.941; MMaa vs. FlyAA P value < 0.05 for the N level-AA ratio interaction, F ratio = 6.54; for 
both comparisons, both N level and AA ratio P value < 0,05). 
 
d. Effects of dietary AA ratio on developmental viability across dietary nitrogen levels of 
dahomey (Wolbachia +), and white dahomey (Wolbachia+ or Wolbachia-). Developmental 
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survival, seen as proportion of eggs eclosing, is decreased in both exome-mismatched ratios 
(HuntAA and MMAA) compared to the exome-matched ratio (FlyAA) and this is independent 
of the presence of Wolbachia (+ vs. -) or the fly strain (dahomey vs. white dahomey). 
However, as for developmental timing, the effect is clear at low dietary N levels (<200N) but 
wanes as dietary N increases. Error bars shown represent SD, while N = 5 biological 
replicates of 25 eggs per treatment (2-way ANOVA analysis with Bonferonni posthoc test, 
HuntAA vs. FlyAA P value < 0.05 for the N level-AA ratio interaction, F ratio = 3.12; MMaa vs. 
FlyAA P value < 0.0001 for the N level-AA ratio interaction, F ratio = 1.02; for both 
comparisons, both N level and AA ratio P value < 0,0001). 
 
e. Effects of dietary AA ratio on developmental time across dietary nitrogen levels of dahomey 
females, and of females that do not secrete insulin-like peptides 2-3, and 5 due to a knock-out 
mutation (dilp2-3,5) (42)(154). Developmental delay for both male and female flies, seen as 
prolonged egg-to-eclosion time (days), occurred in both exome-mismatched ratios (HuntAA 
and MMAA) compared to the exome-balanced ratio (FlyAA) and this is independent of dilps2-
3,5. N = 5 biological replicates of 25 eggs per treatment. Statistical analysis uses Student’s T-
test for pair-wise comparisons. 
 
f. Effects of dietary AA ratio on developmental viability across dietary nitrogen levels of 
dahomey females, and of females that do not secrete insulin-like peptides 2-3, and 5 due to a 
knock-out mutation (dilp2-3,5) (42)(154). Developmental survival, seen as proportion of eggs 
eclosing, is decreased in both exome-mismatched ratios (HuntAA and MMAA) compared to 
the exome-matched ratio (FlyAA) and this is independent of dilps2-3,5. N = 5 biological 
replicates of 25 eggs per treatment. Statistical analysis uses Student’s T-test for pair-wise 
comparisons. 
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4.3.4	The	metabolic	fate	of	ingested	AAs	
 
Having established that exome-matching can promote anabolic traits, other 
aspects of AA metabolism were next considered. There are common 
processing steps that all AAs go through during absorption, metabolism, and 
excretion. Ingested AAs first encounter intestinal cells and gut bacteria, where 
some AAs are terminally metabolized. Next, AAs pass through the rest of the 
splanchnic bed, where more AAs are metabolized in situ. In the liver, AAs can 
have a rather diverse metabolic fate. They can be directly utilized for protein 
synthesis, with the rate of protein synthesis and degradation determining 
proteostasis. Alternatively, they can be broken down to their carbon skeletons 
and amino groups. Although amino groups are typically excreted, carbon 
skeletons can be used for lipogenesis, respiration, or glucogenesis. The 
balance between lipogenesis and lipolysis determines lipostasis, while cellular 
respiration also determines energy homeostasis. Finally, glucose and 
glycogen synthesis determine glucose homeostasis. To compare imbalanced 
dietary AA ratios to the exome-matched ratio, focus was given on the multiple 
downstream biochemical pathways involved in AA processing, metabolism, 
and excretion. A series of phenotypes was assessed linked to such metabolic 
phenomena including nitrogen metabolism, lipostasis, respiration, energy 
homeostasis, glucose homeostasis, and proteostasis (Figure 4.7A).  
 
4.3.5	Nitrogen	losses	
 
Degradation of AAs results in amino groups that are ultimately secreted by the 
fly as uric acid (Figure 4.7A). Comparing nitrogen losses to nitrogen intake 
provides an estimation of nitrogen balance, a measure of the difference 
between anabolism and catabolism of biologically available nitrogen (here, in 
the form of amino acids) (186). Differences in nitrogen balance therefore 
indicate how utilizable a nitrogenous source is (186). Therefore, to assess 
how utilizable the exome-matched (FlyAA) profile is compared to exome-
mismatched (HuntAA, MMAA) profiles, uric acid excretion in ad-libitum fed 
adult females was quantified across AA ratios and dietary nitrogen levels. In 
all tested conditions, FlyAA consistently reduced the excretion of uric acid 
compared to HuntAA or MMAA (Figure 4.7B), indicating that FlyAA is a more 
bio-utilizable AA source. Moreover, we observed a negative correlation 
between day 8 fecundity and day 8 uric acid excretion (Figure 4.7C; R2=0.54), 
suggesting that the higher usability of AAs in FlyAA contributes towards egg 
biosynthesis. In rodents, nitrogen utilization prior to the onset of a starvation 
period positively correlates to excretion of nitrogen during this starvation 
period, as animals on a positive nitrogen balance in the period before the 
onset of starvation secrete more nitrogen after the onset of starvation (211). 
Therefore we asked whether this positive correlation is also seen in flies in 
order to confirm the higher usability of FlyAA. We checked whether flies 
previously maintained on the more usable FlyAA can, upon starvation, 
catabolize and excrete more uric acid than flies previously fed on a less 
utilizable AA ratio (HuntAA, MMAA). During 16 hours of starvation, secretion 
of uric acid in adult females was the highest in females previously kept in 50-
100N FlyAA (Figure 4.7D), reversing the trend observed in ad libitum-fed flies 
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(Figure 4.7B). Combined these results suggest that under normal feeding 
conditions, flies fed FlyAA utilize more of the ingested AAs compared to flies 
fed HuntAA or MMAA, and that upon starvation flies fed FlyAA catabolize 
more of their utilized nitrogen. 
 
 
 
Figure 4.7 
 
a. The metabolic fate of ingested amino acids. Modified from (69). See text for details. 
 
b. Uric acid excretion of 10-day old ad libitum-fed females across different dietary AA profiles. 
For quantification, each bar shown represents 4 biological replicates, each replicate 
representing the uric acid excreted by 10 flies per treatment. Error bars represent SD, stars 
indicate statistically significant differences (P value < 0.05) for pair-wise comparisons 
(Student’s t-test). 
 
c. Correlation of uric acid excretion of 10-day old ad libitum-fed females with day 8 fecundity 
across different dietary AA profiles. For quantification, each point represents 4 biological 
replicates on the x axis (uric acid concentration), and 4-16 biological replicates on the y axis 
(day 8 fecundity). For uric acid, each replicate representing the uric acid excreted by 10 flies 
per treatment, whereas for fecundity each trial used (per treatment) 6 biological replicates of 
10 flies. Error bars represent SD. 
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d. Uric acid excretion of 10-day old 16-hour starved females across different dietary AA 
profiles. For quantification, each bar shown represents 3-4 trials, each trial representing 6 
biological replicates, each replicate representing the uric acid excreted by 10 flies per 
treatment. Error bars represent inter-trial SD, stars indicate statistically significant differences 
(P value < 0.05) for pair-wise comparisons (Student’s t-test). 
 
4.3.6	Lipid	storage	and	starvation	resistance	
 
As discussed above, exome-matching increases body mass in adult male and 
female flies compared to exome-imbalanced dietary AA ratios. To establish if 
such body mass changes are due to changes in body composition, fat storage 
in adult females was examined. Upon analysis of the effect of dietary nitrogen 
in triacylglyceride (TAG) levels, an inverse relationship was observed between 
dietary nitrogen and TAGs in flies kept in YAA (Figure 4.8A). Moreover, flies 
with higher TAG levels survived longer upon starvation (Figure 4.8B), with a 
strong correlation between the two traits (R2=0.93; Figure 4.8C). These 
results suggest that a high utilization of dietary AAs decreases fat storage and 
starvation resistance in flies. We therefore tested whether manipulating the 
AA source, rather than the overall AA intake, also has similar effects upon fat 
storage and starvation resistance. Interestingly, we saw decreased TAG 
storage in flies fed FlyAA (Figure 4.8D), and this was accompanied by a 
reduced starvation resistance across dietary nitrogen levels (Figure 4.8E-F). 
Analysis of this TAG storage and starvation resistance data also revealed a 
strong correlation between the two variables (Figure 4.8G). Therefore, an 
increase utilization of ingested AAs leads to leaner animals, which is 
detrimental for starvation resistance. Importantly, this leanness can be 
conferred by either an increase in the total dietary AA levels, or by a change 
in the profile of the ingested AAs. Interestingly, the decrease in TAG levels 
was not seen at lower dietary nitrogen levels (50N), as flies fed FlyAA were 
able to maintain their adipocity. 
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Figure 4.8 
 
a. Triacylglyceride levels shown as % across dietary nitrogen levels (0N-200N) for flies kept in 
an AA ratio matching that of yeast (YAA). For quantification, each bar shown represents 2-5 
trials, each trial representing 5 biological replicates, each replicate representing 5 flies per 
treatment. Error bars represent inter-trial SD, stars indicate statistically significant differences 
(P value < 0.05) for pair-wise comparisons (Student’s t-test). 
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b. Starvation resistance for 10-day old females on an agar-only medium. Flies were 
previously kept for 8 days across different dietary AA profiles as indicated in the panel. For 
each treatment N=100. 
 
c. The amount of TAGs stored over 8 days of treatment in different dietary nitrogen levels 
(50N-200N) by flies kept in an AA ratio matching that of yeast (YAA) was positively correlated 
to the amount of uric acid excreted (R2 = 0.93). Data points as described in Figure 4.s 8A-B. 
 
d. Triacylglyceride levels across dietary nitrogen levels (0N-300N) for FlyAA, HuntAA, and 
MMAA in 10-day old females. Whole-body TAG levels were measured in adult flies (10 days) 
and normalized to total protein levels (25 flies per group per trial). For quantification, each bar 
shown represents 3-6 trials, each trial representing 5 biological replicates, each replicate 
representing 5 flies per treatment. Error bars represent inter-trial SD, stars indicate 
statistically significant differences (P value < 0.05) for pair-wise comparisons (Student’s t-
test). 
 
e. Starvation resistance for 10-day old females on an agar-only medium. Flies were 
previously kept for 8 days across different dietary AA profiles as indicated in the panel. For 
each treatment N=100. 
 
f. Starvation resistance on an agar-only medium for 10-day old females. Flies were previously 
kept for 8 days across different dietary AA profiles as indicated in the panel. Values shown 
represent the mean from 2-4 independent trials, each trial using per treatment N=100. 
 
g. The amount of TAGs stored over 8 days of treatment in different dietary AA profiles across 
nitrogen levels (50N-200N) was positively correlated to the mean survival upon starvation for 
flies pre-treated on the respective diet (R2 = 0.68). Data points as described in Figure 4.s 8D-
F. 
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4.3.7	Organ	masses	and	protein	content	
 
Apart from the effects of exome-matching upon body composition (TAG 
contents), body masses of adult (10-day-old) females reared in standard 
sugar-yeast media and kept for 8 days in holidic diets of the respective 
treatments also increased significantly with FlyAA (Figure 4.9A). Moreover, 
higher gut dry weights were seen in females fed FlyAA (Figure 4.9B), but no 
differences were observed in the dry weight of whole heads (Figure 4.9C). To 
confirm the increased lean mass of flies fed FlyAA, the protein content in flies 
maintained in different dietary AA ratios was next assessed. Flies kept on 
FlyAA had significantly increased protein contents, both in terms of protein 
content per fly (Figure 4.9D) and of protein content per mg of fly tissue (Figure 
4.9E; data for Figure 4.s 9B-E by Hanna Salmonowicz, Chirag Jain, and 
George Soultoukis). 
 
 
 
Figure 4.9 
 
a. Effects of dietary AA ratio on adult female body mass across dietary nitrogen (N) levels. 
Day 10 female body mass is decreased for flies reared in both exome-mismatched ratios 
compared to flies reared in the exome-balanced ratio. However, as for day 1 body masses, 
the effect is strong at low dietary N levels (<200N) but less so as dietary N increases. Error 
bars shown represent SD between pairs of females weighed, N = 10-20 pairs of females 
weighed per treatment across 2 trials, letters indicate statistically significant differences 
(p<0.05) for pair-wise comparisons (Student’s t-test) in one dietary N level. 	
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b. The dry weight of guts for 10-day old females kept in 100N FlyAA, HuntAA, or MMAA. 
Each bar represents 4 biological replicates, each replicate using 20 guts per treatment. Error 
bars represent SD, letters indicate statistically significant differences (P value < 0.05) for pair-
wise comparisons (Student’s t-test). 
 
c. The dry weight of heads for 10-day old females kept in 100N FlyAA, HuntAA, or MMAA. 
Each bar represents 4 biological replicates, each replicate using 15 heads per treatment. 
Error bars represent SD, letters indicate statistically significant differences (P value < 0.05) for 
pair-wise comparisons (Student’s t-test). 
 
d. Protein content in the whole body of 10-day old females kept in 50-200N FlyAA, HuntAA, or 
MMAA. Each data point represents 5 biological replicates, each replicate using 5 flies per 
treatment. Error bars represent SD, stars indicate statistically significant differences (P value 
< 0.05) for pair-wise comparisons (Student’s t-test). 
 
e. Protein content in the whole body of 10-day old females kept in 100N FlyAA, HuntAA, or 
MMAA. Each data point represents 5 biological replicates, each replicate using 5 flies per 
treatment. Error bars represent SD, stars indicate statistically significant differences (P value 
< 0.05) for pair-wise comparisons (Student’s t-test). 
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4.3.8	Mitochondrial	respiration	
 
To assess the possibility that the ingested AA profile can induce changes in 
mitochondrial biogenesis, whole body levels of the voltage-dependent anion 
channel (VDAC), which is ubiquitously expressed and located in the outer 
mitochondrial membrane and is used as a marker of mitochondrial abundance 
and biogenesis, were first quantified. No differences in VDAC protein levels 
were seen between FlyAA and HuntAA or MMAA in whole female flies or in 
the head and thorax specifically (Figure 4.10A. The respiration rate of female 
flies across diets in a tissue-specific manner was next assessed. Analysis of 
oxygen consumption in the head (Figure 4.10B) and gut (Figure 4.10C) 
revealed no significant differences between females fed on FlyAA, MMAA, or 
HuntAA. However, oxygen consumption in the thorax (Figure 4.10D) and fat 
body (Figure 4.10E) of females fed FlyAA was significantly increased across 
all respiratory substrates, indicating that animals fed FlyAA exhibit a higher 
rate of mithochondrial respiration specifically on these two tissues (Figure 
4.10 data by Chirag Jain, Hanna Salmonowicz and George Soultoukis). 
 
 
4.3.9	Glucose	homeostasis	and	glycogen	synthesis	
 
Although all of our fly test diets contain standard levels of sucrose (29), 
sugars and carbohydrates can also be produced from catabolites generated 
during AA metabolism (Figure 4.7A). Therefore to test if FlyAA, as a more 
usable AA source, enhances glucose utilization in the fly, whole-body glucose 
levels were assessed. However, no changes among the diets or across 
dietary nitrogen levels were observed (Figure 4.10F).  
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Figure 4.10 
 
a. Protein levels of the voltage-dependent anion channel (VDAC) in the heads and thoraces 
of 10-day old females across different dietary AA profiles. For quantification, each bar shown 
represents 3 biological replicates, each replicate using a protein extract from 15 heads and 
thoraces per treatment. Error bars represent SEM, letters indicate statistically significant 
differences (P value < 0.05) for pair-wise comparisons (Student’s t-test). 
 
b. Measurement of mitochondrial oxygen consumption in the head of 10-day old females 
across different dietary AA profiles. Rate of oxygen consumption normalized to dry weight 
content in response to different diet regimes. For quantification, each bar shown represents 4 
biological replicates, each replicate using an extract from 15 heads per treatment. Error bars 
represent SD, stars indicate statistically significant differences (P value < 0.05) for pair-wise 
comparisons (Student’s t-test). 
 
c. Measurement of mitochondrial oxygen consumption in the gut of 10-day old females across 
different dietary AA profiles. Rate of oxygen consumption normalized to dry weight content in 
response to different diet regimes. For quantification, each bar shown represents 4 biological 
replicates, each replicate using an extract from 20 guts per treatment. Error bars represent 
SD, stars indicate statistically significant differences (P value < 0.05) for pair-wise 
comparisons (Student’s t-test). 
 
d. Measurement of mitochondrial oxygen consumption in the thorax of 10-day old females 
across different dietary AA profiles. Rate of oxygen consumption normalized to dry weight 
content in response to different diet regimes. For quantification, each bar shown represents 4 
biological replicates, each replicate using an extract from 2 thoraces per treatment. Error bars 
represent SD, stars indicate statistically significant differences (P value < 0.05) for pair-wise 
comparisons (Student’s t-test). 
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e. Measurement of mitochondrial oxygen consumption in the fat body of 10-day old females 
across different dietary AA profiles. Rate of oxygen consumption normalized to dry weight 
content in response to different diet regimes. For quantification, each bar shown represents 4 
biological replicates, each replicate using an extract from 15 fat bodies per treatment. Error 
bars represent SD, stars indicate statistically significant differences (P value < 0.05) for pair-
wise comparisons (Student’s t-test). 
 
f. Whole body glucose levels of 10-day old females across dietary nitrogen levels (50N-200N) 
and ratios, with 1SY as control. Bars represent the mean of 4 biological replicates, each 
replicate representing 5 flies per treatment. Error bars represent SD, letters indicate 
statistically significant differences (P value < 0.05) for pair-wise comparisons (Student’s t-
test). 
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4.3.10	Proteostasis	
 
To test whether exome-matching affects proteostasis in flies, the effects of 
FlyAA on protein sythesis, proteasome activity, poly-ubiquitination, and 
autophagy were tested (Figure 4.11 data by Hanna Salmonowicz). Polysome 
profiling and 35S-methionine incorporation revealed no differences between 
FlyAA, HuntAA, and MMAA in the protein sythesis rate (Figure 4.11A-D), 
although total levels of 4E-BP1 were significantly higher for MMAA and 0N, 
indicating a higher translational repression (Figure 4.11E). Proteasomal 
degradation was increased by FlyAA in both genders (Figure 4.11F-G), and in 
females this effect was not restricted to the germ-line but was also seen in 
somatic tissues (Figure 4.11H). Ubiquitination status, measured by Western 
blot analysis with a K48-linkage specific poly-ubiquitin antibody, was highly 
elevated by FlyAA (Figure 4.11I). Measures of autophagy were not altered 
between the three dietary AA ratios (Figure 4.11J-K). A decreased survival 
upon proteasome inhibition on FlyAA was also observed (Figure 4.11L), 
suggesting a reliance on proteasomal activity to cope with proteotoxic stress 
load. 
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Figure 4.11 
 
(data by Hanna Salmonowicz) 
 
a. Polysome profiling showing similar patterns across different dietary AA ratios. Curves 
represent the ribosomal/polysomal fractions across a sucrose gradient. Each curve shown 
represents a single representative biological replicate (out of 3) of 60-80 heads and thoraxes.  
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b. Quantification of the AUC (area under curve) in the polysome profiles across different 
dietary AA ratios. No significant shift was detected between the different dietary AA ratios (P 
value > 0.05, one-way ANOVA, and Dunnet post-hoc test). Each box plot represents three 
biological replicates, each using 60-80 heads and thoraxes.  
 
c. The effect of the dietary AA ratio on 35S-methionine incorporation. Bars represent mean 
scintillation counts per minute normalized to protein content (in µg), for 5 trials, each using 5 
heads and thoraxes per dietary AA profile. Error bars represent SEM, and letters indicate no 
statistically significant differences (P value > 0.05, one-way ANOVA, and Dunnet post-hoc 
test).  
 
d. Autoradiograph (left panel) showing the amount of the 35S-methionine incorporated into 
the proteins of dissected heads and thoraces under equal protein loading (middle panel). 
Quantification of the autoradiograph is normalized to the total protein content obtained by 
Coomassie staining (right panel). Each bar represents 5 trials, each using 5 heads and 
thoraxes per dietary AA profile. Error bars represent SEM.  
 
e. 4E-binding protein 1 (4E-BP1) protein and phosphorylation levels in the head and thorax of 
10-day old females across different dietary AA profiles at 100N. For quantification, each bar 
shown represents 4-5 biological replicates, each replicate using a protein extract from 15 
heads and thoraces per treatment. Error bars represent SEM, letters indicate statistically 
significant differences (P value < 0.05) for pair-wise comparisons (Student’s t-test). 
 
f. Proteasome activity of 10-day old females across AAs ratios (HUNTaa, MMaa, FLYaa) at 
100N with 1SY and 0N as controls. The chart shows the activity based on the LLE-AMC 
substrate degradation as both substrates behaved similarly (data not shown). Each bar 
represents 5 biological replicates of 5 flies each. Error bars represent SEM, letters indicate 
statistically significant differences (P value < 0.05) as determined by one-way ANOVA, with a 
Dunnet post hoc test. 
 
g. Proteasome activity of 10-day old males across AAs ratios (HUNTaa, MMaa, FLYaa) at 
100N with 1SY and 0N as controls. The chart shows the activity based on the LLE-AMC 
substrate degradation as both substrates behaved similarly (data not shown). Each bar 
represents 5 biological replicates of 5 flies each. Error bars represent SEM, letters indicate 
statistically significant differences (P value < 0.05) as determined by one-way ANOVA, with a 
Dunnet post hoc test. 
 
h. Proteasome activity of 10-day old female heads and thoraces across AAs ratios (HUNTaa, 
MMaa, FLYaa) at 100N with 1SY and 0N as controls. The chart shows the activity based on 
the LLE-AMC substrate degradation as both substrates behaved similarly (data not shown). 
Each bar represents 5 biological replicates of 15 head and thoraces each. Error bars 
represent SEM, letters indicate statistically significant differences (P value < 0.05) as 
determined by one-way ANOVA, with a Dunnet post hoc test. 
 
i. Western blot analysis of ubiquitination status in 10-day old female heads and thoraces 
across AAs ratios (HUNTaa, MMaa, FLYaa) at 100N with 0N as a control. Quantification 
performed on the basis on 3 biological replicates expressed as arbitrary units and reproduced 
>3 times. Error bars represent SEM, letters indicate statistically significant differences (P 
value < 0.05) as determined by one-way ANOVA, with a Dunnet post hoc test. 
 
j. Western blot analysis of the level of Ref2P across dietary AA ratios. Quantification 
performed on 9 biological replicates, each using 15 heads and thoraces, and expressed as 
arbitrary units. Error bars represent SEM and statistical comparison was performed using 
one-way ANOVA, and Dunnet post hoc test. 
 
k. Western blot analysis of the level of Atg8 across AA ratios. Quantification performed on 9 
biological replicates, each using 15 heads and thoraces, and expressed as arbitrary units. 
Error bars represent SEM and statistical comparison was performed using one-way ANOVA, 
and Dunnet post hoc test. 
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l. Proteotoxic stress resistance in 10-day old females kept in 100N FlyAA, HuntAA, or MMAA, 
as assessed by Bortezomib addition to the media and kept at 29°C. Chi squared p values for 
all the treatments differed significantly between all treatments except HuntAA vs. MMAA. 
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4.3.11	Proteasome	activity,	biogenesis,	and	fecundity	
 
To further establish if proteasome activity can be dictated by modulating the 
most limiting EAA, arginine was modulated in HuntAA and it was observed 
that increasing or decreasing arginine alone augmented or reduced whole 
body proteasome activity (Figure 4.12A). Furthermore, introducing an 80% 
arginine or isoleucine restriction in FlyAA suppressed whole body proteasome 
activity (Figure 4.12B), reflecting the proteasome activities of exome-
mismatched ratios with arginine (HuntAA) or isoleucine (MMAA) limitations 
respectively (Figure 4.11F). However, a correlation between proteasome 
activity and fecundity rate in these diets was observed (Figure 4.12C), so 
proteasome activity was next tested when methionine, earlier seen to be 
replenishable for fecundity, was restricted. Although an 80% restriction of 
Leucine significantly suppressed both proteasomal activity (Figure 4.12D) and 
fecundity (Figure 4.12E), restriction of Methionine by 80% significantly 
decreased whole body proteasome activity (Figure 4.12D) but not fecundity 
(Figure 4.12E). These results suggest that fecundity and proteasome activities 
are not necessarily coupled, as methionine restriction is conditionally essential 
for fecundity but limits in vivo proteasome activity. 
 
To further probe into why restricting isoleucine reduced proteasome activity 
more than restricting arginine, we considered proteasome AA usage. We 
hypothesized that if the composition of the proteasome’s proteome is enriched 
in isoleucine (the limiting EAA in MMAA), and not in arginine (the limiting EAA 
in HuntAA), dietary isoleucine limitations will reduce proteasome biogenesis to 
a greater extent than will dietary arginine limitations. However, the 
proteasome’s proteome (GO:0000502) has a proportional requirement for 
isoleucine that is similar to that for arginine (Figure 4.12F). We next 
considered the proteasome’s core complex 20S pros-α subunit (P12881, 
Uniprot), for which a commercial antibody is available. Analysis of the 
proportional AA usage in the 20S pros-α subunit showed a similar 
proportional requirement for arginine and isoleucine (Figure 4.12F), and 
western blot analysis of the subunit’s protein levels showed similar levels in 
MMAA and HuntAA (Figure 4.12G).  
 
We decided to experimentally test the principle of minimum at the molecular 
level by assessing the effect of single EAA restrictions upon pros-α subunit 
biosynthesis. Tryptophan usage in the exome is 62% higher compared to that 
in pros-α (Figure 4.12F), so we tested whether a 62% restriction of 
Tryptophan in FlyAA ratio reduces pros-α subunit biosynthesis. In contrast, 
threonine, isoleucine, and arginine usages are 32%, 14%, and 19% higher in 
the pros-α subunit compared to FlyAA respectively (Figure 4.12F), so we 
tested whether reducing these three AAs in a FlyAA diet by 62% limits pros-α 
subunit biosynthesis. Pros-alpha subunit levels and proteasome activities 
were reduced in all four single dietary AA-restrictions, including that of 
tryptophan (Figure 4.12H-I). Therefore no correlation was observed between 
the degree of a dietary limitation in an EAA and usage of that EAA towards 
pros-α biosynthesis. However, pros-α subunit levels matched the observed 
proteasome activity in these conditions (Figure 4.12H-I), suggesting that by 
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restricting these individual AAs in FlyAA, proteasome subunit biogenesis and 
proteasomal activity are both similarly altered.  
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Figure 4.12 
 
(data by Dr. Ilian Atanassov, Hanna Salmonowicz, and George Soultoukis) 
 
a. Whole body proteasome activity of 10-day old females fed HuntAA at 100N, but with 
manipulations in Arginine, the most limiting AA. The chart shows the activity based on the 
LLE-AMC substrate degradation as both substrates behaved similarly (data not shown). Each 
bar represents 5 biological replicates of 10 flies each. Error bars represent SEM, letters 
indicate statistically significant differences (P value < 0.05) as determined by one-way 
ANOVA, with a Dunnet post hoc test. 
 
b. Whole body proteasome activity of 10-day old females fed FlyAA at 100N, but with 
manipulations in Arginine, the most limiting AA in HuntAA, or Isoleucine, the most limiting AA 
in MMAA. The chart shows the activity based on the LLE-AMC substrate degradation as both 
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substrates behaved similarly (data not shown). Each bar represents 5 biological replicates of 
10 flies each. Error bars represent SEM, letters indicate statistically significant differences (P 
value < 0.05) as determined by one-way ANOVA, with a Dunnet post hoc test. 
 
c. Observed fecundity for FlyAA, against FlyAA with 80% restrictions in Arginine (20%R) or 
Isoleucine (20%I). The fecundity decrease for the 20%I treatment is more severe than it is for 
the 20%R treatment. Each bar represents 3-4 trials, each trial using (per treatment) 6 
biological replicates of 10 flies. Error bars represent SEM. 
 
d. Whole body proteasome activity of 10-day old females fed FlyAA at 100N, but with 
manipulations in Leucine or Methionine. The chart shows the activity based on the LLE-AMC 
substrate degradation as both substrates behaved similarly (data not shown). Each bar 
represents 5 biological replicates of 10 flies each. Error bars represent SEM, letters indicate 
statistically significant differences (P value < 0.05) as determined by one-way ANOVA, with a 
Dunnet post hoc test. 
 
e. Observed fecundity for the treatments shown in d. Each bar represents 3-4 trials, each trial 
using (per treatment) 6 biological replicates of 10 flies. Error bars represent SEM. 
 
f. Proportional weighted AA usage in the proteasome complex (GO:0000502), in the 
proteasome alpha subunit P12881, and in the exome (FlyAA). 
 
g. Western blot analysis of the level of 20S alpha proteasome subunit in the heads and 
thoraxes of female flies. The quantification shown in the lower panel represent 3 biological 
replicates of 5 females each, and is normalized to the total protein staining. 
 
h. Western blot analysis of proteasome alpha subunit upon single AA limitations. The 
quantification is based on 3 biological replicates consisting of 5 flies each. Statistical analysis 
was performed with the use of One-way ANOVA, and asterisks indicate P<0.05 towards the 
FlyAA control. 
 
i. Proteasome activity upon single AAs limitations in a 100N FlyAA diet. The trial consisted of 
5 biological replicates consisting of 3 flies each. Statistical analysis was performed with the 
use of One-way ANOVA, and asterisks indicate P<0.05 towards the FlyAA control. 
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4.3.12	Effects	of	exome-matching	on	early	adult	viability	
 
The nutritional efficiency of all three dietary AA ratios was similarly defined by 
both developmental viability and early adulthood mortality as a strong 
negative correlation between the two traits was seen across ratios (Figure 
4.13A & Appendix I), indicating that diets with lower dietary AAs decrease 
both developmental and early adulthood viability. This observation is also 
consistent with the increase in early mortality observed under low protein 
conditions of restricted dietary yeast (Figure 4.13B), as diet with a lower 
dietary nitrogen content showed a significantly higher early adulthood 
mortality (Figure 4.13A).  
 
 
 
 
 
Figure 4.13 
 
a. Developmental viability was negatively correlated to the proportion of early adulthood 
deaths, and therefore both traits seemed to be equally good predictors of the nutritional 
efficiency of each dietary AA ratio. The best fit line was described by a polynomial regression 
fit for HuntAA and FlyAA, and a linear regression fit for MMAA. N = 4-10 trials per treatment 
for early adult survivorship (see Appendix I). 
 
b. Effect of low protein intake on early survival. When consuming a low yeast diet (0.4SY), an 
increase in early mortality was observed, compared to a normal yeast diet (1SY); (N = 1000). 
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4.3.13	Exome-matching	vs.	proteome-matching	
 
Comparison of the proportional AA representation in the exomes of different 
organisms reveals considerable differences in AA usage. For example, the 
human exome shows different AA requirement to that of the fly exome (data 
not shown). However, exon transcription and translation are also likely to 
affect AA requirements as they shape the proteome, where most of the 
ingested AAs are ultimately utilized. The whole-body proteome of both flies 
and mice, as recently quantified by SILAC techniques (163, 166), allowed us 
to calculate AA usage in the weighted proteome of both organisms. In the fly, 
there were no differences between the proteome AA usage between genders 
(male vs. female), strains (tud vs. w1118), or tissues (Figure 4.14A). However, 
comparison of the exome and proteome AA usages shows that differences in 
the proportional AA usage between flies and mice are higher between their 
accrued proteomes than it is between their exomes (Figure 4.14B-C). This 
observation suggests that AA usage between organisms may be better 
reflected by the proteome’s, not the exome’s AA requirements. Thus, although 
the exome is an efficient measure for defining AA requirements in the fly, we 
compared the weighted whole fly proteome AA usage to the exome 
requirement (Figure 4.14D). The proteome AA ratio (PAA) was in fact very 
similar to the exome ratio, with the most significant limitation being histidine 
(rH(min) = 0.71). Although this limitation is relatively small compared to that in 
HuntAA (rR(min) = 0.27) or MMAA (rI(min) = 0.36), we determined if feeding flies 
on PAA further boosts anabolic traits such as fecundity and growth compared 
to FlyAA. However, no significant differences were seen between PAA and 
FlyAA for traits including development time (Figure 4.14E), developmental 
viability (Figure 4.14F), or body mass of females (Figure 4.14G) or males 
(Figure 4.14H) upon eclosion. As for FlyAA, the fecundity increase in higher 
dietary nitrogen was also best described by a logarithmic fit for PAA (Figure 
4.14I). Therefore flies fed either the exome or proteome matched AA profiles 
performed distinctly to HuntAA or MMAA in terms of anabolic traits and 
lifespan, suggesting that both exome-matching and proteome-matching are 
good measures of the fly’s AA requirements for egg production. However, 
exome-matching resulted in an elevated fecundity (Figure 4.14I). Interestingly 
histidine, whose restriction or deprivation fails to fully suppress fecundity with 
immediate effect (Figure 4.s 3C-F), is the most limiting EAA in PAA, and 
exome-matched predictions were more accurately reflected the observed 
values when adjusted for the second most-limiting EAA, tryptophan (Figure 
4.14J). The lifespan of flies fed PAA also did not significantly differ to that of 
flies fed FlyAA (Appendix II). 
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Figure 4.14 
 
 
a. The whole-body proteome of flies, as recently quantified by SILAC (163). The calculated 
AA usage in the weighted proteome reveals no differences between the weighted proteome 
AA usage between genders (male vs. female), strains (tud vs. w1118), or tissues (wdah; in-
house data). Data by Dr. Ilian Atanassov. 
 
b. Comparison of the difference in AA usage between the fly and the mouse. The % change 
in fly AA usage compared to mouse AA usage is shown, with dark grey bars showing the % 
change in AA usage on the fly exome over the mouse exome, and light grey bars showing the 
% change in AA usage on the fly proteome over the mouse proteome. Except for leucine and 
threonine, differences in AA usage between the two organisms are higher between their 
proteomes than they are between their exomes. 
 
c. Cumulative difference in AA usage between the fly and the mouse exome compared to the 
cumulative difference in AA usage between the fly and the mouse proteome. The plot shows 
that differences in the proportional AA usage between flies and mice are higher between their 
accrued proteomes than between their exomes. Cumulative distance is the sum of the 
distance measure: sum over all amino acids of (ratio in protein – mean ratio in exome)^2 . 
 
d. Comparison of the fly’s exome (FlyAA) and proteome (PAA) ratios. The two ratios are 
highly similar, with the most significant Paa limitation being histidine (rH(min) = 0.71). This 
limitation is relatively small compared to that of HuntAA (rR(min) = 0.27) or MMAA (rI(min) = 0.36), 
indicating that the proteome profile of 10-day old females does not dramatically differ to the 
exome-predicted proportional AA requirements. 
 
e. FlyAA and PAA developmental time. Both the proteome and the exome ratio supported 
similar developmental times (p>0.05), indicating both dietary AA sources are utilized by the 
developing larvae with equal efficiencies. Error bars shown represent SD, N = 5 biological 
replicates of 125 and 25 eggs per treatment for FlyAA and PAA respectively (2-way ANOVA 
analysis with Bonferonni posthoc test, PAA vs. FlyAA P value = 0.8636 for the time-AA ratio 
interaction, F ratio = 0.1479).  
 
f. FlyAA and PAA developmental viability. Although the proteome ratio supported better 
developmental survival, the difference was not significant (p>0.05), indicating that the dietary 
AA source is utilized by the developing larvae with equal efficiencies. Error bars shown 
represent SD, N = 5 biological replicates of 125 and 25 eggs per treatment for FLYaa and 
Paa respectively (2-way ANOVA analysis with Bonferonni posthoc test, P value = 0.9383 for 
the viability-AA ratio interaction, F ratio = 0.06392; both viability and AA ratio P value > 0.05).  
 
g. Female body mass upon eclosion across exome and proteome ratios and dietary nitrogen 
(N) levels. Upon eclosion (day 1) female body mass is unchanged between flies reared in the 
proteome or the exome ratio. Error bars shown represent SD, N = 5 biological replicates of 
125 and 25 eggs per treatment for FLYaa and Paa respectively. Body masses were 
measured for pairs of flies, with the mean for each pair used for analysis (2-way ANOVA 
analysis with Bonferonni posthoc test, P value = 0.0159 for the mass-AA ratio interaction, F 
ratio = 4.203). 
 
h. Male body mass upon eclosion across exome and proteome ratios and dietary nitrogen (N) 
levels. Upon eclosion (day 1) male body mass is unchanged between flies reared in the 
proteome or the exome ratio. Error bars shown represent SD, N = 5 biological replicates of 
125 and 25 eggs per treatment for FLYaa and Paa respectively. Body masses were 
measured for pairs of flies, with the mean for each pair used for analysis (2-way ANOVA 
analysis with Bonferonni posthoc test, P value = 0.0225 for the mass-AA ratio interaction, F 
ratio = 3.849). 
 
i. Fecundity for female flies fed FlyAA and PAA across dietary nitrogen levels. The egg-laying 
of 8-day-old flies is similar between females maintained in PAA or FlyAA. This suggests that 
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both ratios are equally bio-utilizable for egg production-related anabolic processes. Each data 
point represents N=2-16 trials, each trial using 60 flies per treatment. Error bars represent 
SD. (2-way ANOVA analysis with Bonferonni posthoc test, P value < 0.05 for the fecundity-AA 
ratio interaction, F ratio = 2.689) 
 
j. Observed versus predicted fecundity for flies fed either the SILAC proteome AA usage 
(PAA) or flies fed the exome AA usage ratio (FlyAA) across dietary nitrogen levels (25-200N). 
Each bar represents 3 or more trials, each using (per treatment) 6 biological replicates of 10 
flies. Error bars represent SEM, letters indicate statistically significant differences (P value < 
0.05) as determined by one-way ANOVA, with a Dunnet post hoc test. 
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4.3.14	Effects	of	exome-defined	AA	restriction	or	deprivation	upon	adult	survival	
 
Next, it was set out to determine the effects of an 80% limitation in single 
EAAs compared to the exome requirement (20% of the FlyAA level, or 80% 
restriction) upon lifespan in flies fed 100N, 200N, and 300N FlyAA diets. The 
lifespan response was tested where the identity of the limiting AA altered to 
cover all 10 essential AAs. Results showed that at low dietary nitrogen supply, 
most AA limitations appeared to be detrimental, but at higher dietary nitrogen 
supply several AA limitations appeared to be beneficial for lifespan (Figure 
4.15A). In addition, despite a similar degree of limitation compared to FlyAA, 
different AAs caused a different effect upon lifespan. At 100N FlyAA, an 80% 
restriction of Threonine was more detrimental for survival than an 80% 
restriction of arginine (log rank test P value <0.05), and similarly an 80% 
restriction of leucine was more detrimental than phenylalanine (log rank test P 
value <0.05; Figure 4.15A). These results demonstrated that compared to the 
exome requirement, and when considering the lifespan response, the identity 
of the limiting AA should be taken into account even when the degree of 
limitation is identical between different AAs.  
 
Furthermore, upon analysis of survival at a diet with an ample amount of AAs 
(300N HuntAA) but 100% deprived of each single EAA separately, the 
deprivation of some EAAs had a more detrimental effect than that of others, 
with Isoleucine-deprived flies surviving significantly less compared to flies 
deprived of Arginine, and Threonine deprivation having a very severe impact 
on survival (Figure 4.15B). When considering the median survival in the diet 
with an ample amount of AAs (100N FlyAA) but 80% limited of each single 
EAA separately (first dataset from Figure 4.15A), there was no correlation 
between median survival in the 100% deprivation of each single EAA 
separately (dataset from Figure 4.15B) and median survival in the 80% 
restriction of each single EAA separately (first dataset from Figure 4.15A), as 
shown in the comparison between the two survival responses (Figure 4.15C). 
Thus the survival response to a 100% EAA deprivation is distinct to and does 
not necessarily correlate with the survival response to an 80% EAA limitation. 
Moreover, there was no correlation between survival upon deprivation of a 
single EAA and the usage for that EAA in the whole fly proteome (SILACAA) 
(Figure 4.15D). Therefore the abundance of an AA in the fly’s weighted 
proteome or exome is not a reliable predictor for survival upon deprivation 
from that EAA.  
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Figure 4.15 
 
a. Survivorship effect of single EAA deprivations in FlyAA 100N, 200N, and 300N. The effect 
of each deprivation is shown as % to the median survival observed in the respective control 
(100N, 200N, or 300N FlyAA). At lower dietary nitrogen levels (100N), deprivation of some 
EAAs (Thr, Met) has a more severe detrimental effect than that of others (Phe, Arg), while at 
higher dietary nitrogen levels (300N) the deprivation of certain EAAs (Ile, Phe) had a more 
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positive effect than that of others (Thr, Trp, His). For each treatment, N = 180. The log-rank 
test was used to compare survivorships in 80% restrictions of a single AA across the 3 dietary 
nitrogen levels (letters show significance when P value < 0.05). No comparisons of survival in 
80% restrictions of different AAs are shown. 
 
b. Survivorship effect of single EAA 80% restrictions in 300N HuntAA. Deprivation of some 
EAAs (Thr, Met) has a more severe detrimental effect than that of others (Phe, Arg). For each 
treatment, N = 200. Letters show significance when Log-rank test P value < 0.05. 
 
c. Relationship between median lifespan (MLS) upon a 100% EAA deprivation (Y-axis) and 
median lifespan (MLS) upon 80% EAA restriction (X-axis) in diets with ample amounts of non-
deprived/non-restricted EAAs (300N HuntAA and 100N FlyAA respectively). No correlation 
was observed between the two survival responses upon linear regression analysis (R2 value 
= 0.23). 
 
d. Relationship between median survival upon an EAA deprivation, and the abundance of that 
EAA in the fly’s SILAC proteome (SILACAA). No correlation was observed between the two 
traits upon linear regression analysis (R2 value = 0.032). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	 123	
4.3.15	Effects	of	larval	(L2)	free	AA-matching	
 
Circulating, intracellular, and protein-bound AA profiles differ significantly, but 
circulating and intracellular AAs fluctuate more dynamically and play a 
prominent metabolic role (4). The whole free AA profile of developing 
Drosophila larvae has been reported (162), so it was decided to also test if 
supplying AAs in a profile that matches the free AAs in the larval body (L2AA) 
can promote larval development more than FlyAA (Figure 4.16A). Upon 
comparison, L2AA seemed extremely different to FlyAA, with the most limiting 
EAA being tryptophan (rW(min) = 0.03), whose limitation was predicted to be 
very severe. Indeed, upon rearing Drosophila eggs in diets containing L2AA at 
25N to 300N it was found that development was severely delayed 
independently of dietary nitrogen levels (Figure 4.16B), and developmental 
survival was similarly reduced (Figure 4.16C). Confirming the severe 
deficiency of the Trp limitation in L2AA compared to FlyAA, increasing dietary 
nitrogen from 25N to 300N resulted in no detectable increase in day 8 
fecundity for flies kept in L2AA diets (Figure 4.16D). These observations show 
that matching the dietary AA profile to the whole body free AA composition of 
the developing larva is not efficient in meeting the AA requirements of the 
growing larva.  
 
 
 
Figure 4.16 
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a. Comparison of the fly’s exome (FLYaa) ratio and the whole larval body (L2) ratio. The two 
ratios are highly dissimilar, with the most significant L2aa limitation being tryptophan (r W(min) = 
0.03). This is a very severe limitation as it is predicted that only 3% of the exome’s 
proportional AA requirement is met by the L2 ratio.  
 
b. FlyAA and L2AA developmental time. The whole larval body ratio severely delayed 
development (p<0.05), indicating that the dietary AA source is utilized by the developing 
larvae with equal efficiencies. Error bars shown represent SD, N = 5 biological replicates of 
125 and 25 eggs per treatment for FlyAA and L2AA respectively (2-way ANOVA analysis with 
Bonferonni posthoc test, P value = 0.0156 for time-AA ratio interaction, F ratio = 3.643; both 
time and AA ratio P value < 0,0001).  
 
c. FlyAA and L2AA developmental viability. The whole larval body ratio severely decreased 
developmental viability (p<0.05), indicating that the dietary AA source is utilized by the 
developing larvae with equal efficiencies. Error bars shown represent SD, N = 5 biological 
replicates of 125 and 25 eggs per treatment for FlyAA and L2AA respectively (2-way ANOVA 
analysis with Bonferonni posthoc test, P value = 0.0002 for the viability-AA ratio interaction, F 
ratio = 8.026; both viability and AA ratio P value < 0,0001).  
 
d. Fecundity for female flies fed FlyAA and L2AA across dietary nitrogen levels. The egg-
laying of 8-day-old flies is increasing at higher dietary nitrogen levels for flies fed the FlyAA 
ratio, but remains at basal low levels for flies fed the whole larval body (L2AA) ratio. This 
suggests that L2AA is poorly bio-utilizable for egg-production-related anabolic processes. 
Each data point represents 2-16 trials, each trial using 40-60 flies per treatment. Error bars 
represent SD (2-way ANOVA analysis with Bonferonni posthoc test, P value < 0.00001 for the 
AA ratio effect, F ratio = 19.15).  
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4.4	Discussion	
 
The genetic composition of a species may affect the response to ingested 
AAs and contribute to the diversity of protein sources consumed across 
species. In this chapter, a genome-based technique for designing an 
enhanced quality protein is presented. The results herein show that the 
exome is a powerful measure for defining AA requirements in flies. Dietary 
limiting EAAs are accurately predicted by the fly exome, and dietary AA ratios 
can be qualitatively defined by the degree of their disproportion to the exome 
AA usage more accurately than when compared to other approaches. For 
example, HuntAA, an empirical ratio refined to support development time and 
survival (199), is a less efficient AA source for anabolic traits than the exome 
usage (FlyAA). Similarly, a dietary AA ratio matching the free AA composition 
of developing larvae (L2AA) (162) delays development and diminishes 
fecundity compared to FlyAA. Therefore, exome-matching is an effective 
measure of determining AA requirements for anabolic life-history traits (i.e. 
development and fecundity) compared to previously reported measures.  
 
4.4.1	Fly	development	and	fecundity	
 
The principle of the minimum poses that the most limiting nutrient in a diet can 
prevent successful utilization of other, non-limiting nutrients that are, as a 
result, acquired in excess (31). Accordingly, we find that exome-defined 
limiting EAAs prevent the anabolic usage of non-limiting EAAs. In addition, the 
law of diminishing returns holds that each succeeding increment of the limiting 
essential nutrient will produce a smaller increment of growth than the 
preceding increment (31, 190). In agreement, we observed a decrease in the 
effect of the limiting EAA with incremental increases in its concentration, or in 
the concentration of dietary nitrogen, upon fly development, growth, and 
fecundity. At high AA supply, the physiological needs for development were 
equally met by diverse dietary AA ratios, but at low dietary nitrogen they were 
adequately met only by the exome-matched diet.  
 
The egg-laying observations described in this chapter are in accord with 
earlier studies showing that elimination of methionine, arginine, or histidine, 
even for 8 days, does not completely suppress egg production (212), 
suggesting that the former can be restored in part by utilization of cysteine, 
methionine, or sulphur from other molecules, and that arginine and histidine 
may also be slowly metabolically replenished, as in other organisms. Indeed, 
methionine salvage in Drosophila alleviates the suppression of fecundity by 
DR (213), so although methionine is an essential AA, being the start codon in 
approximately 50% of the mammalian exome (214) and its supply is critical for 
the fly’s metabolic homeostasis, when in shortage methionine can be partially 
obtained through the utilization of other metabolites. Therefore, restricting or 
depriving methionine or histidine alone does not reduce fecundity to the 
extend other EAA restrictions or deprivations do, and that fecundity 
observations are better predicted on the basis of the most limiting AA when 
these two EAAs are treated as replenishable as previously reported (212). 
Thus, any predictive model based on the exome AA usage should take into 
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account the identity of the limiting AA, so that any predictions based on the 
exome AA usage are accurate and valid. Arginine synthesis via the urea cycle 
in insects is also unclear, although no evidence is reported in the fly and for 
other insects.  
 
4.4.2	Fly	diet	perception	
 
The perception of FlyAA as a higher quality AA source was evident in adult 
Drosophila food choice experiments, where mated females consistently 
selected FlyAA over any other choice of AAs they were offered. Although the 
food preference of larvae was not tested, it is likely that FlyAA would also 
appear attractive to developing larvae as recent studies show that larvae 
make foraging choices that minimize development time (215). 
 
4.4.3	Fly	body	composition	
 
Fat storage is a critical component of the lifespan response to DR both in 
vertebrates and invertebrates (5). In flies, inhibition of fatty acid synthesis or 
oxidation genes inhibits lifespan extension upon DR (216). In the experiments 
described above, flies fed higher levels of dietary AAs had lower lipid storage, 
and in agreement with a higher usage of FlyAA, we also saw reduced lipid 
storage in flies fed FlyAA, especially at higher dietary nitrogen levels. These 
changes, however, negatively correlated to the lean mass and protein 
content, which has highest in FlyAA. As flies consume similar amounts of food 
on the three tested dietary AA ratios, the greater body size and gut dry weight 
of flies on FlyAA is likely to be due to the more efficient use of ingested AAs, 
and due to an increase in nutrient or caloric intake. In addition, the lack of an 
effect of exome-matching upon the dry weight of heads may be linked to the 
observation that the fly’s brain is well protected from nutritional stress (217). 
Other insects, such as crickets, also grow bigger on high protein diets, and 
accumulate greater somatic lipid stores on diets with a low P:C ratio, and 
greater somatic protein stores on high protein foods (218). Therefore a higher 
protein content or a more usable AA source both increase lean mass and 
decrease fat mass in at least some invertebrate models. Importantly the levels 
of stored TAGs, both as a function of total dietary AA levels and of the dietary 
AA profile, were correlated to starvation resistance. These results are 
reminiscent of observations in humans, where individuals with greater fat 
mass can survive longer upon starvation (219). However, flies fed an AA-
depleted diet (0N) died faster despite the highest levels of stored lipids. This is 
in line with evidence suggesting that although fat storage is a critical 
determinant in starvation resistance, starved obese humans and animals may 
die independently of fat storage (220). Moreover, dietary protein can affects a 
variety of stress responses; for example, a low hypoxic tolerance is observed 
in flies fed high protein diets (221). Therefore it would be an interesting 
prospect to further evaluate the effects of ingested AA profiles upon various 
stress responses in the fly. 
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4.4.4	Fly	nitrogen	balance	
 
Uric acid is the main nitrogenous excretory substance in most terrestrial 
uricotelic insects and constitutes about 80% of the excreted nitrogen in 
Drosophila (222). The uric acid results described above show that an exome-
balanced AA ratio increases the utilization of dietary nitrogen (in the form of 
AAs), thereby decreasing the amount of uric acid excreted and resulting in 
higher protein contents in these animals. These findings strongly support a 
higher AA utilization caused by exome-matching towards the promotion of 
anabolic traits. Moreover, during starvation the depletion of body proteins and 
urinary nitrogen excretion reflects continuous demands for AA oxidation (220). 
The results in this chapter suggest that nitrogen catabolism during starvation 
is higher for animals with larger amounts of stored protein, which may 
contribute to their lowered starvation resistance. 
 
4.4.5	Fly	mitochondria	and	respiration	
 
Although no overall effect of DR on mitochondrial density is observed, it is 
difficult to assess mitochondrial functionality ex vivo {Magwere:2006tq}. 
Interestingly, the VDAC-to-total protein ratio was not altered by the dietary AA 
ratio, suggesting the lack of an effect of the ingested AA profile upon 
mitochondrial density. Moreover, no differences were observed in oxygen 
consumption in the head and gut, but there was significantly increased 
oxygen consumption in the thorax and fat body of females fed the exome-
matched diet, suggesting a higher oxidative phosphorylation for those flies. As 
TAGs are precursors that fuel fatty acid oxidation, a higher oxidative 
phosphorylation could explain the observed reduction in TAG storage in these 
flies. 
 
4.4.6	Fly	proteostasis	and	proteasome	assembly	
 
Proteasomal degradation was elevated with exome-matching. The increase in 
both protein content and protein degradation suggested increased protein 
metabolism rate upon exome-matching. Moreover the increased pS6K levels 
in flies fed FlyAA are in agreement with cell-based and mouse models with 
increased TOR activation, where an increased proteasome biogenesis and 
activity is observed (224). Furthermore, these flies relied on proteasomal 
function more than flies on exome-mismatched diets, as inhibition of 
proteasomes resulted in decreased starvation resistance in flies fed FlyAA. 
Moreover, the results described in this chapter show that the effects of tissue 
specific AA bioavailability or other transcriptional or translational regulatory 
mechanisms are critical in establishing biosynthesis of individual peptides, 
and that proteasome peptide biosynthesis cannot be predicted or modulated 
simply through dietary AA manipulation on the basis of AA requirement by the 
proteasome’s proteome. These results support a critical role for the identity of 
the limiting AA in determining proteasome activity. However, the hypothesis of 
the principle of minimum directly modulating the biosynthesis of single 
proteasomal subunits was not supported. 
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4.4.7	Exome-matching	versus	proteome-matching		
 
The set of encoded proteins alone (exome AA usage) does not take into 
account the fact that a number of encoded proteins are of very low abundance 
or are not expressed in an organism or tissue at all. Furthermore, the 
expressed cellular proteins are not equimolar but instead have very large 
differences in their cellular copy numbers. However, the exome AA usage can 
be calculated as either the proportional frequency of an AA across the whole 
exome, or as the mean of the proportional AA representation in all individual 
exons. That the two methods give nearly identical values for all 20 AAs (data 
not shown) means that there is a normal distribution in the variance between 
single exons and the mean exome AA usage. But can whole body AA usage 
be skewed (unequally distributed) at a particular moment? To answer this, we 
would need to sample which exons, and to what extent, are transcribed and 
translated at any moment, and to calculate real AA usage across different life 
stages, a technically challenging task. But if the set of exons transcribed and 
translated at a given moment is sampled, then in statistical terms this 
sample’s mean is likely to be closer to the real mean (the ‘population’ mean, 
here represented by the exome AA usage) when the sample size is larger. 
Indeed, recent evidence from single or multiple point sampling suggests that 
thousands of exons are transcribed and translated simultaneously both in flies 
and mice (207, 225). Interestingly, a diet taking into account the cumulative 
abundance of proteins and the actual AA composition of the fly’s proteome 
ratio (ProteomeAA) promoted anabolic traits to the same extent as the 
exome-metched diet (FlyAA). The observation that in both flies and mice, the 
exome AA profile of the organism resembles its weighted proteome AA profile 
suggests that for these sampled proteomes, the whole body AA usage is 
equally distributed around the exome AA usage. Therefore, it appears that the 
exome AA usage represents a good approximation to the AA usage of an 
organism. However, the time-dependent AA requirements of organisms are 
also determined by factors such as gender, health state, reproductive status, 
intra- and inter-species metabolic diversity, tissue-specific AA usage, age, and 
others. The worm proteome, for example, shows dramatic changes with age 
(226), which may reflect changes in AA usage and AA requirements. In 
addition, emerging evidence suggests that many complex elements in the 
mammalian proteome make it hard to estimate real AA usage by the weighted 
proteome. Therefore, information of which exons are transcribed and 
translated may lead to the design of dietary AA ratios that better match AA 
usage, as calculated by whole-body transcription and translation profiles. 
Whether matching the dietary AA supply to account for such factors could 
further benefit anabolic traits would be an interesting challenge to address. 
Interestingly, the fly SILAC proteome AA profile is very similar to the average 
AA profile of 550,116 peptide sequence entries from over 250 species 
(http://web.expasy.org/docs/relnotes/relstat.html; data not shown), perhaps 
because the biophysical properties of AA side-chains universally apply to 
protein structure requirements across species, resulting in similar AA usages. 
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4.4.8	General	conclusions	and	summary	and	key	points	
 
These results demonstrate that small dietary AA modulations can dictate 
many physiological processes that may ultimately impact on long-term health. 
It is thus important to understand how modulations in dietary AAs exert their 
biochemical and physiolometabolic effects. In this chapter, several 
physiometabolic effects of exome-matching are described. Exome-matching 
promoted fecundity, enhanced developmental time and viability, resulted in 
leaner flies and increased mitochondrial respiration specifically in the fat body. 
Moreover, exome-matching increased nitrogen utilization, lean mass and 
protein content, and proteasomal function in both somatic and reproductive-
tissues. There are ongoing experiments to characterize the effects of exome-
matching on longevity. 
 
Moreover, although the degree of limitation of a limiting EAA in the diet is 
important, these findings also support a key role of the identity of the limiting 
EAA in mediating the physiological responses to a dietary EAA imbalance. 
This is in accord with previous studies showing that the identity of the limiting 
EAA is critical for the effects of protein and single EAA utilization for fly 
fecundity (212) and development (199). Thus, although a measure to aid the 
identification of limiting EAAs is of great importance (that measure here 
defined as the exome), further work is required to resolve the precise 
biological reasons for such indiscrepancies between different identities of the 
most limiting EAA.  
 
A complication in the evaluation of the effects of ingested AAs may stem from 
the fact that dietary-AA dependent processes are not necessarily regulated in 
an identical way across species. Therefore, in the next chapter the effects of 
exome-matching upon mouse growth, metabolism, and physiology will be 
examined. 
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Appendix I 
 
Raw data used in Figure 4.5e.  
 
* in the "Electronic filename" column, a grey bold font indicates that for these trials, during the 
preparation of the holidic media, the acetate buffer was added after the autoclaving step (see 
online supplementary material in (29)). 
 
 
 
 
	 131	
 
 
			
Appendix II 	
Lifespan effect of the weighted fly SILAC proteome AA profile (ProteomeAA, also referred to 
as SILACAA) compared to compared to that of the fly exome AA profile (FlyAA). All trials 
shown implemented a late addition of the acetate buffer (see online supplementary material in 
(29)). (2-way ANOVA analysis with Bonferonni posthoc test, P value = 0.2816 for survival-AA 
ratio interaction, F ratio = 6.343; both time and AA ratio P value > 0.05).  
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Chapter	5:	Exome-matching	in	the	mouse	diet	promotes	
growth	and	determines	insulin	resistance		
 
 
5.1	Abstract	
 
In the previous chapters, the effects of exome-matching on Drosophila’s 
anabolic traits, physiology, and metabolism were explored, and dramatic 
effects were observed upon a range of physiometabolic aspects. To test how 
transferable these results may be to mammals, this chapter explores the 
effects of exome-matching upon mouse growth, behavior, physiology, body 
composition, activity, respiration, glucose homeostasis, and other health 
features. The results described in this chapter demonstrate a critical role of 
the ingested dietary AA profile upon all these health aspects. Therefore these 
findings carry possible implications for interventional applications on the 
ageing process of mammals, including in the context of human nutrition. 
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5.2	Introduction	
 
 
In chapters 3 and 4 we have seen that the effects of exome-matching on 
Drosophila’s anabolic traits, physiology, and metabolism are dramatic. Dietary 
supply of AAs in the proportions used by the fly exome promoted greatly 
anabolic traits including fecundity, development time, viability, and body mass 
growth. Moreover, exome-matching increased TOR activity and resulted in 
diets that were more attractive to Drosophila. In addition, these flies had lower 
triglyceride levels and starvation resistance, greater mitochondrial respiration 
in the fat body, augmented levels of dietary AA utilization and protein 
accretion, and elevated proteasomal activity. Therefore, exome-matching 
appeared to define several physiometabolic aspects in flies, although whether 
or not these effects of exome-matching upon metabolism and physiology 
affect long term health and ageing are currently being explored.  
 
In Chapter 2 and 3 we also saw that exome-matching is a reliable predictor of 
the limiting EAA in rodent diets experimentally verified to be restricted for 
specific EAAs. To test how transferable these results may be to mammals, a 
semi-defined mouse diet was used to assess the effects of exome-matching 
upon mouse growth. Moreover, given the dramatic effects of exome-matching 
upon fly physiology, several other mouse phenotypes were assessed. There 
included feeding behavior, physiology, body composition, activity, respiration, 
glucose homeostasis, and other health aspects. The results described in this 
chapter demonstrate the critical role of the ingested dietary AA profile upon all 
these features in mice. Therefore the effects of exome-matching described in 
this chapter carry possible implications for interventional applications on the 
ageing process of mammals, as well as in the context of human nutrition. 
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5.3	Results	
5.3.1	Growth	effect	of	exome-matching	against	a	casein-matched	AA	supply	
 
To test whether our exome approach is applicable to mammals, we 
determined if the exome, as a quantitative measure for defining dietary AA 
requirements, can be used as a reliable predictor of growth in mice. Thus the 
dietary protein range adequate for the detection of growth effects induced by 
AA imbalance was first determined. By testing protein levels known to be 
restricting for mouse growth and in agreement with previous published data 
(3, 180), it was determined that a CP content level of between 4% and 7% is 
optimal (Figure 5.1A). Thus the degree of limitation in the most limiting 
essential AA (EAA) as defined by the exome can be tested as an accurate 
predictor of growth rates at these low (4-7% CP) dietary nitrogen levels. 
Therefore, it was first determined whether semi-defined free AA diets promote 
growth to the same extent as whole protein diets in mice. A diet with almost 
half of its crude protein (CP) content supplied as free AAs in the proportions 
found in casein (CaseinAA), the normal protein component of standard rodent 
chow, promoted mouse growth to the same extent as a diet with a similar CP 
content containing only whole casein protein (Casein) (Figure 5.1B). As in 
flies, protein restriction suppresses the growth (28) and reproductive output of 
rodents (6). Therefore the ability of exome-matching to enhance mouse 
growth at low dietary nitrogen conditions of 6% CP was next addressed using 
semi-defined free AA diets.  
 
After translating the mouse (Mus musculus) genome in silico it was found that 
the proportional representation (P) of AAs in the exome (MouseAA) was 
substantially different from that in CaseinAA (Figure 5.1C), with arginine as 
the exome-predicted limiting AA in CaseinAA (r R (min) = 0.47) (Figure 5.1D). 
The fly findings supported a conditionally-essential role of arginine for egg-
laying, and in mice arginine is also reported to be conditionally-essential for 
growth (28). Yet, some studies have found that limitation in dietary arginine 
can suppress growth (202), while it can also suppress growth when in dietary 
excess (26). Therefore arginine is reported to be conditionally essential when 
limiting, having a limited effect upon growth, but also to be antagonistically 
detrimental for growth when in excess. Moreover, arginine in casein is 
reported to be only about 70% bioavailable (28). To assess the role of 
arginine in CaseinAA, its effect upon growth was first assessed when AAs are 
supplied at low CP levels (4%) in the form of whole casein protein (Casein 
4%). Despite a predicted growth improvement of approximately 41% (r W (min) / 
r R (min) = 0.65 / 0.47 = 1.41), increasing the dietary supply of arginine by 
approximately 2-fold to restore its levels to the exome requirement in this diet 
failed to improve growth (Figure 5.1E). Therefore arginine was found to be 
conditionally essential at the tested CP levels in casein. Therefore the ability 
of exome-matching to enhance mouse growth at low dietary nitrogen 
conditions of 6% CP against CaseinAA was next addressed with arginine not 
treated as an EAA.  
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Figure 5.1 
 
a. Mean body mass (grams per mouse) for pair-fed and ad libitum-fed diets supplied as whole 
casein protein across a range of CP contents (4%, 7%, and 28%). The pair-fed range 
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between 4% and 7% CP was deemed optimal for the testing of AA-imbalanced diets. Growth 
curves are based on 10 female C3B6F1/J hybrids for each diet (N=10).  
 
b. Mean body mass (grams per mouse) for pair-fed casein as whole protein (CP content 7%), 
and a diet comprised of a 5.5:4.5 mix of whole casein:free AAs supplied as CaseinAA. No 
difference was seen between the two diets, suggesting a similar utilization for the two AA 
sources (polynomial regression analysis P value > 0.05, N=10).  
 
c. Comparison of CaseinAA, MouseAA, and mMMAA (see text for details). Each bar 
represents the molar proportional representation of each EAA in the diet. 
 
d. Comparison of casein and mouse exome EAA ratios. In this instance, tryptophan (W) is the 
most limiting EAA in CaseinAA (r W(min) = 0.65), compared to the mouse exome ratio 
(MouseAA).  
 
e. Mean body mass (grams per mouse) for pair-fed mice on a 4% CP casein diet without 
(Casein 4%) or with an arginine supplementation (Casein 4% + Arg). Although both groups 
had restricted growth compared to an ad libitum group fed 28% CP casein (Casein 28%), the 
supplementation of arginine had no effect on growth (polynomial regression analysis P value 
> 0.05, N=10). 
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Using this model, mice fed CaseinAA were predicted to have a 59% growth 
limitation (1/0.65) compared to mice fed a dietary AA ratio matching the 
exome (MouseAA; Figure 5.1D). In fact, mice fed MouseAA gained 38% more 
body mass than mice fed CaseinAA (Figure 5.2A). Moreover, animals fed 
MouseAA at 6% CP (MouseAA 6%) matched the growth rate of animals fed 
CaseinAA at 8% CP (CaseinAA 8%) when considering the linear part of the 
growth curve (Figure 5.2A). By 10 weeks of age, animals fed MouseAA 6% 
also matched the growth rate of animals ad libitum-fed CaseinAA 6% (Figure 
5.2A). Consequently, the protein efficiency (PER) and food efficiency (FER) 
ratios were the highest for animals fed MouseAA 6% (Figure 5.2B). Body size 
(nose-rump length) was also significantly lower in CaseinAA 6% compared to 
MouseAA 6%, which matched the body size of mice fed CaseinAA 8% (Figure 
5.2C). Dry matter intake indicated that the amount of food consumed was 
equal between the pair-fed groups, but was 25% higher for the CaseinAA 6% 
ad libitum group (Figure 5.2D). When normalized to body mass (BM), mice on 
CaseinAA 6% consumed 17% more dry matter than mice on MouseAA 6% 
(Figure 5.2E). Water consumption was 35% higher in CaseinAA 6% 
compared to the MouseAA 6% (Figure 5.2F), or 45% higher when normalized 
to BM (Figure 5.2G). The intake for all macronutrients and energy is shown on 
Figure 5.2H.  
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Figure 5.2 
 
a. Growth rates for females fed ad libitum fed CaseinAA 6%, or pair-fed CaseinAA 6%, 
MouseAA 6%, or CaseinAA 8% (% indicates CP content). The linear part of the growth 
curves (lower panel) indicates that MouseAA 6% supported a 38% faster growth rate 
compared to CaseinAA 6% (linear regression analysis P value < 0.0001), based on net mass 
gain for that period (weeks 3 to 6.4 of age). Growth curves are based on 20 female C3B6F1/J 
hybrids for each diet (N=20). 
  
b. Effect of dietary AA ratio on protein (upper panel) and food (lower panel) efficiencies. Two 
common indices of diet efficiency, the protein efficiency ratio (PER) and the food efficiency 
ratio (FER; see methods), responded according to the exome-based predictions. After 20 
weeks of dietary treatment on the different AA ratios, mean PER and FER were the highest in 
MouseAA (6%), and similarly reduced in ad libitum-fed CaseinAA (6%), in pair-fed CaseinAA 
(6%), and in pair-fed CaseinAA (8%). Neither the feeding mode, nor the increase in total AAs 
changed the PER of CaseinAA, reflecting the degree of limitation for Trp in CaseinAA (rEAA(min) 
= 0.65). Bars represent the mean for each group (N = 20).  
 
c. Effect of dietary AA ratio on body size (nose-rump length) after 20 weeks on the respective 
dietary regime. Body size was the greatest in ad libitum-fed CaseinAA (6%), while it was 
identical between pair-fed MouseAA (6%) and CaseinAA (8%). In contrast, pair-fed CaseinAA 
6% had the shortest body size. Bars represent the mean for each group (N = 20), and error 
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bars represent SD. Letters indicate statistically significant differences (P value < 0.05) for 
pair-wise comparisons (Student’s t-test). 
 
d. Cumulative food intake across dietary regimes. Bars shown represent the cumulative dry 
matter consumed by 20 females after 20 weeks (age 24 weeks) in the respective dietary 
regime. As all but one group (ad libitum-fed CaseinAA 6%) were pair-fed, there was no cage-
to-cage variability, so no error bars are shown for this cumulative measure (N = 1). 
 
e. Food intake normalized to body mass across dietary regimes. Bars shown represent the 
cumulative dry matter consumed by 20 females after 20 weeks (age 24 weeks) in the 
respective dietary regime, normalized to the mean body mass for each group (N = 20). 
Letters indicate statistically significant differences (P value < 0.05) for pair-wise comparisons 
(Student’s t-test). 
 
f. Water intake across dietary regimes. Figure 5.shows the cumulative water consumed by 20 
females after 20 weeks (age 24 weeks) in the respective dietary regime. Bars shown 
represent the mean water intake between 4 cages (each housing 5 mice) per diet (N = 4). 
Error bars represent SD, letters indicate statistically significant differences (P value < 0.05) for 
pair-wise comparisons (Student’s t-test). 
 
g. Water intake normalized to body mass across dietary regimes. Animals fed CaseinAA (6%) 
consumed significantly more water independently of the regime (ad libitum or pair-fed), 
compared to animals fed MouseAA (6%) or CaseinAA (8%). Figure 5.shows the cumulative 
water consumed by 20 females after 20 weeks (age 24 weeks) in the respective dietary 
regime, normalized to the mean body mass for each group. Bars shown represent the mean 
water intake between 4 cages (each housing 5 mice) per diet (N = 4). Error bars represent 
SD, letters indicate statistically significant differences (P value < 0.05) for pair-wise 
comparisons (Student’s t-test). 
 
h. Cumulative macronutrient consumption across dietary regimes. Values shown represent 
the mean amounts consumed by a female after 20 weeks (age 24 weeks) in the respective 
dietary regime. Crude protein (CP) was calculated as N x 6.25 = CP %. Energy was 
calculated by normalizing the energy content of the diets (16.6 MJ/kg; all diets were 
isoenergetic) to the mean dry matter intake per group. 
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In a repeat experiment at identical dietary nitrogen levels and under a pair-
feeding regime ensuring identical food intakes among diets, MouseAA 
promoted a 32% higher body mass growth than mice fed CaseinAA (Figure 
5.3A). Therefore the mean growth improvement from both experiments was 
35%. Moreover, when the exome (MouseAA) was replaced as a measure of 
predicting growth with the weighted mouse SILAC proteome (mSILACAA), 
CaseinAA was predicted to be only 20% limiting (Figure 5.3B), which was 
lower than the observed growth suppression, suggesting that MouseAA is a 
more accurate predictor for growth than mSILACAA.  
 
It was next confirmed whether, similarly to flies, mice also perceive a 
balanced AA ratio differently. As in the previous experiment, ad libitum fed 
mice given the CaseinAA diet consumed 13% more dry matter than mice fed 
the MouseAA diet (P value < 0.05, Student’s t-test), or 21% more dry matter 
per gram of body mass (P value < 0.05, Student’s t-test; Figure 5.3C). In a 
separate experiment, mice fed MouseAA ad libitum grew significantly more 
than mice fed CaseinAA ad libitum (Figure 5.3D), so the growth promoting 
effect was independent of the feeding mode as it was observed in both ad 
libitum and pair-fed mice. In addition, in the ad-libitum regime animals fed 
MouseAA consumed less protein than that consumed by mice fed Casein AA 
(Figure 5.3E), so the enhanced protein and food efficiency ratios observed in 
the pair-fed animals persisted upon animals fed ad libitum. Moreover, mice ad 
libitum-fed MouseAA consumed significantly less water compared to mice ad 
libitum-fed CaseinAA (Figure 5.4F). Combined, these observations 
demonstrate that the exome-matched diet contains a higher quality protein 
that is both perceived as more satiating and sustains a higher growth rate 
even when it results in a lower protein intake. 
 
Finally, to confirm that the growth-limiting effect of CaseinAA compared to 
MouseAA would be less clear at higher CP levels, we tested the growth effect 
of the two AA profiles at 7.4% CP and compared it to the effect observed at 
6.1% CP. Indeed, the growth difference between CaseinAA vs. MouseAA was 
diminished when dietary nitrogen was increased to 7.4% CP (Figure 5.3G). 
This supports the idea that, as in flies, an interaction between dietary nitrogen 
levels and dietary AA ratios determines AA utilization and growth in mice, with 
growth rate no longer very limited at higher protein/AA levels, confirming 
previous reports (180).  
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Figure 5.3 
 
a. Growth rates for mice pair-fed CaseinAA or MouseAA. The linear part of the growth curves 
(3.0 to 6.4 weeks of age) indicates that CaseinAA suppresses growth compared to MouseAA, 
based on net mass gain for that period (linear regression analysis, P value = 0.0003). Growth 
curves are based on 20 female C3B6F1/J hybrids for each diet (N=20), housed 5 per cage 
(mean body mass per cage shown as single data point for each treatment). Curves represent 
the linear fit model for each treatment +/- 95% CI. 
 
b. Comparison of AAs in CaseinAA to the mouse SILAC proteome AA usage (mSILACAA). 
Considering that the arginine-limitation in CaseinAA (rR(min) = 0.56) is conditionally essential, 
mSILACAA predicts that the next limiting EAA is tryptophan at rW(min) = 0.80, and therefore 
only a 20% limitation for CaseinAA. 
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c. Effect of dietary AA ratio on food intake. Mean ad libitum dry matter intake for mice fed the 
MouseAA and the CaseinAA ratio. Data are shown as food intake and normalized to body 
mass for two time points: at 6.4 weeks of age, representing the linear growth curve part, and 
at 23 weeks of age, representing the end-point. Mice fed on the CaseinAA diet consumed 
significantly more dry matter per day at both time points than mice fed the MouseAA diet, 
whether normalized to body mass or not (p<0.05, Student’s t-test, N = 20).  
 
d. Growth rates for mice ad libitum-fed CaseinAA or MouseAA. CaseinAA suppresses growth 
compared to MouseAA (polynomial regression analysis, P value < 0.05, N=20).  
 
e. Protein intake for mice ad libitum-fed CaseinAA and MouseAA. Values represent the 
cumulative intake of 20 animals per diet for the first 20 weeks of age. 
 
f. Water intake for mice ad libitum-fed and pair-fed on CaseinAA or MouseAA. Mice ad 
libitum-fed MouseAA consumed significantly less water compared to mice ad libitum-fed 
CaseinAA, but this difference was not significant between pair-fed animals (letters indicate 
significant change, p<0.05, Student’s t-test, N = 4). 
 
g. Relationship of dietary EAA limitation and dietary nitrogen levels on growth. The growth 
increase promoted by MouseAA over that promoted by CaseinAA is here expressed as a 
percentage ((mass gain in MouseAA / mass gain in CaseinAA)*100), for two dietary crude 
protein (CP) levels (N x 6.25). At lower CP levels (6.1%), the observed growth increase for 
MouseAA relative to that of CaseinAA is 32% and nearly matches the predicted increase of 
35% (this value is a consequence of r W(min) = 0.65 in CaseinAA, indicating a 35% limitation for 
Trp). However, at higher dietary CP levels (7.4%), the observed increase is only 10%, much 
shorter of the 35% predicted value, indicating that at high dietary AA levels the effect of the 
exome-defined imbalance diminishes. For the observed series, data are based on 20 female 
C3B6F1/J hybrids for each diet (N=20), while error bars represent SD. 
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5.3.2	Growth	effect	of	exome-matching	against	an	exome-mismatched	AA	supply	
 
Similarly to the approach in flies, a MisMatched AA ratio for mice (MMAA) was 
designed that was predicted to be equally as mismatched as CaseinAA is to 
MouseAA, but with a different proportion of all 20 amino acids and with the 
identity, but not degree, of its most limiting EAA altered (Figure 5.4A). 
MouseAA supported a higher growth rate against MMAA (Figure 5.4B). We 
further assessed the exome-based identification of the most limiting AA in 
mMMAA, in an approach similar to what we did previously with Arginine in 
flies fed HuntAA. We generated two more AA ratios, a modified MMAA ratio 
(MMAA-T) that contained 30% less of the exome-predicted limiting AA (Thr) 
than mMMAA did, and a second modified MMAA ratio (MMAA-M) that 
contained 30% less of a predicted surplus AA (Met) than MMAA. According to 
our model, we anticipated that reducing the predicted most limiting AA 
(mMMAA-T) would further depress growth, while reducing a predicted surplus 
AA (MMAA-M) would have no impact on growth. This prediction was 
confirmed as mice fed the MMAA-Thr diet were growth-depressed compared 
to mice fed the original MMAA diet (Figure 5.4B), while in contrast mice fed 
the MMAA-Met ratio matched the growth rate of mice fed MMAA (Figure 
5.4B). Mice fed CaseinAA (r W (min) = 0.65), MMAA (r T (min) = 0.65), or MMAA-M 
(r T (min) = 0.65) also promoted food and protein efficiencies to a similar extent 
(Figure 5.4C-D). Combined these data strongly suggest that the exome 
defines AA requirements in mice, and consequently may determine the 
response of anabolic traits such as growth in mice feeding on diets of different 
AA profiles. 
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Figure 5.4 
 
a. Comparison of mismatched (MMAA) and mouse exome (MouseAA) EAA ratios. Threonine 
(T) is the most limiting EAA in MMAA (r T(min) = 0.65). Therefore the degree of limitation for Thr 
in MMAA is the same to that for tryptophan in CaseinAA (r W(min) = 0.65). 
 
b. Growth rates for females fed MouseAA, MMAA, MMAA-M, and MMAA-T. The linear part of 
the growth curves (3.0 to 6.4 weeks of age) indicates that MMAA and MMAA-M suppress 
growth by 14% and 20% respectively compared to MouseAA, based on net mass gain for that 
period (linear regression analysis, P values = 0.2265 and 0.0177). In contrast, MMAA-T 
suppressed growth by 48% (linear regression analysis, P value < 0.0001), nearly matching 
the 54% predicted suppression. Growth curves are based on 20 female C3B6F1/J hybrids for 
each diet (N=20), housed 5 per cage (mean body mass per cage shown as single data point 
for each treatment). Plots shown represent the linear fit model for each treatment, +/- 95% CI. 
 
c/d. Effect of dietary AA ratio on protein (c) and food (d) efficiencies at 23 weeks of age. Both 
indices, the protein efficiency ratio (PER) and the food efficiency ratio (FER; see methods), 
shown after 20 weeks of dietary treatment (23 weeks of age). Although both indices were 
higher in MouseAA, and similarly reduced in CaseinAA, MMAA, and MMAA-M, most likely 
reflecting the identical degree of their limitation for Trp or Thr (rEAA(min) = 0.65), due to a large 
inter-cage variance and plateauing of the growth curves by this age, these changes were not 
significant. However, MMAA-T had the lowest indices, as a consequence of the degree of its 
limitation (rT(min)=0.46). Bars shown represent the mean for each group (N = 20). Letters 
A
C
A
A
A
A
C
A
A
A
MMAA-T
CaseinAA 6% 
MouseAA
MMAA
MMAA-M
W
at
er
 in
ta
ke
 (m
l/m
ou
se
/d
ay
) 
0
4
2
1
3
5
6
7
A
B
C
B
L
VR K
T
IFH M
W
P in MouseAA
0 
0.14 
P 
in
 M
M
AA
0.14 0 
MMAA vs MouseAA
2 3 4 0 1
Food Efficiency ratio (FER)
Protein Efficiency ratio (PER)
0.2 0.4 0 0.6 
a b
d
c
y = 1.95x + 7.36
y = 1.77x + 7.51
y = 1.63x + 8.12
y = 1.00x + 9.73
M
as
s 
(g
/m
ou
se
) 
12 
22 
17
27
Age (weeks) 
3 7 11 15 19 23 
MMAA MMAA-T
MMAA-M
3 4 5 6
11
13
15
17
19
21
MouseAA
B
od
y 
m
as
s 
(g
/m
ou
se
) 
Age (weeks) 
rT (min)= 0.65
3.75
4.00
3.69
3.27
3.78
0.653
0.613
0.602
0.539
0.620 e
	 146	
indicate statistically significant differences (P value < 0.05) for pair-wise comparisons 
(Student’s t-test).  
e. Water intake for mice ad libitum-fed and pair-fed on MouseAA, MMAA, MMAA-T, and 
MMAA-M. Mice pair-fed MouseAA consumed significantly less water compared to all other 
pair-fed mice (letters indicate significant change, p<0.05, Student’s t-test, N = 4). 
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5.3.3	Nitrogen	excretion	
 
The observed increase in body mass for mice fed MouseAA compared to 
CaseinAA suggested a better utilization of dietary AAs. To confirm whether 
utilization of ingested AAs was indeed higher for MouseAA, urea excretion 
normalized to water intake and body mass (227, 228) was first assessed. 
Mice fed CaseinAA (both ad libitum or pair-fed at 6% or 8% CP) a higher 
excretion of urine urea loss compared to mice fed MouseAA (6%) (Figure 
5.6A). This result indicated that exome-matching reduces urea and nitrogen 
losses.  
To further characterize nitrogen losses, a nitrogen balance analysis was 
carried out (186). Absolute nitrogen intake and losses were quantified in 
purpose-fit metabolic cages after 20 weeks of treatment, equivalent to 23 
weeks of age (see Figure 5.4B for position on growth curve), with all mice 
allowed ad libitum access to food (see methods). Again, mice previously fed 
MouseAA consumed significantly less food and nitrogen than mice fed 
CaseinAA regardless of feeding mode (ad libitum or pair-fed; Figure 5.6B-C; 
Figure 5.key indicates treatment up to nitrogen balance assessment; for all 
results shown, all mice were allowed ad libitum access to food). There was 
also a strong correlation between dry matter intake and faecal output (Figure 
5.6D). The amount of urine excreted was also higher in mice fed CaseinAA 
(Figure 5.s 3E-F), and it was also correlated to water intake across diets 
(Figure 5.6G). Again mice fed MouseAA secreted less urine than mice fed 
CaseinAA (Figure 5.6H). Moreover, the net protein utilization (NPU) is a 
measure of the efficiency of the ingested nitrogenous source, and is 
expressed as the ratio of utilized:ingested nitrogen. Although all animals had a 
positive nitrogen balance (more nitrogen utilized than excreted; data not 
shown), mice pair-fed CaseinAA had a significantly lower NPU value 
compared to mice fed MouseAA (Figure 5.6I). These results demonstrated 
that, as in flies, exome-matching increases the utilization of dietary nitrogen 
source in mice compared to common protein sources such as casein. 
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Figure 5.6 
(Figure 5.key indicates treatment up to nitrogen balance assessment. For all experiments 
shown, all mice were allowed ad libitum access to food) 
 
a. Daily urea excretion normalized to body mass, for mice after 20 weeks on the respective 
dietary regime. From the three regimes consuming equal amounts of nitrogen in the form of 
AAs (pair-fed CaseinAA 6%, MouseAA 6%, and CaseinAA 8%), MouseAA had the lowest 
levels of urea excretion. Bars represent the mean for each group (N = 5), and error bars 
represent SD. Letters indicate statistically significant differences (P value < 0.05) for pair-wise 
comparisons (Student’s t-test).  
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b. Daily dry matter intake, for mice after 20 weeks on the respective ad libitum regime. Mice 
fed MouseAA had lower food consumption than mice fed CaseinAA. Bars represent the mean 
for each group (N = 5), and error bars represent SD. Letters indicate statistically significant 
differences (P value < 0.05) for pair-wise comparisons (Student’s t-test).  
 
c. Daily dry matter intake, for mice after 20 weeks on the respective pair-fed regime. Mice fed 
MouseAA had lower food consumption than mice fed CaseinAA. Bars represent the mean for 
each group (N = 5), and error bars represent SD. Letters indicate statistically significant 
differences (P value < 0.05) for pair-wise comparisons (Student’s t-test).  
 
d. Correlation of daily dry matter intake with daily fecal excretion. Data points represent the 
mean for each group (N = 5), and error bars represent SD. Regression analysis fit R2 value = 
0.96. 
 
e. Daily urine volume excreted for mice after 20 weeks on the respective ad libitum regime. 
Mice fed MouseAA had lower urine excretions than mice fed CaseinAA. Bars represent the 
mean for each group (N = 5), and error bars represent SD. Letters indicate statistically 
significant differences (P value < 0.05) for pair-wise comparisons (Student’s t-test).  
 
f. Daily urine volume excreted for mice after 20 weeks on the respective pair-fed regime. Mice 
fed MouseAA had lower urine excretions than mice fed CaseinAA. Bars represent the mean 
for each group (N = 5), and error bars represent SD. Letters indicate statistically significant 
differences (P value < 0.05) for pair-wise comparisons (Student’s t-test).  
 
g. Correlation of daily water intake with daily urine excretion. Data points represent the mean 
for each group (N = 5), and error bars represent SD. Regression analysis fit R2 value = 0.94. 
 
h. Daily urea excretion (mg) for mice after 20 weeks on the respective dietary regime. Mice 
fed MouseAA had the lowest levels of urea excretion. Bars represent the mean for each 
group (N = 5), and error bars represent SD. Letters indicate statistically significant differences 
(P value < 0.05) for pair-wise comparisons (Student’s t-test).  
 
i. Net protein utilization (NPU) for mice after 20 weeks on the respective dietary regime. Mice 
fed MouseAA had the highest levels of NPU, with mice pair-fed (but not ad libitum-fed) 
CaseinAA having significantly lower NPU. Bars represent the mean for each group (N = 5), 
and error bars represent SD. Letters indicate statistically significant differences (P value < 
0.05) for pair-wise comparisons (Student’s t-test).  
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5.3.4	Lipid	storage	and	body	composition	
 
To examine how body composition is affected by the different dietary AA 
ratios, fat and lean contents were determined both in vivo and histologically 
(Figure 5.7 data by George Soultoukis, Hanna Salmonowicz, Martin Purrio, 
Dr. Andrea Mesaros, Dr. Youssef Hassan, and Dr. Alain De Bruin). Although 
post-weaning mice started with identical fat contents, by week 23 mice fed 
MouseAA 6% had significantly elevated lean mass contents (Figure 5.7A), as 
well as increased body fat, matching the body fat profile of mice fed CaseinAA 
8% (Figure 5.7B). To establish if the feeding mode (ad libitum vs. pair-fed) 
can alter the fat storage response to the ingested AAs, the body fat in animals 
fed MouseAA 6% and CaseinAA 6% ad libitum was also checked and it was 
observed that these differences persisted (Figure 5.7C). Differences in fat 
storage were also assessed histologically. Compared to CaseinAA 6%, 
abdominal white adipose tissue (aWAT) was greater in MouseAA 6%, and 
similar to CaseinAA 8%, while no change was seen between ad libitum and 
pair-fed CaseinAA 6% (Figure 5.7D). Moreover, the difference in fat mass 
between pair-fed or ad libitum-fed MouseAA 6% and CaseinAA 6% persisted 
after normalizing fat mass either to body size (nose-rump length; Student’s t-
test P value < 0.05) or after expressing it as a ratio to total lean mass (% lean 
mass x BM; Student’s t-test P value < 0.05; data not shown). Abdominal fat 
lesions were not found to differ among groups (data not shown), but fat 
storage in skeletal muscle was significantly lower in CaseinAA 6% compared 
to MouseAA 6% or CaseinAA 8% (Figure 5.7E-F). Moreover mice fed 
CaseinAA 6% had reduced skin thickness (Figure 5.7G), which was primarily 
the consequence of reduced subcutaneous adiposity (SCAT) (Figure 5.7H) 
and a constant SCAT:skin thickness ratio (Figure 5.7I).  
 
To establish how ingested AAs alter lipostasis in more detail, we investigated 
the molecular mechanisms behind these changes in adiposity. Mice fed 
CaseinAA 6% had no elevated levels of circulating ketones, higher levels of 
which are typically associated with increased lipolysis (Figure 5.7J). We also 
observed higher levels of the rate-limiting enzyme in de novo lipogenesis, 
fatty acid synthase (FASN; Figure 5.7K) in the livers of mice pair-fed 
MouseAA 6%. Moreover, although there were no changes in the hepatic 
levels of the rate-limiting enzyme in de novo triglyceride synthesis stearoyl-
CoA desaturase 1 (SCD-1) (Figure 5.7L), mice fed MouseAA 6% had 
significantly increased levels of both liver triglycerides (Figure 5.7M) and 
plasma triglycerides, with the effect on circulating TAGs seen on both ad-
libitum and pair-fed animals (Figure 5.7N). 
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Figure 5.7 
 
(Data by George Soultoukis, Hanna Salmonowicz, Martin Purrio, Dr. Andrea Mesaros, Dr. 
Youssef Hassan, and Dr. Alain De Bruin) 
 
a. Effect of dietary AA ratio on lean mass after 20 weeks on the respective dietary regime. 
Lean mass was identical between ad libitum-fed CaseinAA (6%), and pair-fed MouseAA (6%) 
or CaseinAA (8%). In contrast, pair-fed CaseinAA (6%) had the lowest lean mass. Bars 
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represent the mean for each group (N = 20), and error bars represent SD. Letters indicate 
statistically significant differences (P value < 0.05) for pair-wise comparisons (Student’s t-
test). 
 
b. Body composition (fat %) across dietary AA ratios. Post-weaning fat mass was identical 
between all groups, as was fat % after 10 weeks of treatment (age 14 weeks). However, fat % 
was significantly increased in mice pair-fed MouseAA (6%) or CaseinAA (8%) after 20 weeks 
of treatment (age 23 weeks). Bars represent the mean for each group (N = 20), and error bars 
represent SD. Letters indicate statistically significant differences (P value < 0.05) for pair-wise 
comparisons (Student’s t-test). 
 
c. Body composition (fat % and lean mass) across dietary AA ratios. Post-weaning fat mass 
was identical between the two groups, but fat % was significantly increased in mice ad 
libitum-fed MouseAA 6% compared to mice ad libitum-fed CaseinAA 6% after 10 and 20 
weeks of treatment on the respective diet (age 13 and 23 weeks respectively). Lean mass 
was unchanged between the groups across the time points. Bars represent the mean for 
each group (N = 20 for weeks 3 and 13, N = 10 for week 23), and error bars represent SD. 
Letters indicate statistically significant differences (P value < 0.05) for pair-wise comparisons 
(Student’s t-test). Data by George Soultoukis, Martin Purrio and Dr. Andrea Mesaros. 
 
d. Effect of dietary AA ratio on abdominal white adipose tissue (aWAT) wet mass. After 20 
weeks of treatment on the respective diet (age 24 weeks), aWAT was significantly increased 
in mice pair-fed MouseAA (6%) or CaseinAA (8%). Bars represent the mean for each group 
(N = 20), and error bars represent SD. Letters indicate statistically significant differences (P 
value < 0.05) for pair-wise comparisons (Student’s t-test). 
 
e. Histological analysis of skeletal muscle intermyofibrillar fat. After 20 weeks of treatment on 
the respective diet (age 24 weeks), the right quadricep femoris muscle was assessed and 
given an arbitrary value reflecting the visible intermyofibrillar fat (as indicated by arrows). Two 
examples are shown here for mice pair-fed CaseinAA 6% (left panel) or CaseinAA 8% (right 
panel). Data Dr. Youssef Hassanand Dr. Alain De Bruin. 
 
f. Quantified effect of dietary AA ratio on skeletal muscle intermyofibrillar fat, assessed as 
described above. Mice pair-fed CaseinAA 6% had the lowest score. Bars represent the mean 
arbitrary value for each group (N = 20), and error bars represent SD. Letters indicate 
statistically significant differences (P value < 0.05) for pair-wise comparisons (Student’s t-
test). Data by George Soultoukis, Dr. Youssef Hassanand Dr. Alain De Bruin. 
 
g. Skin thickness (epidermis to panniculus carnosus) thickness across dietary AA ratios. Mice 
pair-fed CaseinAA (6%) had the thinnest skin thickness. Bars represent mean values (N = 
20), and error bars represent SD. Letters indicate statistically significant differences (P value 
< 0.05) for pair-wise comparisons (Student’s t-test). Data by George Soultoukis, Dr. Youssef 
Hassanand Dr. Alain De Bruin. 
 
h. Subcutaneous adipose tissue (SCAT) thickness across dietary AA ratios. Mice pair-fed 
CaseinAA (6%) had the thinnest SCAT layers. Bars represent mean values (N = 20), and 
error bars represent SD. Letters indicate statistically significant differences (P value < 0.05) 
for pair-wise comparisons (Student’s t-test). Panels on right show representative histological 
cross sections. Data by Dr. Youssef Hassanand Dr. Alain De Bruin. 
 
i. The ratio of skin thickness (epidermis to panniculus carnosus) thickness to subcutaneous 
adipose tissue (SCAT) thickness across dietary AA ratios was constant across the dietary 
regimes. Bars represent mean values (N = 20), and error bars represent SD. Letters indicate 
statistically significant differences (P value < 0.05) for pair-wise comparisons (Student’s t-
test). Data by George Soultoukis, Dr. Youssef Hassanand Dr. Alain De Bruin. 
 
j. Blood ketones across dietary AA ratios. Mice pair-fed MouseAA (6%) or CaseinAA (8%) 
had the lowest levels of circulating ketones. Bars represent mean values (N = 20), and error 
bars represent SD. Letters indicate statistically significant differences (P value < 0.05) for 
pair-wise comparisons (Student’s t-test). Data by Martin Purrio and George Soultoukis. 
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k. Hepatic fatty acid synthase (FASN) across dietary AA ratios. Mice pair-fed MouseAA (6%) 
had significantly increased levels of FASN. Bars represent mean values (N = 6), and error 
bars represent SD. Stars indicate a statistically significant difference (P value < 0.05) in a 
pair-wise comparison (Student’s t-test). Data by Hanna Salmonowicz and George Soultoukis. 
 
l. Effect of dietary AA ratio on the hepatic level of the rate-limiting enzyme in de novo 
triglyceride synthesis stearoyl-CoA desaturase 1 (SCD-1), assessed by Western Blotting 
analysis. There were no detectable changes between the dietary AA profiles after 20 weeks 
of treatment (24 weeks of age) on the respective diet. Bars represent mean values of 4 trials 
(N = 4), each trial using 4-6 animals. Error bars represent SD and letters indicate no 
statistically significant difference (P value > 0.05) for pair-wise comparisons (Student’s t-test). 
 
m. Hepatic triacylglycerides (TAGs) across dietary AA ratios. Mice pair-fed MouseAA (6%) 
had significantly increased levels of liver TAGs. Bars represent mean values (N = 9-10), and 
error bars represent SD. Letters indicate statistically significant differences (P value < 0.05) 
for pair-wise comparisons (Student’s t-test). Data by Hanna Salmonowicz and George 
Soultoukis. 
 
n. Plasma triacylglycerides (TAGs) across dietary AA ratios. Mice fed MouseAA (6%) had 
significantly increased levels of liver TAGs compared to mice fed CaseinAA (6%) 
independently of the feeding mode (ad libitum or pair-fed). Bars represent mean values (N = 
9-10), and error bars represent SD. Letters indicate statistically significant differences (P 
value < 0.05) for pair-wise comparisons (Student’s t-test). 
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5.3.5	Nutrient	sensing	
 
There was no significant change in the hepatic level or activation of the 
mammalian target of rapamycin (mTOR) (Figure 5.8A), of its downstream 
effector S6 kinase (S6K) (Figure 5.8B), or in the hepatic levels of the 
ribosomal subunit S6 (not shown). Moreover, there were no changes detected 
in the hepatic level or activation of the nutrient sensor AMP-activated protein 
kinase (AMPK), which senses low-energy states by detecting high AMP levels 
(Figure 5.8C), apart from a decrease in AMPK phosphorylation by ad libitum 
or higher (8%) CP regimes. No differences were detected in the levels of 
protein or activation of the nutrient responsive IIS pathway protein kinase B 
(Akt) (Figure 5.8D). Notably, these measurements were done on hepatic 
tissue extracted at 24 weeks of age, by which point the growth of animals had 
reached a plateau (Figure 5.2A). However, mice fed CaseinAA 6% had higher 
levels of p-GCN2 (Figure 5.8E).  
 
 
 
 
Figure 5.8 
 
(data by George Soultoukis and Hanna Salmonowicz) 
 
a. Effect of dietary AA ratio on the hepatic level and activation of a key mediator of AA 
sensing, the target or rapamycin (TOR), assessed by Western blotting. There were no 
detectable changes in the level or activation of TOR between the dietary AA profiles after 20 
weeks of treatment (24 weeks of age) on the respective diet. Bars represent mean values of 4 
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blots (N = 4), each using 6-10 animals. Error bars represent SD and letters indicate no 
statistically significant difference (P value > 0.05) for pair-wise comparisons (Student’s t-test). 
 
b. Effect of dietary AA ratio on the hepatic level and activation of a key mediator of TOR 
signaling, S6 kinase (S6K), assessed by Western blotting. There were no detectable changes 
in the level or activation of S6K between the dietary AA profiles after 20 weeks of treatment 
(24 weeks of age) on the respective diet. Bars represent mean values of 4 blots (N = 4), each 
using 3-6 animals. Error bars represent SD and letters indicate no statistically significant 
difference (P value > 0.05) for pair-wise comparisons (Student’s t-test). Data by Hanna 
Salmonowicz and George Soultoukis. 
 
c. Effect of dietary AA ratio on the hepatic level and activation of the nutrient sensor AMP-
activated protein kinase (AMPK), assessed by Western blotting. There were no detectable 
changes in the total AMPK levels between the dietary AA profiles after 20 weeks of treatment 
(24 weeks of age) on the respective diet. However, AMPK was activated less by mice ad 
libitum-fed CaseinAA (6%), or mice pair-fed CaseinAA (8%). Bars represent mean values of 6 
blots (N = 6), each blot using 3-6 animals. Error bars represent SD and letters indicate 
statistically significant differences (P value < 0.05) for pair-wise comparisons (Student’s t-
test). Data by Hanna Salmonowicz and George Soultoukis. 
 
d. Effect of dietary AA ratio on the hepatic level and activation of the key nutrient responsive 
IIS pathway protein kinase B (Akt), assessed by Western blotting. There were no detectable 
changes in the level or activation of Akt between the dietary AA profiles after 20 weeks of 
treatment (24 weeks of age) on the respective diet. Bars represent mean values of 4 blots (N 
= 4), each using 3-6 animals. Error bars represent SD and letters indicate no statistically 
significant difference (P value > 0.05) for pair-wise comparisons (Student’s t-test). 
 
e. Effect of dietary AA ratio on the hepatic level and activation of the key AA responsive 
protein GCN2, assessed by Western blotting. GCN2 was activated by pair-fed CaseinAA, as 
tested after 20 weeks of treatment (24 weeks of age) on the respective diet. Bars represent 
mean values of 4 blots (N = 4), each using 3-4 animals. Error bars represent SEM and letters 
indicate statistically significant differences (P value < 0.05) for pair-wise comparisons 
(Student’s t-test). Data by Hanna Salmonowicz and George Soultoukis. 
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5.3.6	Respiration	
 
It was next explored whether the nutritional efficiency differences observed 
between CaseinAA and MouseAA could affect energy homeostasis. To 
address this question, we analyzed oxygen consumption for mice chronically 
fed these diets in a pair-fed or ad libitum mode. Although no differences were 
seen between animals chronically fed these ratios ad libitum, animals pair-fed 
CaseinAA (6%) had increased oxygen consumption and carbon dioxide 
generation compared to mice pair-fed MouseAA (6%) (Figure 5.s 10A-B), so 
there were no changes in the respiratory exchange ratio (RER; Figure 5.10C). 
Energy expenditure was also decreased by pair-feeding MouseAA (6%) 
(Figure 5.10D), perhaps contributing to the non-significantly lower body 
temperature (Figure 5.10E). To further probe this phenotype, we investigated 
the abundance of the steady state levels of the five mitochondrial electron 
transport chain (ETC) complexes (I-V). The steady state levels of the 
mitochondrial CI were increased in mice fed CaseinAA (6%), compared to 
mice fed MouseAA (6%), as was the proportion of CI:CIV (Figure 5.10F).  
The observed reduction in oxygen consumption for mice fed MouseAA (6%) 
was not due to lowered activity levels in these mice. When comparing mice 
pair-fed MouseAA (6%) or CaseinAA (6%), there were no significant changes 
in home cage horizontal or vertical activity levels (Figure 5.s 10G-J), or in the 
total distance traversed by these animals over a period of 24 hours (Figure 
5.10K). However, animals ad libitum-fed MouseAA (6%) had lower levels of 
activity compared to animals pair-fed MouseAA, and there were no 
differences between the CaseinAA ad libitum-fed vs. pair-fed regimes (Figure 
5.s 10G-K). 
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Figure 5.9 
 
(Data by Martin Purrio, Dr. Andrea Mesaros, Stanka Matic, and George Soultoukis)  
 
a. Oxygen consumption across dietary AA ratios. Mice pair-fed MouseAA (6%) had 
significantly decreased levels of oxygen consumption compared to mice pair-fed CaseinAA 
(6%). Bars represent mean values (N = 8), and error bars represent SD. Letters indicate 
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statistically significant differences (P value < 0.05) for pair-wise comparisons (Student’s t-
test). Data by Martin Purrio and Dr. Andrea Mesaros. 
 
b. Carbon dioxide generation across dietary AA ratios. Mice pair-fed MouseAA (6%) had 
significantly decreased levels of carbon dioxide generation compared to mice pair-fed 
CaseinAA (6%). Bars represent mean values (N = 8), and error bars represent SD. Letters 
indicate statistically significant differences (P value < 0.05) for pair-wise comparisons 
(Student’s t-test). Data by Martin Purrio and Dr. Andrea Mesaros. 
 
c. Effect of dietary AA ratio on the respiratory exchange ratio (RER). The RER values 
remained unchanged across all treatments. Bars represent mean values (N = 8), and error 
bars represent SD. No statistically significant differences (P value < 0.05) were detected for 
pair-wise comparisons (Student’s t-test). Data by Martin Purrio and Dr. Andrea Mesaros. 
 
d. Heat production across dietary AA ratios. Mice pair-fed MouseAA (6%) had significantly 
decreased levels of heat generation compared to mice pair-fed CaseinAA (6%). Bars 
represent mean values (N = 8), and error bars represent SD. Letters indicate statistically 
significant differences (P value < 0.05) for pair-wise comparisons (Student’s t-test). Data by 
Martin Purrio and Dr. Andrea Mesaros. 
 
e. Body temperature across dietary AA ratios. Mice pair-fed MouseAA (6%) had the lowest 
body temperature, but this decrease was not significant. Bars represent mean values (N = 
20), and error bars represent SD. Letters indicate statistically significant differences (P value 
< 0.05) for pair-wise comparisons (Student’s t-test). Data by Martin Purrio and Dr. Andrea 
Mesaros. 
 
f. Effect of dietary AA ratio on the level of the electron transport chain components, assessed 
by Western Blotting analysis of the relative steady state levels of the 5 OXPHOS complexes. 
Mice pair-fed MouseAA (6%) had significantly decreased levels of complex I. Bars represent 
mean values (N = 9-10), and error bars represent SD. Letters indicate a statistically significant 
difference (P value < 0.05) in a pair-wise comparison (Student’s t-test). Data by Stanka Matic. 
 
g-j. Effect of dietary AA ratio on horizontal and vertical activity levels. Bars represent mean 
values (N = 8), and error bars represent SD. Letters indicate statistically significant 
differences (P value < 0.05) for pair-wise comparisons (Student’s t-test). Data by Martin 
Purrio, Dr. Andrea Mesaros, and George Soultoukis. 
 
k. Effect of dietary AA ratio on total distance traversed over a period of 24 hours. Bars 
represent mean values (N = 8), and error bars represent SD. Letters indicate statistically 
significant differences (P value < 0.05) for pair-wise comparisons (Student’s t-test). Data by 
Martin Purrio, Dr. Andrea Mesaros, and George Soultoukis. 
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5.3.7	Glucose	homeostasis	and	glycogen	synthesis	
 
To examine the effects of exome-matching upon glucose homeostasis, we 
assessed blood glucose levels in both pair-fed and ad-libitum regimes. 
Although there were no changes in circulating glucose between the pair-fed 
CaseinAA and MouseAA regimes, mice ad-libitum-fed MouseAA had higher 
blood glucose (Figure 5.10A), and insulin (Figure 5.10B), but an increase in 
leptin was not significant (Figure 5.10C). Yet, as mentioned, there was no 
difference in the levels or activation of insulin-activated protein kinase Akt 
(Figure 5.8D). As higher circulating glucose and insulin levels are associated 
with decreased insulin sensitivity and Type 2 diabetes, it was decided to 
determine whether mice on MouseAA 6% had changes in insulin and glucose 
sensitivity. Interestingly, mice pair-fed MouseAA showed no change to mice 
pair-fed CaseinAA (Figure 5.10D-E), but when the two diets were consumed 
ad-libitum mice on MouseAA were both glucose tolerant and insulin resistant 
compared to CaseinAA (Figure 5.10F-G). To further probe the effects of 
exome-matching upon glucose homestasis, glycogen storage was also 
assessed histologically. There was a tendency for decreased liver glycogen 
storage in mice fed the exome ratio (Figure 5.10H), which corresponded to a 
higher activation of glycogen synthase kinase 3 (GSK-3) (Figure 5.10I), an 
inhibitor of glycogen synthase (GS), which converts glucose to glycogen.  
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Figure 5.10 
 
(Data by George Soultoukis, Martin Purrio, Dr. Andrea Mesaros, Dr. Youssef Hassan, Dr. 
Alain De Bruin, Joanna Goncalves, and Hanna Salmonowicz) 
 
a. Blood glucose across dietary AA ratios. Mice ad-libitum MouseAA (6%) had significantly 
elevated levels of circulating glucose compared to all other treatments. Bars represent mean 
values (N = 10), and error bars represent SD. Letters indicate statistically significant 
differences (P value < 0.05) for pair-wise comparisons (Student’s t-test). Data by Martin 
Purrio, Dr. Andrea Mesaros, and George Soultoukis. 
 
b. Plasma insulin across dietary AA ratios. Mice fed ad-libitum MouseAA (6%) had 
significantly elevated levels of circulating insulin compared to mice fed ad-libitum CaseinAA 
(6%). Bars represent mean values (N = 7-8), and error bars represent SD. Letters indicate 
statistically significant differences (P value < 0.05) for pair-wise comparisons (Student’s t-
test). Data by Joanna Goncalves and George Soultoukis. 
 
c. Plasma leptin across dietary AA ratios. Mice ad-libitum MouseAA (6%) had higher levels of 
circulating leptin compared to mice ad-libitum CaseinAA (6%), but this increase was not 
significant (Student’s t-test, p=0.062). Bars represent mean values (N = 5-7), and error bars 
represent SD. Data by Joanna Goncalves and George Soultoukis. 
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d. Glucose tolerance test (GTT) across dietary AA ratios. The blood glucose levels of mice 
pair-fed MouseAA (6%) responded similarly to those of mice pair-fed CaseinAA (6%). Bars 
represent mean values (N = 10), and error bars represent SD. Curves were compared with 2-
way ANOVA analysis and Bonferonni posthoc test (P value > 0.05). Data by George 
Soultoukis, Martin Purrio, and Dr. Andrea Mesaros. 
 
e. Insulin tolerance test (ITT) across dietary AA ratios. The circulating insulin levels of mice 
pair-fed MouseAA (6%) responded similarly to those of mice pair-fed CaseinAA (6%). Bars 
represent mean values (N = 10), and error bars represent SD. Curves were compared with 2-
way ANOVA analysis and Bonferonni posthoc test (P value > 0.05). Data by George 
Soultoukis, Martin Purrio, and Dr. Andrea Mesaros. 
 
f. Glucose tolerance test (GTT) across dietary AA ratios. The blood glucose levels of mice ad 
libitum-fed MouseAA (6%) increased less than those of mice ad libitum-fed CaseinAA (6%). 
Bars represent mean values (N = 10), and error bars represent SD. Curves were compared 
with 2-way ANOVA analysis and Bonferonni posthoc test (P value < 0.05). Data by George 
Soultoukis, Martin Purrio, and Dr. Andrea Mesaros. 
 
g. Insulin tolerance test (ITT) across dietary AA ratios. The circulating insulin levels of mice ad 
libitum-fed CaseinAA (6%) decreased significantly compared to those of mice ad libitum-fed 
MouseAA (6%). Bars represent mean values (N = 10), and error bars represent SD. Stars 
indicate a statistically significant difference (P value < 0.05) and curves were compared with 
2-way ANOVA analysis and Bonferonni posthoc test. Data by George Soultoukis, Martin 
Purrio, and Dr. Andrea Mesaros. 
 
h. Effect of dietary AA ratio on liver glycogen storage, assessed histologically. Mice pair-fed 
MouseAA (6%) had the lowest score. Bars represent the mean arbitrary value for each group 
(N = 5-10), and error bars represent SD. Letters indicate statistically significant differences (P 
value < 0.05) for pair-wise comparisons (Student’s t-test). (Data by George Soultoukis, Dr. 
Youssef Hassan, and Dr. Alain De Bruin) 
 
i. Effect of dietary AA ratio on the level and activation of the glycogen synthase kinase 3 
(GSK-3), the inhibitor of glycogen synthase, assessed by Western Blotting analysis. Mice 
pair-fed MouseAA (6%) had significantly increased levels of phospho-GSK-3, the activated 
form of GSK-3, compared to mice pair-fed CaseinAA (6%). Bars represent mean values (N = 
6), and error bars represent SD. Letters indicate a statistically significant difference (P value < 
0.05) in a pair-wise comparison (Student’s t-test). (Data by George Soultoukis and Hanna 
Salmonowicz) 
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5.3.8	Proteostasis	
 
As in flies, we tested the effects of exome-matching upon proteostasis in mice 
by assessing protein content, proteasome activity, poly-ubiquitination, and 
autophagy. No differences were detected in the polysome profiles between 
animals fed MouseAA and CaseinAA (Figure 5.11A) or in the 
monosome:polysome ratio (data not shown). Also unchanged were the 
amounts of protein content per wet mass in the brain, gut, muscle, or liver 
(Figure 5.11B), as well as the liver DNA:protein ratio (Figure 5.11C). However 
proteasome activity in the liver (Figure 5.11D) and muscle (Figure 5.11E) was 
reduced by MouseAA, contrasting the findings in flies. No differences were 
seen in the gut (Figure 5.11F) or brain (Figure 5.11G). Ubiquitination status in 
the liver was not significantly changed (Figure 5.11H). No changes in 
autophagy activation were induced in the liver by MouseAA (Figure 5.11I; 
data for Figure 5.11 by Hanna Salmonowicz).  
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Figure 5.11 
 
(data for Figure 5.11 by Hanna Salmonowicz) 
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a. Polysome profiling showing similar patterns across different dietary AA ratios. Curves 
represent the ribosomal/polysomal fractions across a sucrose gradient. Each curve shown 
represents a single representative biological replicate (N = 4-6) from animals treated for 20 
weeks (23 weeks of age). Middle panel shows quantification of the AUC (area under curve) in 
these polysome profiles. Right panel shown monosome:polysome AUC ratio. No significant 
changes were detected between CaseinAA and MouseAA (N = 4-6, P value > 0.05 for pair-
wise comparisons using Student’s t-test; means are shown, while error bars represent SD). 
 
b. Protein content per mass of tissue for brain, intestine, muscle, and liver showed no 
differences between CaseinAA and MouseAA. For each bar, N=8-10, while error bars 
represent SD and letters indicate no statistically significant difference (P value > 0.05) for 
pair-wise comparisons (Student’s t-test). 
 
c. Protein to DNA ratio in the liver of mice fed CaseinAA or MouseAA showed no differences 
between the two treatments. For each bar, N=10, while error bars represent SD and letters 
indicate no statistically significant difference (P value > 0.05) for pair-wise comparisons 
(Student’s t-test). 
 
d. Effect of dietary AA ratio on liver proteasome activity. The chart shows the activity based 
on the LLE-AMC substrate degradation as both substrates behaved similarly (data not 
shown). Each bar represents the mean proteasomal activity (N=8-10), and error bars 
represent SEM. Letters indicate statistically significant differences (P value < 0.05) for pair-
wise comparisons (Student’s t-test). 
 
e. Effect of dietary AA ratio on muscle proteasome activity. The chart shows the activity 
based on the LLE-AMC substrate degradation as both substrates behaved similarly (data not 
shown). Each bar represents the mean proteasomal activity (N=10), and error bars represent 
SEM. Letters indicate statistically significant differences (P value < 0.05) for pair-wise 
comparisons (Student’s t-test). 
 
f. Effect of dietary AA ratio on gut proteasome activity. The chart shows the activity based on 
the LLE-AMC substrate degradation as both substrates behaved similarly (data not shown). 
Each bar represents the mean proteasomal activity (N=9), and error bars represent SEM. 
Letters indicate statistically significant differences (P value < 0.05) for pair-wise comparisons 
(Student’s t-test). 
 
g. Effect of dietary AA ratio on brain proteasome activity. The chart shows the activity based 
on the LLE-AMC substrate degradation as both substrates behaved similarly (data not 
shown). Each bar represents the mean proteasomal activity (N=9), and error bars represent 
SEM. Letters indicate statistically significant differences (P value < 0.05) for pair-wise 
comparisons (Student’s t-test). 
 
h. Quantification of Western blot analysis of hepatic ubiquitination levels across dietary AA 
ratios. Quantification performed on the basis on 5 biological replicates is expressed as 
arbitrary units and reproduced >3 times. Error bars represent SEM, letters indicate statistically 
significant differences (P value < 0.05) for pair-wise comparisons (Student’s t-test). 
 
i. Quantification of Western blot analysis of microtubule-associated proteins 1A/1B light chain 
3A (MAP1LC3A). A high ratio of LC3-I to LC3-II indicates defective autophagy induction. 
Quantification performed on the basis on 5 biological replicates is expressed as arbitrary units 
and reproduced >3 times. Error bars represent SEM, letters indicate statistically significant 
differences (P value < 0.05) for the pair-wise comparison (Student’s t-test). 
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5.3.9	Organ	growth	and	biosynthesis		
 
To assess whether the growth suppression induced by CaseinAA has a 
general systemic growth-inhibitory effect or it affects tissues differentially, we 
performed a histological screen of a number of tissues. First, the wet mass of 
several organs with critical metabolic roles, including abdominal WAT, liver, 
kidney, heart, thymus, muscle, and brain was recorded (Figure 5.12A). The 
wet mass of abdominal WAT, kidney, liver, and brain was significantly lower in 
mice pair-fed CaseinAA (6%), compared to mice pair-fed MouseAA (6%) 
(Figure 5.12A). These differences diminished when data were normalized to 
the respective body or lean masses, but not when normalized to body size 
(nose-to-rump length) (Figure 5.12A).  
 
As the fly SILAC proteome was also a good measure of defining anabolic 
traits (see Chapter 4), the mouse SILAC proteome was also considered. To 
further compare the predictive accuracy at the tissue level, the mass of 
several organs was measured and compared to the mSILACAA. However, 
neither MouseAA or mSILACAA were a reliable predictor for organ specific 
growth rates (Figure 5.12B). The tissue-specific mSILACAA (tsmSILACAA) 
usage was next quantified to establish if different tissues use AAs differently, 
and therefore if tsmSILACAA can better predict organ-specific growth. 
Nevertheless, tissue-specific AA usage was very similar for all tissues (Figure 
5.12C), with glycine and glutamine elevated in the whole body possibly 
because in some mammals, including humans, glycine and glutamine are 10-
50 times more concentrated in intracellular pools (4). Therefore, these results 
suggest that, as in flies, predictions based on dietary AA ingestion and on the 
principle of the minimum are not always accurate when assessing growth at 
the tissue-specific level. Moreover, upon assessing whole body lean mass 
growth, tsmSILACAA was a more accurate predictor for growth than 
MouseAA for a range of diets with different limiting AAs (Figure 5.12D).  
 
It was next asked if the abundance of circulating AAs can affect the accuracy 
of predictions for organ growth rates, by accounting for the bio-availability of 
ingested AAs into circulation. Ingested AAs are absorbed by the gut and into 
the portal vein, where they are available for first pass (splanchnic bed) 
metabolism. We therefore assessed portal vein AAs. No changes were 
detected in the portal vein plasma concentrations of amino acids between 
mice pair-fed CaseinAA or MouseAA (Figure 5.12E). Yet, when considering 
the relationship between diet and portal vein AA concentrations, a moderate 
correlation (R2=0.494) was observed in the fold change between the diet 
amino acid concentration in CaseinAA compared to MouseAA, and the fold 
change between the mean portal vein plasma amino acid concentration in 
CaseinAA compared to that in MouseAA (Figure 5.12F). Although cysteine 
was not analysed, methionine (Figure 5.12E) or several sulphur-amino acid 
metabolites (Figure 5.12G) were unchanged. Of all 85 metabolites quantified 
(including nucleic acids, sugars, TCA cycle intermediates, and lipid 
metabolites), only three were found to be significantly changed. Nicotinamide-
adenine dinucleotide (NAD), betaine, and phosphoethamolamine (PEA) were 
all significantly elevated in mice fed CaseinAA (Figure 5.12H). 
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a
Organ
White adipose tissue (abdominal) 0,9337 0,8837 1,2309 1,3035 0,0064 1,39
Kidney (r) 0,3220 0,2775 0,3052 0,3150 0,0003 1,10
Liver 1,2216 0,9168 1,0131 0,9958 0,0021 1,10
Heart 0,1438 0,1190 0,1246 0,1231 0,2005 1,05
Thymus 0,0747 0,0463 0,0505 0,0498 0,3276 1,09
Skeletal muscle (r) - quadricep femoris 0,2197 0,1935 0,2147 0,2084 0,1092 1,11
Brain 0,5102 0,5042 0,5155 0,5047 0,0500 1,02
White adipose tissue (abdominal) 0,0334 0,0368 0,0434 0,0456 0,0745 1,18
Kidney (r) 0,0116 0,0116 0,0110 0,0113 0,0703 0,95
Liver 0,0438 0,0383 0,0365 0,0359 0,1046 0,95
Heart 0,0052 0,0050 0,0045 0,0045 0,0303 0,91
Thymus 0,0026 0,0019 0,0018 0,0018 0,3736 0,93
Skeletal muscle (r) - quadricep femoris 0,0079 0,0081 0,0077 0,0075 0,4742 0,95
Brain 0,0183 0,0211 0,0187 0,0182 0,0001 0,89
White adipose tissue (abdominal) 0,0921 0,0917 0,1260 0,1328 0,0092 1,37
Kidney (r) 0,0318 0,0288 0,0312 0,0322 0,0009 1,08
Liver 0,1206 0,0951 0,1035 0,1018 0,0051 1,09
Heart 0,0143 0,0123 0,0127 0,0126 0,3607 1,03
Thymus 0,0074 0,0048 0,0052 0,0051 0,4117 1,07
Skeletal muscle (r) - quadricep femoris 0,0217 0,0201 0,0219 0,0213 0,1717 1,09
Brain 0,0504 0,0523 0,0527 0,0516 0,5924 1,01
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Skeletal muscle (r) - quadricep femoris 0,0095 0,0097 0,0098 0,0096 0,8149 1,01
Brain 0,0221 0,0252 0,0236 0,0234 0,0002 0,94
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Figure 5.12 
 
(Data by George Soultoukis, Martin Purrio, and Dr. Ilian Atanassov; metabolite analysis 
carried out at the FIMM (see methods)) 
 
a. The wet mass of abdominal WAT (aWAT), liver, kidney, heart, thymus, muscle, and brain. 
For each value shown, N = 20 per AA profile. The raw wet mass data shown are normalized 
to whole body mass, body size, or lean mass. P-value column shown represents the 
comparison of MouseAA 6% vs. CaseinAA 6%. Data by George Soultoukis and Martin Purrio.  
 
b. Predictions for organ specific growth rates in mice fed CaseinAA. Predictions are based on 
the exome AA usage (MouseAA), or on the organ-specific weighted proteome usage 
(tsmSILACAA). Neither ratio is a good predictor for specific organ growth in mice fed 
CaseinAA. For organ masses, tissues were harvested and wet mass was recorded (N=10). 
 
c. Tissue-specific AA content in the weighted proteome of different organs as determined by 
SILAC. Data by Dr. Ilian Atanassov. 
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d. The tissue-specific weighted proteome usage (tsmSILACAA) is a better predictor for lean 
mass growth than the exome AA usage (MouseAA), across four diets with 3 different limiting 
AAs (indicated in brackets).  
 
e. Portal vein plasma amino acid concentrations for mice pair-fed CaseinAA (n=4) or 
MouseAA (n=6). No significant changes between the two groups were observed in any of the 
amino acids analysed (for each AA comparison, two-tailed Student’s T-test, p-value > 0.05). 
 
f. Relationship between diet and portal vein AA concentrations. The squared coefficient of 
correlation value (R2=0.494) indicates a moderate but significant correlation in the fold 
change between the diet AA concentration in CaseinAA compared to MouseAA, and the fold 
change between the mean portal vein plasma AA concentration in CaseinAA compared to 
that in MouseAA (P value = 0.00055, two-tailed probability). 
 
g. No significant changes were detected in the portal vein plasma sulphur-amino acid 
metabolite concentrations between mice pair-fed CaseinAA (n=4) or MouseAA (n=6) (for 
each metabolite comparison, two-tailed Student’s T-test, p-value > 0.05). B. Portal vein 
plasma concentrations of metabolites that were significantly altered between mice pair-fed 
CaseinAA (n=4) and MouseAA (n=6) included betaine, NAD, and PEA (for each metabolite 
comparison, two-tailed Student’s T-test, p-value < 0.05). 
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5.3.10	Histopathological	effects	of	exome-matching 
 
Histological analysis of livers showed that hepatocyte anisokaryosis, an 
indication of restricted cell size, occurred in a significantly higher occurrence 
in mice fed CaseinAA (Figure 5.13A). Animals pair-fed CaseinAA 6% also had 
the highest incidence of mild hepatic atrophy (Figure 5.13B). However, there 
were no differences in hepatocyte binucleation occurrence between the 
groups (Figure 5.13C). Another effect on livers was the higher incidence in 
vacuolar hepatopathy in animals fed CaseinAA 6% ad-libitum (Figure 5.13D). 
Moreover, staining analysis of the vacuoles to distinguish between three types 
of vacuolar contents (hydropic, lipid, and mixed contents) revealed differences 
in the vacuolar type. Mice pair-fed MouseAA 6% had a vacuolar profile which 
was distinct to that of mice CaseinAA 6% (ad-libitum or pair-fed) but similar to 
that of mice pair-fed CaseinAA 8% (Figure 5.13E). Although no differences in 
skeletal muscle lesions were seen, animals pair-fed CaseinAA 6% had the 
lowest quadricep muscle masses (Figure 5.12A), which was matched by their 
higher incidence of myofibrillar atrophy and necrosis (Figure 5.13F). 
 
In rodents, protein deprivation reduces jejunal villus height and crypt depths, 
and supplementation of some AAs in the diet rescues these effects (229), so it 
was tested whether  intestinal morphology was also defined by the ingested 
AA profile. However, no differences in cryptal length or villar length were seen 
in the small intestine (Figure 5.13G-H). Other parameters examined but not 
found to differ included kidney anisokaryosis, tubulonephrosis, glomerular 
lesions, sternal bone and cartilage lesions, bone marrow cellularity %, 
erythroid:myeloid ratio, and megakaryocyte content (data not shown).  
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Figure 5.13  
 
(Data by Dr. Youssef Hassan, Dr. Alain De Bruin and George Soultoukis) 
 
a. Effect of dietary AA ratio on hepatocyte anisokaryosis, assessed histologically. Hepatocyte 
nuclei were assessed and given an arbitrary value reflecting the incidence of anisokaryosis. 
Mice pair-fed MouseAA (6%) or CaseinAA (8%) had the lowest score. Bars represent the 
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mean arbitrary value for each group (N = 20), and error bars represent SD. Letters indicate 
statistically significant differences (P value < 0.05) for pair-wise comparisons (Student’s t-
test). Cross-sections on the right show representative examples of scoring. 
 
b. Effect of dietary AA ratio on hepatocellular atrophy, assessed histologically. Mice pair-fed 
CaseinAA (6%) had the highest incidence of hepatocellular atrophy. Hepatic atrophy 
incidence was as follows: pair-fed CaseinAA (6%) (4/20 mice), pair-fed MouseAA (6%) (3/20 
mice), pair-fed CaseinAA (8%) (2/20 mice). Bars represent the % value for each group (N = 
20).  
 
c. Effect of dietary AA ratio on hepatocyte binucleation, assessed histologically. Liver tissue 
was assessed and given an arbitrary value reflecting the incidence of binucleation. No 
differences were observed between the tested dietary AA profiles. Bars represent the mean 
arbitrary value for each group (N = 20), and error bars represent SD. Letters indicate no 
statistically significant differences (P value > 0.05) for pair-wise comparisons (Student’s t-
test). 
 
d. Effect of dietary AA ratio on hepatic vaculopathy, assessed histologically. Liver tissue was 
assessed and given an arbitrary value reflecting the incidence of vacuolar hepatopathy. Mice 
ad libitum-fed CaseinAA (6%) had the highest score. Bars represent the mean arbitrary value 
for each group (N = 20), and error bars represent SD. Letters indicate statistically significant 
differences (P value < 0.05) for pair-wise comparisons (Student’s t-test). 
 
e. Effect of dietary AA ratio on the type of hepatic vaculopathy. Liver tissue was stained for 
hydropic, lipid, or mixed vacuolar hepatopathy type (see methods) and given an arbitrary 
value reflecting the incidence of each type. The profile of mice ad libitum-fed CaseinAA (6%) 
was similar to that of mice pair-fed CaseinAA (6%), while the profile of mice pair-fed 
MouseAA (6%) resembled that of mice pair-fed CaseinAA (8%). Vacuolar hepatopathy types 
were assessed on the number of mice with a vaculopathy, which varied per group and was as 
follows:  ad libitum-fed CaseinAA (6%) (9/20 mice), pair-fed CaseinAA (6%) (5/20 mice), pair-
fed MouseAA (6%) (9/20 mice), pair-fed CaseinAA (8%) (4/20 mice).  
 
f. Effect of dietary AA ratio on myofibrilar atrophy, assessed histologically. Mice pair-fed 
CaseinAA (6%) had the highest incidence of myofibrilar atrophy, whose incidence was as 
follows: pair-fed CaseinAA (6%) (2/20 mice), pair-fed MouseAA (6%) (1/20 mice), pair-fed 
CaseinAA (8%) (1/20 mice). Bars represent the % value for each group (N = 20).  
 
g. Effect of dietary AA ratio on intestinal cryptal length, assessed histologically. Jejunum 
cross-sections were assessed for their cryptal length. No differences were observed between 
the tested dietary AA profiles. Bars represent the mean arbitrary value for each group (N = 
10), and error bars represent SD. Letters indicate statistically significant differences (P value 
< 0.05) for pair-wise comparisons (Student’s t-test). 
 
h. Effect of dietary AA ratio on intestinal villar length, assessed histologically. Jejunum cross-
sections were assessed for their villar length. No differences were observed between the 
tested dietary AA profiles. Bars represent the mean arbitrary value for each group (N = 10), 
and error bars represent SD. Letters indicate statistically significant differences (P value < 
0.05) for pair-wise comparisons (Student’s t-test). 
 
 
 
 
 
 
 
 
 
 
	 172	
5.3.11	Skeletal	effects	and	bone	quality	
 
Apart from the differences in skeletal length evidenced by changes in nose-to-
rump length between MouseAA and CaseinAA (Figure 5.2C), the quality of 
nutrition can also affect bone quality (230). Therefore several bone 
parameters were analysed by computer tomography (CT) scanning (see 
methods for details). For pair-fed mice, MouseAA resulted in increased 
cortical and trabecular structure thickness, and increased trabecular bone 
volume and bone mineral density (BMD) (Figure 5.14A-D). For ad libitum fed 
mice, in contrast, only cortical structure thickness was elevated in animals fed 
MouseAA compared to animals fed Casein AA (Figure 5.14E-H). 
 
 
 
 
 
 
 
Figure 5.14  
 
(Data by Dr. Andrea Mesaros, Martin Purrio, and George Soultoukis) 
 
a. Effect of dietary AA ratio on cortical structure thickness (CST) as analysed by CT. Mice 
pair-fed MouseAA (6%) had a higher CST value. Bars represent the mean value for each 
group (N = 7), and error bars represent SD. Letters indicate a statistically significant 
difference (P value < 0.05) for the pair-wise comparison (Student’s t-test).  
 
 
b. Effect of dietary AA ratio on trabecular structure thickness (TST) as analysed by CT. Mice 
pair-fed MouseAA (6%) had a higher TST value. Bars represent the mean value for each 
group (N = 7), and error bars represent SD. Letters indicate a statistically significant 
difference (P value < 0.05) for the pair-wise comparison (Student’s t-test).  
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c. Effect of dietary AA ratio on trabecular bone volume % (TBV %) as analysed by CT. Mice 
pair-fed MouseAA (6%) had higher TBV. Bars represent the mean value for each group (N = 
7), and error bars represent SD. Letters indicate a statistically significant difference (P value < 
0.05) for the pair-wise comparison (Student’s t-test).  
 
d. Effect of dietary AA ratio on bone mineral density (BMD) as analysed by CT. Mice pair-fed 
MouseAA (6%) had higher BMD. Bars represent the mean value for each group (N = 7), and 
error bars represent SD. Letters indicate a statistically significant difference (P value < 0.05) 
for the pair-wise comparison (Student’s t-test).  
 
e. Effect of dietary AA ratio on cortical structure thickness (CST) as analysed by CT. Mice ad 
libitum-fed MouseAA (6%) had higher CST. Bars represent the mean value for each group (N 
= 5-9), and error bars represent SD. Letters indicate a statistically significant difference (P 
value < 0.05) for the pair-wise comparison (Student’s t-test).  
 
f. Effect of dietary AA ratio on trabecular structure thickness (TST) as analysed by CT. Mice 
ad libitum-fed MouseAA (6%) had no change in their TST compared to mice ad libitum-fed 
CaseinAA (6%). Bars represent the mean value for each group (N = 5-9), and error bars 
represent SD. Letters indicate no statistically significant difference (P value > 0.05) for the 
pair-wise comparison (Student’s t-test).  
 
g. Effect of dietary AA ratio on trabecular bone volume % (TBV %) as analysed by CT. Mice 
ad libitum-fed MouseAA (6%) had no change in their TBV compared to mice ad libitum-fed 
CaseinAA (6%). Bars represent the mean value for each group (N = 5-9), and error bars 
represent SD. Letters indicate no statistically significant difference (P value > 0.05) for the 
pair-wise comparison (Student’s t-test).  
 
h. Effect of dietary AA ratio on bone mineral density (BMD) as analysed by CT. Mice ad 
libitum-fed MouseAA (6%) had no change in their BMD compared to mice ad libitum-fed 
CaseinAA (6%). Bars represent the mean value for each group (N = 5-9), and error bars 
represent SD. Letters indicate no statistically significant difference (P value > 0.05) for the 
pair-wise comparison (Student’s t-test).  
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5.3.12	Exome-matching	vs.	proteome-matching	and	body-matching	
 
The additive AA abundance in the proteome, in tissue free AAs, and in 
circulating AAs, is what ultimately shapes the body composition AA ratio. In 
mice this AA profile, which we refer to as BodyAA, has been reported and 
proposed as a measure of dietary AA requirements (153, 231). Therefore it 
was next tested whether BodyAA is different to the AA profile of the accrued 
mouse proteome (mSILACAA) or to the exome profile (MouseAA). With the 
exception of tryptophan (rW(min) = 0.65), BodyAA was very similar to 
ProteomeAA (Figure 5.15A), which is in accord with the observation that free 
AAs represent only a small fraction of the mammalian body’s total AA content 
(4). However, comparison of BodyAA to the exome usage (MouseAA) 
predicted a more severe limitation in the tryptophan content of BodyAA (rW(min) 
= 0.53) (Figure 5.15B). Moreover, MouseAA was very similar to SILACAA 
(rW(min) = 0.82) (Figure 5.15C), with only an 18% limitation of tryptophan in 
SILACAA, so no significant growth effects were predicted and SILACAA was 
not tested experimentally. Therefore, as BodyAA showed a higher dissimilarity 
to MouseAA, it was decided to compare these two AA profiles for growth. 
Analysis of growth rates for mice pair-fed MouseAA or BodyAA showed a 
significant increase in growth for mice fed MouseAA (linear regression P value 
= 0.036; Figure 5.15D). Moreover addition of the exome-predicted limited EAA 
in BodyAA did not increase growth (linear regression P value = 0.0037; Figure 
5.15D). These results demonstrate that the exome is a better measure for 
defining AA requirements than the whole body AA composition. 
 
 
 
 
Figure 5.15 
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a. The mouse whole body AA ratio (BodyAA) vs. the mouse SILAC proteome (mSILACAA) 
ratio. The SILACAA-predicted most limiting EAA in the whole body AA ratio (BodyAA) is 
tryptophan (r W(min) = 0.65).  
 
b. The mouse whole body AA ratio (BodyAA) vs. the mouse exome (MouseAA) ratio. The 
exome-predicted most limiting EAA in the whole body AA ratio (BodyAA) is tryptophan (r W(min) 
= 0.53).  
 
c. The mouse SILAC proteome (mSILACAA) ratio vs. the mouse exome ratio (MouseAA). 
The exome-predicted most limiting EAA in mSILACAA is tryptophan (r W(min) =0.82). 
Therefore, the two ratios appear highly similar. 	
d. Growth rates for females fed BodyAA, MouseAA, and BodyAA + tryptophan (W). The linear 
part of the growth curves indicates that BodyAA suppresses growth by 20% compared to 
MouseAA (linear regression P value = 0.0306), based on net mass gain for that period 
(weeks 3 to 6.4 of age). Moreover addition of the exome-predicted limited EAA in BodyAA did 
not increase growth (MouseAA vs. BodyAA+W linear regression P value = 0.0037). Growth 
curves are based on 20 female C3B6F1/J hybrids for each diet (N=20).  
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5.3.13	Exome-matched	against	NRC-matched	AA	supply	
 
As mentioned earlier, despite the many methods previously used in 
calculating dietary AA requirements, today there is consensus that the 
determination of dietary protein quality should take into account data from all 
existent methods (4, 25). Thus, in laboratory animal nutrition, 
recommendations are based on combining such experimental data along with 
empirical growth data. Yet, AA recommendations for well-defined model 
organisms can also vary considerably between such recommendations. In 
mice, independent sources, including the American Institute of Nutrition (AIN) 
(232) and the National Research Council (NRC) (28) recommend dietary AA 
profiles that are distinct to each other (Figure 5.16A), meaning that different 
expert panels arrive to different AA recommendations depending on the 
published information they use. Both ratios are also distinct to the mouse 
exome profile (Figure 5.16B-C). So it was next determined if the exome, as a 
less ambiguous measure for defining dietary AA requirements, can be used 
as an alternative and more reliable predictor of growth. 
 
Based on the exome AA usage, it was predicted that the most limiting EAA in 
NRCAA would be tryptophan  (r W (min) = 0.55) (Figure 5.16C). However, 
NRCAA promoted growth more than MouseAA (Figure 5.s 16D-E). Moreover, 
when attempting to correct the NRCAA’s limitations, as predicted by the 
exome, by increasing tryptophan by ~1.5 fold (to eliminate the W limitation; 
NRCAA+W) or by ~1.5-fold addition of tryptophan combined to a ~2-fold 
addition of arginine (NRCAA+W+R) as a control for arginine’s dispensability, a 
significant growth suppression in both cases was observed (Figure 5.16E). 
Importantly, addition of arginine in NRCAA+W, resulting in the NRCAA+W+R 
diet, significantly suppressed growth by 14% in the linear part of the growth 
phase, a trend that persisted at least until 32 weeks of age (Figure 5.16E). 
Thus, although at limiting levels arginine did not promote growth (Figure 
5.1E), surplus arginine in NRCAA+W significantly reduced growth. Mice fed 
NRCAA also had significantly increased lean and fat mass compared to mice 
fed MouseAA, NRCAA+W, and NRCAA+W+R, following both 10 or 20 weeks 
of treatment (Figure 5.16F), and the FER and PER indices were similarly 
affected, with NRCAA increasing the efficiency of both food and protein 
(Figure 5.16G). Mice fed NRCAA also had significantly reduced water 
consumption (Figure 5.16H). 
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Figure 5.16 	
a. Comparison of the American Institute of Nutrition (AINAA) and the National Research 
Council (NRCAA) recommended dietary AA profiles. AINAA is limited for methionine 
compared to NRCAA. 
 
b. Comparison of AINAA to the mouse exome AA usage (MouseAA) reveals that the AINAA 
is limited for Arginine and Tryptophan compared to MouseAA. 
 
c. Comparison of NRCAA to the mouse exome AA usage (MouseAA) reveals that the NRCAA 
is limited for Arginine and Tryptophan compared to MouseAA. 
 
d. Body mass across dietary AA ratios. Post-weaning body mass was similar between 
MouseAA and NRCAA, but was significantly increased in mice pair-fed NRCAA compared to 
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mice pair-fed MouseAA 6% after 10 and 20 weeks of treatment on the respective diet (age 13 
and 23 weeks respectively). Bars represent the mean for each group (N = 20 for weeks 3 and 
14, N = 10 for week 24), and error bars represent SEM. Letters indicate statistically significant 
differences (P value < 0.05) for pair-wise comparisons (Student’s t-test).  
 
e. Body mass growth comparison of mice fed MouseAA and NRCAA. Mice fed NRCAA had 
an increased growth rate, and this improvement was ~11% at week 6.4 (polynomial 
regression analysis P value = 0.03), and ~30% at week 9 (polynomial regression analysis 
slope P value < 0.05, linear mixed effects analysis P value = 0.12). Moreover, correcting 
NRCAA by matching its tryptophan (NRCAA+W) or arginine and tryptophan (NRCAA+W+R) 
contents to the exome requirement decreased growth against MouseAA (for both MouseAA 
vs. NRCAA+W or vs. NRCAA+W+R, polynomial regression analysis slope P value < 0.05) 
 
f. Lean mass across dietary AA ratios. Post-weaning lean mass was similar between the 
groups, but was significantly increased in mice pair-fed NRCAA compared to mice pair-fed 
MouseAA 6% after 10 and 20 weeks of treatment on the respective diet (age 13 and 23 
weeks respectively). Bars represent the mean for each group (N = 20 for weeks 3 and 14, N = 
10 for week 24), and error bars represent SD. Letters indicate statistically significant 
differences (P value < 0.05) for pair-wise comparisons (Student’s t-test). Data by George 
Soultoukis, Martin Purrio and Dr. Andrea Mesaros. 
 
g. Food efficiency and protein efficiency were improved by NRCAA compared to MouseAA, 
both at 6.4 weeks of age, and at 18 weeks of age. Bars represent the mean for each group (N 
= 20 for weeks 3 and 14, N = 10 for week 24), and error bars represent SD. Letters indicate 
statistically significant differences (P value < 0.05) for pair-wise comparisons (Student’s t-
test).  
 
h. Water intake for mice ad libitum-fed and pair-fed on MouseAA, MMAA, MMAA-T, and 
MMAA-M. Mice pair-fed MouseAA consumed significantly less water compared to all other 
pair-fed mice (letters indicate significant change, p<0.05, Student’s t-test, N = 4). 
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The observation that moderate additions of tryptophan or arginine in NRCAA 
suppress growth suggest that complex interactions between specific AAs, 
such as substrate antagonisms or other less well-understood effects (26), 
may have significant effects upon growth. It is notable that NRCAA has twice 
the content in methionine and phenylalanine compared to MouseAA. 
Autoclaving and irradiation, both common sterilization steps in laboratory 
rodent food preparation, can diminish the levels of certain AAs including 
methionine and cysteine (177) and may result in a lower methionine content in 
the MouseAA food than that required by the exome AA usage.  
 
Moreover in the liver, methionine enters many transulfation, transmethylation, 
and folate metabolism reactions (56), and an estimated 35%-100% of the 
ingested methionine, phenylalanine, and branched-chain AAs, is used by the 
splanchnic bed (first pass metabolism), never reaching systemic circulation 
(48, 56). Therefore, it is possible that the high content of NRCAA in 
methionine and phenylalanine allows a sufficient amount of these two AAs to 
reach circulation, to meet AA usage demands, and consequently to promote 
growth more efficiently than MouseAA. This could explain why mice fed 
NRCAA grow faster than mice fed MouseAA. However, this explanation does 
not account for the growth-suppressing effect induced by increasing 
tryptophan by ~1.5 fold (to match the W content in MouseAA; NRCAA+W) or 
by ~1.5-fold addition of tryptophan combined to a ~2-fold addition of arginine 
(NRCAA+W+R). Yet, previous growth studies have observed that some 
tryptophan additions become toxic and suppress growth (26), and this could 
be an explanation for these effects. Alternatively, complex interactions 
between AAs could contribute to these effects. However, this is a poorly 
understood topic: for example, antagonisms between lysine and arginine can 
suppress growth upon addition of lysine or arginine only in the diet (26). 
Excess leucine or methionine depress rat growth independently of food 
intake, with excess leucine increasing the growth requirement for tryptophan 
(26). Yet, there is a lack of comprehensive studies due to the many 
dimensions of potential interactions, and the effects of AA imbalance-induced 
decreases in growth, and upon health and lifespan, are poorly characterized. 
In a previously published study, moderately increasing methionine and 
phenylalanine to proportions similar to those in the NRCAA proportions did 
not increase rodent growth (180, 233), and actually decreased it significantly. 
A 6% fibrin diet (Figure 5.17A) with supplementations of 0.4% w/w methionine 
and 0.6% w/w phenylalanine (Figure 5.17B) decreased growth in rats by 
~30% compared to the unsupplemented 6% fibrin diet (Figure 5.17C). 
Therefore it is unclear if the additions of tryptophan or tryptophan+methionine 
are toxic, or if the excess methionine and phenylalanine simply cause 
interactions with surplus tryptophan to suppress growth. 
 
Nonetheless, NRCAA, an empirical-based recommended AA profile promoted 
anabolism more than exome-matching did. Nevertheless, exome-matching is 
a valid measure of defining requirements, and is based on a method that 
considers quantifiable genomic information, and is not simply empirical as 
NRCAA is. This also means exome-matching is immediately more applicable 
to new model organisms with sequenced genomes, compared to other 
methods that are simply empirical, arduous, and consider data accumulated 
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over decades to derive some recommendations; such methods are arguably 
less efficient for immediate use. Therefore exome-matching is a quick, 
accessible, and quantifiable approach for defining the AA requirements in 
mice. 
 
 
 
a. Comparison of the AA profile in fibrin (FibrinAA) and the rat exome AA usage (RatAA) 
profile. FibrinAA is limited for Leucine compared to RatAA. 
 
b. Comparison of the AA profile in fibrin supplemented with Methionine and Phenylalnine 
(FibrinAA+M+F) and the rat exome AA usage (RatAA) profile. FibrinAA+M+F is limited for 
Leucine compared to RatAA. 
 
c. Rat body mass gain following 2 weeks of treatment on FibrinAA and on FibrinAA+M+F. 
Data replotted from those publiched in (233). 
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5.4	Discussion	
 
5.4.1	Mouse	growth	
 
As reported in Chapter 4, the degree of limitation in the most limiting essential 
AA (EAA) as defined by the exome can be used as an accurate predictor of 
anabolism in flies. Using the same model in mice, it is demonstrated in this 
Chapter that an imbalanced ratio also suppresses anabolic traits and growth 
in mice. Limiting dietary EAAs were predicted by the mouse exome, and 
dietary AA ratios were qualitatively defined by the degree of their 
disproportion to the exome AA usage more accurately than when compared to 
other approaches. Mouse exome-matching (MouseAA) promoted growth 
more so than casein, the common protein source in commercial mouse feeds. 
Ad libitum–fed mice also consumed less MouseAA food than CaseinAA food, 
suggesting exome-matching defines murine diets to be more satiating. 
MouseAA was also more efficient for anabolic traits than the whole body AA 
ratio (BodyAA), a previously used measure of AA requirements (153). 
Importantly, across species, AA intake can itself alter the body’s AA 
composition (189, 234), which introduces a critical confounding variable in this 
approach. Therefore, exome-matching is an effective measure of determining 
AA requirements across species compared to previously reported measures.  
Mice fed at higher CP levels (CaseinAA 8%) had growth rates matched by an 
exome-matched diet fed at lower CP levels (MouseAA 6%). Morevover the fly 
findings supported a conditionally-essential role of arginine for egg-laying, and 
it was therefore set out to confirm the nature of the essential role of arginine 
for anabolic traits in mice. Previous studies in mice have shown that arginine 
is essential (28) but replenishable for rodent growth (235), with limited effects 
on growth when restricted in the diet. Yet, excess dietary arginine can also 
suppress growth (26). Indeed our results provide further support to these 
findings, as it was observed that arginine addition in an arginine-limited diet 
did not improve growth, but even small arginine additions in a diet containing 
adequate amounts of arginine (NRCAA) resulted in significant growth 
suppression. It is likely that these growth-suppressing effects of surplus 
arginine occur because arginine can exhibit substrate antagonism against 
certain AAs for specific transporters (46). Indeed, it has been observed that 
antagonisms between lysine and arginine can suppress growth upon addition 
of lysine or arginine only in the diet (26). Thus, a conditionally essential AA 
whose restriction has no effect on growth (arginine) can in fact suppress 
growth when consumed in excess. Recent findings on the unique 
mechanisms involved in AA sensing by TOR, and in specific, on the unique 
mechanism involved in arginine sensing, also provide intrigue into the unique 
role of arginine in AA sensing and growth signaling (236). 
 
5.4.2	Mouse	metabolic	rate	
 
In contrast to flies, exome-matching in mice resulted in a decreased oxygen 
consumption, both during the day and night cycles. In mice compared to 
higher protein diets, low protein diets increase thermogenesis, body surface 
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temperature (237), energy expenditure, mitochondrial activity, and oxygen 
consumption (3, 238), all of which were observed in mice fed the exome-
mismatched CaseinAA diet. CaseinAA therefore caused a decreased 
utilization of nutrients (lower food and protein efficiencies) and mimicked a 
lower protein diet consumption by elevating all these aspects of metabolic 
rate. However, the RER was not changed by exome-matching, suggesting no 
shift to fat as an energy fuel. Finally, as mice were kept at temperatures (22-
23°C) below their thermoneutral zone (30°C) it is worth mentioning that SCAT 
thickness also affects heat loss. Indeed, exome-matching increased SCAT, 
and decreased energy expenditure and body temperature (although the body 
temperature was not decreased significantly). 
Oxygen consumption depends on mitochondrial function, and mitochondrial 
activity is decreased in type 2 diabetes (218). Moreover, diet induced obesity 
is associated with impaired mitochondrial function and mitochondrial dynamic 
processes, and impacts on mitochondrial bioenergetics and on the metabolic 
response to nutrients (239, 240). In agreement to these observations, exome-
matching resulted in lower oxygen consumption, higher insulin-resistance, 
and higher levels of obesity compared to mice fed CaseinAA. As a decrease 
in hepatic proteasomal activity was also observed, it is also possible that 
compromised hepatic proteasome function contributed to the decreased 
mitochondrial function in a feedback loop process between the two systems 
(241). However, exome-matching reduced the abundance of complex I in the 
mouse liver, which could confer metabolic advantages. Hepatic mitochondrial 
complex I contents can be reduced by dietary protein restriction (242), and a 
low abundance of complex I protein levels can promote mitochondrial 
efficiency and longevity in mice (243). Indeed fatter, more insulin-resistant 
mice can be longer lived due to the C:P ratio consumed (3). Moreover, high 
protein diets can reduce fat deposition, unlike what was seen in MouseAA-fed 
mice here, and this can shorten lifespan in mice (244). Therefore, more work 
is needed to further appreciate the role of mitochondrial function across a 
range of dietary protein levels and AA profiles. For example, more steady 
state single subunit levels could be assessed, as well as complex, 
supercomplex, and activity levels (including complex I activity). 
Finally, in rodents, DR increases spontaneous activity levels (245), including 
voluntary wheel activity (246). In our set-up, ad libitum fed mice had reduced 
levels of spontaneous activity compared to pair-fed mice, and this effect was 
significant in ad libitum-fed exome-matched mice.  
 
5.4.3	Mouse	body	composition	
 
In ad libitum-fed mice, low dietary protein increases adiposity as a 
consequence of a higher food intake, but these animals are as healthy as DR 
ones (3, 247). However, here we show that under a fixed AA intake, the 
profile of ingested AAs determines fat storage. In wild type mice, GCN2 
represses liver fatty acid synthesis and promotes fat mobilization when 
animals are fed a leucine-deprived diet (248). Our results show that a 
tryptophan-limited CaseinAA diet also reduces adiposity in mice. Therefore, 
more usable AA sources (MouseAA) enable fat storage, an effect that is 
apparent particularly at low dietary protein conditions. However, a decrease in 
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fat storage and an improved insulin sensitivity is seen upon an increase in the 
total AA intake both in mice and humans (3) (24), so it remains possible that a 
balanced AA profile will reduce adiposity at higher levels of dietary protein 
compared to an imbalanced one, as was observed in flies. In humans, protein 
sources with a high nutritional value, such as whey protein, promote a 
reduction of adipose tissue during diet restriction-induced weight loss (142), 
which decreases both fat and lean mass, thereby exacerbating an 
unfavourable body composition known as sarcobesity (249). Therefore, the 
assessment of fat storage across various levels of dietary AA intake would 
better elucidate how the profile of ingested AAs interacts with the total AA 
intake to determine fat storage. Moreover, the ability of animals to maintain 
their adiposity despite DR is critical for gaining the health benefits of DR (92), 
and a lifespan analysis in exome-matched and exome-mismatched dietary AA 
profiles would establish the interaction between dietary AA profiles, total AA 
intake, adiposity, and health. Therefore, as the role of fat deposition in 
mediating the health benefits of protein restriction, single AA restriction, and 
AA imbalance requires further investigation. 
 
In mice and humans, DR reduces triglycerides and increases some ketones 
(including β-hydroxybutarate) (250), and our results indicated similar effects in 
mice fed the exome-imbalanced CaseinAA. Additionaly, imbalanced AA 
intakes can inhibit lipogenesis, and methionine or tryptophan restrictions 
reduce fat storage in rodents, while methionine restriction also reduces 
hepatic triglycerides (13, 14). In leucine or methionine-restricted diets, 
fibroblast growth factor 21 (FGF21) is a common downstream effector of 
GCN2 activation that represses liver fatty acid synthesis and increases fatty 
acid mobilization (13) (79, 251). The results in this Chapter are in accord with 
these observations, as exome-mismatching reduced liver and plasma 
triglycerides, and increased oxygen consumption. An increased oxidative 
capacity and reduced lipogenic function is a critical component of the hepatic 
response to diets with limiting dietary AAs including methionine-restricted 
diets (13). Interestingly, mice on the exome-matched diet also had a 
significantly increased subcutaneous fat and skin thickness, which 
presumably contributes to a better insulation and decreased heat loss, 
thereby resulting in less need for thermogenesis. Therefore although mice 
pair-fed MouseAA had a significantly lower energy expenditure, their surface 
body temperature was not significantly reduced, which is in agreement with 
previous studies showing that subcutaneous fat differences as a function of 
dietary protein do not necessarily explain differences in thermogenesis and 
body surface temperature (237). 
 
Another tissue-specific effect of protein restriction in rodents is the positive 
correlation seen between intestinal villus length and growth rate (229, 252). 
This effect is presumably linked to the abundance and usability of intraluminal 
AAs (229, 253). However, although in our exome-matched mice we saw a 
higher growth rate, no changes in villus or cryptal length were detected at 24 
weeks of age, although it is possible that an effect may occur at younger 
ages. Brain mass, which can be spared during growth-depressing nutritional 
stress, was also significantly increased by exome-matching but the difference 
disappeared upon normalization to body mass. Lean and muscle mass was 
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also increased by exome-matching, a higher quality AA source, which is in 
accord with the findings that a balanced AA source such as whey protein, or 
essential AA supplementation can promote an increase in muscle protein 
synthesis during diet restriction-induced weight loss in elderly obese 
individuals (142), or during muscle atrophy induced by casting in mice (254). 
Interestingly, mice fed CaseinAA had a higher incidence of hepatic and 
muscle atrophy, and its been previously shown that a higher induction of IGF-
1, PI3K, and Akt suppresses muscle atrophy (255). The insulin levels of mice 
fed CaseinAA were decreased compared to mice fed MouseAA, indicating a 
possible suppression of the IIS pathway in mice fed CaseinAA, consistent with 
their higher muscle atrophy incidence. Moreover, although hepatic levels or 
activation of Akt was not decreased at 24 weeks, when growth curves 
approach a plateau phase, differences in Akt levels or activation could have 
occurred during the more critical linear growth phase, thereby contributing to 
their higher muscle atrophy incidence. 
 
5.4.4	Mouse	glucose	homeostasis	
 
Accumulation of fat and lipids in tissues and circulation can interfere with 
insulin signaling and lead to insulin resistance (256), while in mice and 
humans DR reduces circulating glucose (250). Mice fed MouseAA utilize a 
significantly higher proportion of the ingested AAs and display insulin 
resistance, suggesting that the higher utilization of dietary AAs in MouseAA 
results in an effect similar to that observed upon increasing the total amount 
of ingested AAs. As more dietary AAs are used by mice fed MouseAA (both 
ad libitum and pair-fed), more AA catabolism occurs, generating carbon 
skeleton products, including glucose. However, glucose levels were elevated 
in ad libitum-fed MouseAA mice only, indicating that pair-fed mice in a low 
protein diet enable homeostatic mechanisms to prevent an increase in basal 
glucose levels as a function of the ingested AA profile. Although glycogen 
accumulation is one of the protective mechanisms of DR in yeast and worms, 
elevated glycogen storage is not a hallmark of the DR-induced benefits in 
mammals (257), and in humans DR actually reduces glycogen stores (250). 
Yet, exome-matching increased adiposity and decreased glycogen storage, 
assessed histologically, under pair-fed conditions suggesting that an AA 
profile with a higher nutritional value can shift the metabolism of glucose away 
from glycogen synthesis and towards fat synthesis. In skeletal or heart 
muscle, the inhibitor of glycogen synthase GSK-3 is induced by insulin-like 
growth factor-1 (IGF1) (255) or insulin (258). Mice fed MouseAA diet had 
higher levels of circulating insulin, a greater body size, and increased levels 
and activation of GSK-3, resulting in decreased liver glycogen storage. High 
protein diets are known to reduce hepatic glycogen storage in mice, and 
insulin resistance can lead to a reduction in glycogen synthesis (259). Given 
the decreased respiration in mice fed MouseAA, the most probable end 
product for glucose and its by-products may be fat precursors. Interestingly, 
mice ad libitum-fed MouseAA had a similar glucose homeostasis profile to 
long-lived insulin receptor substrate 1 null mice (Irs1-/-), which also show 
glucose tolerance, insulin resistance, and elevated basal levels of insulin 
(260). Insulin and leptin are satiety hormones, and high circulating levels of 
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these hormones reduce food intake (111, 261), in accord with what was 
observed for mice fed the exome-matched diet. Such hormonal modulations 
induced by dietary AA profiles can reflect long-term metabolic adaptations to a 
diet, as opposed to short-term responses including GCN2 mediated 
responses (111). Combined, our results support these findings and further 
show that a dietary AA profile that is highly utilizable can phenocopy a higher 
protein diet, and result in obesity, higher insulin resistance, increased glucose 
tolerance, reduced food intake, and decreased glycogen storage. 
 
5.4.5	Mouse	proteostasis	
 
Insulin resistance is associated with proteasome dysfunction, exhibited as 
increased levels of proteasome subunit transcripts and decreased 
proteasome activity (262). The decreased proteasomal activities of mouse 
liver and muscle tissues upon exome-matching might, therefore, be 
secondary to the increased fat accumulation and increased insulin resistance 
observed in these animals. As mentioned, in the liver a decrease in 
proteasomal activity caused by impairment of proteasome function can drive 
the malfunction of mitochondrial function in a feedback loop process between 
the two systems (241). However, more work would be required to establish 
the cause of the observed reduction in hepatic proteasome activity. In 
addition, although no changes were seen in the modulation of TOR protein 
levels or activation as a function of the ingested AA profile, recent studies 
suggest that proteostatic mechanisms can function independently of TOR 
modulation (263). Interestingly, in both mice and flies (Chapter 4) 
proteasomes proved to be more sensitive to dietary modulations than the 
autophagic machinery, regardless of whether the observed effects are primary 
or secondary. Moderate, rather than severe, modulations in the AA 
proportions were sufficient to exert responses to dietary AAs. This may 
provide a valuable hint about the function of degradation machineries, and 
about which one of them responds more upon chronic dietary AA 
interventions.  
 
 
5.4.6	Mouse	nitrogen	balance	
 
It has long been recognized that diets containing an imbalanced AA ratio can 
reduce nitrogen retention compared to a balanced AA ratio (26), while the 
observation that imbalanced AA sources reduce nitrogen retention is also 
widely accepted in humans (25). An imbalanced dietary AA supply can induce 
excessive water intake and urine loss. The urine output in methionine-
restricted mice, for example, is higher than for controls presumably due to the 
osmotic demands of excreting nutrients that cannot be metabolized into 
protein due to the limiting levels of sulphur AAs (203). Our results are in 
agreement with these observations, as mice ingesting an exome-mismatched 
AA profile had a lower nitrogen retention, owing to poor AA utilization, which is 
a consequence of this AA imbalance. Another important aspect of such 
feeding regimes, however, involves feeding frequency. Ad libitum-fed mice 
snack throughout the day much more often, whereas DR mice eat all food at 
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one go as soon as its offered to them (less feeding episodes) (245). Water 
consumption per mass of food ingested is same for DR animals, but again 
through less drinking episodes. It is likely that such differences in feeding 
patterns can alter certain phenotypes including energy homeostasis, insulin 
signaling, and nitrogen utilization.  
 
5.4.7	Mouse	bone	quality		
Apart from the increase in skeletal length observed in pair-fed animals on the 
MouseAA regime, the AA profiles also affected several bone quality 
parameters. Bone health is affected by many nutrients, with the type and 
quality of dietary protein playing a predominant role (264). High quality protein 
sources that promote growth hormones are associated with increased BMD 
and lower porosity (264). For pair-fed mice, exome-matching resulted in 
increased cortical and trabecular structure thickness, increased trabecular 
bone volume and bone mineral density (BMD) compared to CaseinAA-fed 
mice. These observations are in accord with the hypothesis that MouseAA is 
a higher quality nutritional source than CaseinAA. In mice, several nutrient-
responsive pathways modulate skeletal development, and bone mineralization 
and ossification processes, including Akt-Foxo, mTOR, and GSK-3 mediated 
pathways (265). The observation that mice pair-fed CaseinAA had decreased 
levels of activated GSK-3 may explain their lower levels of bone volume and 
mineralization (265). Moreover, reduction in IGF-I, typically associated with 
reduced growth such as that observed in animals pair-fed CaseinAA, is also 
linked to decreased bone quality and strength with age (266). Therefore, it 
would be interesting for future studies to explore the effects of dietary AA-
mediated effects on bone health with ageing. 
For ad libitum fed mice, in contrast, only cortical structure thickness was 
elevated in animals fed MouseAA compared to animals fed Casein AA. The 
fact that several parameters were unchanged in the ad libitum-fed (more 
obese) animals is in accord with the finding that bone quality in rodents is 
more sensitive to leaner than it is to more obese animals (267). Moreover, DR 
in mice increases BMD (268) but DR mice are typically leaner and BMD can 
also partially reflect body mass (269). Accordingly, mice pair-fed MouseAA 
were heavier and also had elevated BMD compared to mice pair-fed 
CaseinAA. In humans too, decreased trabecular and cortical strength and 
lower BMD, consistent with increased risk of fracture, are associated with 
dietary restriction (230, 270). Therefore, the findings described here suggest 
that exome-matching can have a significant impact upon bone quality, 
primarily by increasing BMD. Moreover, it is possible that as in mice, exome-
matching in humans could define diets for the promotion of long-term bone 
health. In this respect, it would be interesting to investigate the long-term 
effects of exome-matching in murine bone health with age. 
 
5.5	Conclusions	
 
Malnutrition is a leading cause of growth attenuation in children (271). In this 
Chapter it is observed that an ingested AA profile matched to the mouse 
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exome requirements can prevent mouse growth attenuation. Moreover, the 
results demonstrate that small dietary AA modulations can dictate many 
physiological processes that ultimately impact on long-term health in mice. 
Critical health aspects, such as obesity and insulin resistance, were 
determined by the ingested AA profile. It is thus important to understand how 
modulations in dietary AAs exert their biochemical and physiolometabolic 
effects. However, the role of fat metabolism in promoting health in DR is still 
not clear, and the role of fat deposition in mediating the health benefits of 
protein or single AA restriction also requires further investigation.  
 
The weighted proteome’s AA usage was a better predictor for mouse lean 
mass growth than the exome requirement. However, no correlation was seen 
between the tissue-specific weighted proteome (tsmSILACAA) and the growth 
rate for the specific organs in question. In flies, proteasome peptide 
biosynthesis could not be predicted or modulated simply through dietary AA 
manipulation on the basis of AA requirement by the proteasome’s proteome. 
As in flies, these results suggest that ingested AA profiles do not directly 
modulate the biosynthesis of single organs on the basis of the principle of 
minimum. The biosynthesis of specific organs or of sets of proteins (e.g. 
proteasome complex) is not merely a function of what AAs are ingested, but 
are rather modulated by other regulatory processes possibly including 
transcriptional, translational, and metabolic parameters.  
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Chapter	6:	General	discussion		
6.1	Summary	
 
The results presented in this thesis show that an exome-matched supply of 
dietary AAs promoted production traits in both flies and mice better than other 
commonly used dietary AA sources, including AAs provided in the proportion 
found in yeast or in casein respectively. In both animals, exome-defined 
limiting EAAs decreased dietary protein efficiency for anabolic processes. 
These results show that dietary AA balance is critical for the modulation of key 
life history traits, including growth, reproduction, and for key health aspects 
including fat metabolism in both flies and mice. Because this model is driven 
by the genome sequence of the organism in question, the principle can be 
applied to any organism whose genome sequence is known. Therefore our 
findings carry possible implications for interventional applications in human 
nutrition. 
 
The data in this thesis also suggest a quantitative relationship between the 
levels of dietary nitrogen (in the form of AAs), the dietary AA profile, and key 
life history traits such as development, reproduction, and health. Failing to 
account for the interaction between the limiting EAA and the total nitrogen 
intake can lead to fallacies in growth data interpretation (180, 272, 273). The 
principle of the minimum poses that the most limiting nutrient in a diet can 
prevent successful utilization of other, non-limiting nutrients that are, as a 
result, acquired in excess (31). Accordingly, we find that exome-defined 
limiting EAAs prevent the anabolic usage of non-limiting EAAs. In addition, the 
law of diminishing returns holds that each succeeding increment of the limiting 
essential nutrient will produce a smaller increment of growth than the 
preceding increment (31, 190). In agreement, we observed a decrease in the 
effect of the limiting EAA with incremental increases in its concentration, or in 
the concentration of dietary nitrogen, upon fly development, growth, and 
fecundity, as well as mouse growth. At high AA supply, the physiological 
needs for development were equally met by diverse dietary AA ratios, but at 
low dietary nitrogen they were adequately met only by the exome-matched 
diet. Interestingly, certain AA intakes, such as that in casein, have been 
shown in the past to delay fly growth and development time (145) but to be 
adequate for lifespan (274). The resonation of the effects of a dietary AA 
imbalance upon anabolic traits at low dietary AA supply is not a new 
observation in rodents (180).  	
However, although the degree of limitation of a limiting EAA in the diet is 
important, the findings described in this thesis also support a key role of the 
identity of the limiting EAA in mediating the physiological responses to a 
dietary EAA imbalance. This is in accord with previous studies showing that 
the identity of the limiting EAA is critical for the effects of protein and single 
EAA utilization for fly fecundity (212), fly development (199), and for rat 
growth (273). Other studies in rodents also support a key role for the 
proportion of the limiting EAA to other, non-limiting EAAs (233). Moreover, 
even minor disproportions of EAAs can be detrimental for health (26). Thus, 
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although a measure to aid the identification of limiting EAAs is of great 
importance (that measure here defined as the exome), further work is 
required to resolve the precise biological reasons for such indiscrepancies 
between different identities of the most limiting EAA.  
 
Finally, the weighted proteome’s AA usage was a better predictor for mouse 
lean mass growth than the exome requirement. However, no correlation was 
seen between the tissue-specific weighted proteome (tsmSILACAA) and the 
growth rate for the specific organs in question. In flies, proteasome peptide 
biosynthesis could not be predicted or modulated simply through dietary AA 
manipulation on the basis of AA requirement by the proteasome’s proteome. 
These results suggest that ingested AA profiles do not directly modulate the 
biosynthesis of single organs or of specific gene ontologies on the basis of the 
principle of minimum. Thus the biosynthesis of specific organs or of sets of 
proteins (e.g. proteasome complex) is not merely a function of what AAs are 
ingested, but are rather modulated by other regulatory processes possibly 
including transcriptional, translational, and metabolic parameters.  
 
A complication in the evaluation of the effects of ingested AAs may stem from 
the fact that dietary-AA dependent processes are not necessarily regulated in 
an identical way across species. In many model organisms, as well as 
humans, DR results in leanness, limiting obesity to confer multiple metabolic 
advantages that favour longevity (5). However, DR or PR flies increase their 
fat storage (275, 276). In mice DR reduces fat storage (6) but PR increases it, 
yet both DR and PR promote healthspan and lifespan (8, 13). Moreover, mice 
subjected to DR have an extended lifespan particularly when they can 
maintain their adiposity (6, 92). The physiological effects of single AA 
modulations may also be inconsistent across species. While long-lived 
methionine-restricted (MR), leucine-restricted (LR), or tryptophan-restricted 
(TR) mice have depleted fat storage (13, 14, 79), increasing evidence 
suggests that flies fed diets limited in single AAs have higher levels of body 
lipids. Mice subjected to DR or MR also have a higher energetic efficiency 
than ad libitum-fed mice aiding thermoregulation (13), in contrast to flies which 
are poikilothermic. Thus life-extending interventions through dietary AAs 
appear to cause disparate effects in lipostasis and energy homeostasis 
between flies and mice. Indeed, some findings were contrasting between flies 
and mice. Exome-matching in flies resulted in lower lipid content, but in mice it 
increased fat storage. Nonetheless, many common features between the two 
organisms were observed, including a general induction in anabolic 
processes. 
 
6.2	Conclusions	
 
The genetic composition of a species may affect the response to ingested 
AAs and contribute to the diversity of protein sources consumed across 
species. In humans, recent nutrigenomics methods employ the use of genetic 
information on inborn errors of metabolism to direct the use of dietary AAs in 
clinical research (106). Yet, the advance of multiple –omics technologies has 
opened the possibility of evaluating dietary AA requirements across species 
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through novel approaches. Here, a genome-based technique for designing an 
enhanced quality protein is presented, and it is shown that the exome is a 
powerful measure for defining AA requirements across species. 
 
Malnutrition is a leading cause of growth attenuation in children (271). In both 
flies and mice, an ingested AA profile matched to the organism’s exome 
requirements prevented growth attenuation at low dietary protein levels. 
However, such response mechanisms appear to be species-dependent. Stark 
contrasting physiometabolic responses to dietary AA modulations were 
observed between mice and flies. The role of fat metabolism in promoting 
health in DR is still not clear, and the role of fat deposition in mediating the 
health benefits of protein or single AA restriction also requires further 
investigation.  
 
However, here it is shown for the first time how the interaction between 
nitrogen levels and limiting AAs impacts on multiple physiometabolic aspects. 
Following ingestion, the net amount of usable AAs depends both on the total 
nitrogen intake and on the AA profile ingested, and determines both 
production traits and health. In Drosophila, an exome-balanced AA source is 
more usable and maximizes anabolism, suggesting that optimized anabolic 
traits increase growth signaling. In contrast, exome-imbalanced dietary AA 
ratios are less usable and maximize anabolism only at higher dietary nitrogen 
levels. Nonetheless, traits such as growth, development time, and 
reproductive output, however, require high nitrogen supply to approach their 
maximum levels, regardless of the AA profile. Importantly, exome-matching 
also defines anabolic traits in mice as exome-mismatched AA ratios 
supported a slower growth rate, which can be a predictor of murine lifespan 
(36). Specifically, the growth rate at ~20 weeks of age, which is also report 
here, has been proposed as an accurate predictor of lifespan in mice (36). 
Therefore, it is possible that the observed phenotypes linking dietary AAs to 
anabolic traits and health also determine lifespan. This is an interesting 
prospect that warrants further investigation, as it would directly link an exome-
matched profile of ingested AAs to longevity, with a wide range of implications 
for both human and animal nutrition.  
 
Despite the complexity of the multitude of factors that can alter AA usage, 
nutrigenomics may be the most promising approach for defining AA 
requirements. The exome-based approach can be used in designing 
enhanced protein quality in diets, thereby improving growth and reproduction, 
and predicting the effects of dietary nitrogen upon key life history traits. An 
optimally balanced nitrogen source can define nitrogen requirements for 
anabolic traits and health when the total intake of dietary amino acids is 
relatively low. In humans, a higher satiety effect is linked to higher protein 
diets used in clinical weight management (23). The results in this thesis may 
have broad implications to the application of dietary regimes aimed at weight 
loss as it is shown that apart from the protein content of a diet, the AA profile 
also determines satiety and food selection in mammals. Enhancing dietary 
protein quality is also a keen interest of the food industry, with economic 
advantages in increasing the efficiency of biomass production and 
environmental advantages in minimising pollution from nitrogenous waste 
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production. Moreover, protein efficiency optimization can also find application 
in improved animal health and growth for sustainable food production (277), 
enhanced recovery for humans from intense exercise (278) and surgery, and 
in maximising the nutritional value of food to aid recovery from malnutrition. 
 																																												
	 193	
																																																	
	 194	
References	
 
1. Keenan KP, Wallig MA, Haschek WM. 2013. Toxicol Pathol. 
41(2):190–209 
2. Simpson SJ, Raubenheimer D. 2010. Calorie Restriction, Aging and 
Longevity. Dordrecht: Springer Netherlands. 12 p. 
3. Solon-Biet SM, McMahon AC, Ballard JWO, Ruohonen K, Wu LE, et 
al. 2014. Cell Metabolism. 19(3):418–30 
4. Lupton JR, Brooks GA, Butte NF, Caballero B, Flatt JP, et al. 2001. 
Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty 
Acids, Cholesterol, Protein, and Amino Acids. Washington D.C.: The 
National Academies Press. 1 p. 
5. Fontana L, Partridge L. 2015. Cell. 161(1):106–18 
6. Weindruch R, Walford RL. 1988. The Retardation of Aging and 
Disease by Dietary Restriction. Springfield, IL: Charles C. Thomas 
Pub Ltd. 1 p. 
7. Mair W, Piper MDW, Partridge L. 2005. Plos Biol. 3(7):e223 
8. Grandison RC, Piper MDW, Partridge L. 2009. Nature. 
462(7276):1061–64 
9. Horáková M, Deyl Z, Hausmann J, Macek K. 1988. Mechanisms of 
Ageing and Development. 45(1):1–7 
10. Nakagawa S, Lagisz M, Hector KL, Spencer HG. 2012. Aging Cell. 
11(3):401–9 
11. Mirzaei H, Suarez JA, Longo VD. 2014. Trends Endocrinol. Metab. 
25(11):558–66 
12. Douris N, Melman T, Pecherer JM, Pissios P, Flier JS, et al. 2015. 
Biochim. Biophys. Acta. 11(1852):2056–65 
13. Orgeron ML, Stone KP, Wanders D, Cortez CC, Van NT, Gettys TW. 
2014. Progress in molecular biology and translational science. 
121:351–76 
14. Zimmerman JA, Malloy V, Krajcik R, Orentreich N. 2003. Experimental 
Gerontology. 38:47–52 
15. Shin AC, Fasshauer M, Filatova N, Grundell LA, Zielinski E, et al. 
2014. Cell Metabolism. 20(5):898–909 
16. López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. 2013. 
Cell. 153(6):1194–1217 
17. Rizza W, Veronese N, Fontana L. 2014. Ageing Research Reviews. 
13:38–45 
18. Brandhorst S, Choi IY, Wei M, Cheng C-W, Sedrakyan S, et al. 2015. 
Cell Metabolism. 22(1):86–99 
19. Kabil H, Kabil O, Banerjee R, Harshman LG, Pletcher SD. 2011. 
Proceedings of the National Academy of Sciences. 108(40):16831–36 
20. Hine C, Harputlugil E, Zhang Y, Ruckenstuhl C, Lee BC, et al. 2015. 
Cell. 160(1-2):132–44 
21. Li P, Yin Y-L, Li D, Woo Kim S, Wu G. 2007. BJN. 98(02):237 
22. Parrella E, Maxim T, Maialetti F, Zhang L, Wan J, et al. 2013. Aging 
Cell. 12(2):257–68 
23. Westerterp-Plantenga MS, Nieuwenhuizen A, Tome D, Soenen S, 
Westerterp KR. 2009. Annu. Rev. Nutr. 29:21–41 
24. Tremblay F, Lavigne C, Jacques H, Marette A. 2007. Annu. Rev. Nutr. 
	 195	
27:293–310 
25. Consultation ROAJWFUE. 2007. Protein and amino acid requirements 
in human nutrition. Geneva: World Health Organization. 1 p. WHO 
Technical Report Series ed. 
26. Harper AE, Benevenga NJ, Wohlhueter RM. 1970. Physiol Rev. 
50(3):428–558 
27. Park B-C. 2006. Asian-Aust. J. Anim. Sci. 19(9):1361–68 
28. Benevenga NJ, Calvert C, Eckhert CD, Fahey GC, Greger JL, et al. 
1995. Nutrient Requirements of Laboratory Animals. Washington, 
D.C.: National Academy Press. 1 p. Fourth Revised Edition ed. 
29. Piper MDW, Blanc E, Leitão-Goncalves R, Yang M, He X, et al. 2014. 
Nat Meth. 11(1):100–105 
30. Tucker LA, Erickson A, LeCheminant JD, Bailey BW. 2015. J Diabetes 
Res. 2015:206959 
31. Brody S. 1945. Reinhold Publishing Corp., p. 1023 
32. Almquist HJ. 1953. Arch. Biochem. Biophys. 44(1):245–47 
33. McCay CM, Crowell MF, Maynard LA. 1935. The Journal of Nutrition. 
10:63–79 
34. Junger MA, Rintelen F, Stocker H, Wasserman JD, Vegh M, et al. 
2003. J. Biol. 2(3):20 
35. Enesco HE, Samborsky J. 1986. Arch Gerontol Geriatr. 5(3):221–33 
36. Miller RA, Harper JM, Galecki A, Burke DT. 2002. Aging Cell. 1(1):22–
29 
37. Selman C, Nussey DH, Monaghan P. 2013. Current Biology. 
23(10):R451–53 
38. Rollo CD. 2002. Evol Dev. 4(1):55–61 
39. Bartke A. 2012. Gerontology 
40. Partridge L, Gems D, Withers D. 2005. Cell. 120:461–72 
41. O'Brien DM, Kyung-Jin Min, Larsen T, Tatar M. 2008. Current Biology. 
18(4):R156 
42. Hoffman JM, Creevy KE, Promislow DEL. 2013. PLoS ONE. 
8(4):e61082 
43. Tabatabaie V, Atzmon G, Rajpathak SN, Freeman R, Barzilai N, 
Crandall J. 2011. Aging. 3(12):1–4 
44. Jahan-Mihan A, Luhovyy BL, Khoury El D, Anderson GH. 2011. 
Nutrients. 3(5):574–603 
45. Rutherfurd SM, Moughan PJ. 2012. BJN. 108 Suppl 2:S298–305 
46. Bröer S. 2008. Physiol Rev. 88(1):249–86 
47. Zhang Z, Adelman AS, Rai D, Boettcher J, Lőnnerdal B. 2013. 
Nutrients. 5(12):4800–4821 
48. Davila A-M, Blachier F, Gotteland M, Andriamihaja M, Benetti P-H, et 
al. 2013. Pharmacol. Res. 68(1):95–107 
49. Metges CC, Petzke KJ. 2007. BJN. 94(05):621–22 
50. Wikoff WR, Anfora AT, Liu J, Schultz PG, Lesley SA, et al. 2009. 
Proceedings of the National Academy of Sciences. 106(10):3698–
3703 
51. McDonald P, Edwards RA, Greenhalgh JFD, Morgan CA, Sinclair LA. 
2010. Animal Nutrition. London: Pearson. 1 p. 7 ed. 
52. Zhang C, Li S, Yang L, Huang P, Li W, et al. 2013. Nat Commun. 
4:2163 
	 196	
53. Wu GD, Chen J, Hoffmann C, Bittinger K, Chen Y-Y, et al. 2011. 
Science. 334(6052):105–8 
54. Erkosar B, Storelli G, Defaye A, Leulier F. 2013. Cell Host Microbe. 
13(1):8–14 
55. Neuman H, Debelius JW, Knight R, Koren O. 2015. FEMS Microbiol 
Rev. 39(4):509–21 
56. Stoll B, Burrin DG. 2006. Journal of Animal Science. 84 Suppl:E60–
E72 
57. Hinton T, Noyes DT, Ellis J. 1951. Physiological Zoology. 24(4):335–
53 
58. Ball RO, Courtney-Martin G, Pencharz PB. 2006. The Journal of 
Nutrition, pp. 1682S–1693S 
59. Sarup P, Pedersen SMM, Nielsen NC, Malmendal A, Loeschcke V. 
2012. PLoS ONE. 7(10):e47461 
60. Tomás-Loba A, Bernardes de Jesus B, Mato JM, Blasco MA. 2012. 
Aging Cell. 12(1):93–101 
61. Selman C, Kerrison ND, Cooray A, Piper MDW, Lingard SJ, et al. 
2006. Physiological Genomics. 27(3):187–200 
62. Richards SE, Wang Y, Claus SP, Lawler D, Kochhar S, et al. 2013. J. 
Proteome Res. 12(7):3117–27 
63. Wang TJ, Larson MG, Vasan RS, Cheng S, Rhee EP, et al. 2011. Nat. 
Med. 17(4):448–53 
64. Wijeyesekera A, Selman C, Barton RH, Holmes E, Nicholson JK, 
Withers DJ. 2012. J. Proteome Res. 11(4):2224–35 
65. Kilberg MS, Pan YX, Chen H, Leung-Pineda V. 2005. Annu. Rev. Nutr. 
25(1):59–85 
66. Wauson EM, Lorente-Rodríguez A, Cobb MH. 2013. Molecular 
Endocrinology. 27(8):1188–97 
67. Pochini L, Scalise M, Galluccio M, Indiveri C. 2014. Front Chem. 2:61 
68. Nicklin P, Bergman P, Zhang B, Triantafellow E, Wang H, et al. 2009. 
Cell. 136(3):521–34 
69. Berg JM, Tymoczko JL, Stryer L. 2006. Biochemistry. New York: W. H. 
Freeman. 1 p. 6 ed. 
70. Lemaitre B, Miguel-Aliaga I. 2013. Annu. Rev. Genet. 47(1):377–404 
71. Libert S, Pletcher SD. 2007. Cell. 131(7):1231–34 
72. Bjordal M, Arquier N, Kniazeff J, Pin JP, Leopold P. 2014. Cell. 
156(3):510–21 
73. Gietzen DW, Hao S, Anthony TG. 2007. Annu. Rev. Nutr. 27(1):63–78 
74. Chaveroux C, Lambert-Langlais S, Cherasse Y, Averous J, Parry L, et 
al. 2010. Biochimie. 92(7):736–45 
75. Chantranupong L, Wolfson RL, Sabatini DM. 2015. Cell. 161(1):67–83 
76. Alves VS, Motta FL, Roffé M, Delamano A, Pesquero JB, Castilho BA. 
2009. Biochemical and Biophysical Research Communications. 
378(1):41–44 
77. Efeyan A, Comb WC, Sabatini DM. 2015. Nature. 517(7534):302–10 
78. Dang Do AN, Kimball SR, Cavener DR, Jefferson LS. 2009. 
Physiological Genomics. 38(3):328–41 
79. De Sousa-Coelho AL, Relat J, Hondares E, Pérez-Martí A, Ribas F, et 
al. 2013. J. Lipid Res. 54(7):1786–97 
80. Leib DE, Knight ZA. 2015. Cell Rep. 13(6):1081–89 
	 197	
81. Karnani MM, Venner A, Jensen LT, Fugger L, Burdakov D. 2011. J. 
Physiol. (Lond.). 589(Pt 3):639–51 
82. Steculorum SM, Paeger L, Bremser S, Evers N, Hinze Y, et al. 2015. 
Cell. 162(6):1404–17 
83. Deval C, Chaveroux C, Maurin A-C, Cherasse Y, Parry L, et al. 2009. 
FEBS J. 276(3):707–18 
84. Suryawan A, O'Connor PMJ, Bush JA, Nguyen HV, Davis TA. 2009. 
Amino Acids. 37(1):97–104 
85. Stenesen D, Suh JM, Seo J, Yu K, Lee K-S, et al. 2013. Cell 
Metabolism. 17(1):101–12 
86. Chotechuang N, Azzout-Marniche D, Bos C, Chaumontet C, 
Gausserès N, et al. 2009. Am. J. Physiol. Endocrinol. Metab. 
297(6):E1313–23 
87. Tews JK, Kim YW, Harper AE. 1980. The Journal of Nutrition. 
110(3):394–408 
88. Davis AJ, Austic RE. 1994. The Journal of Nutrition. 124(9):1667–77 
89. Grant TD, Snell EH, Luft JR, Quartley E, Corretore S, et al. 2012. 
Nucleic Acids Res. 40(8):3723–31 
90. Palii SS, Kays CE, Deval C, Bruhat A, Fafournoux P, Kilberg MS. 
2009. Amino Acids. 37(1):79–88 
91. Takenaka A, Oki N, Takahashi SI, Noguchi T. 2000. The Journal of 
Nutrition. 130(12):2910–14 
92. Liao C-Y, Rikke BA, Johnson TE, Gelfond JAL, Diaz V, Nelson JF. 
2011. Aging Cell. 10(4):629–39 
93. Linford NJ, Beyer RP, Gollahon K, Krajcik RA, Malloy VL, et al. 2007. 
Aging Cell. 6(5):673–88 
94. Demetriades C, Doumpas N, Teleman AA. 2014. Cell. 156(4):786–99 
95. Kim J, Guan K-L. 2011. Annu. Rev. Biochem. 80(1):1001–32 
96. Chantranupong L, Wolfson RL, Orozco JM, Saxton RA, Scaria SM, et 
al. 2014. Cell Rep. 9(1):1–8 
97. Wolfson RL, Chantranupong L, Saxton RA, Shen K, Scaria SM, et al. 
2015. Science 
98. Wang S, Tsun Z-Y, Wolfson RL, Shen K, Wyant GA, et al. 2015. 
Science, pp. 188–94 
99. Tsun Z-Y, Bar-Peled L, Chantranupong L, Zoncu R, Wang T, et al. 
2013. Molecular Cell, pp. 495–505 
100. Li L, Kim E, Yuan H, Inoki K, Goraksha-Hicks P, et al. 2010. J. Biol. 
Chem. 285(26):19705–9 
101. Jewell JL, Kim YC, Russell RC, Yu F-X, Park HW, et al. 2015. 
Science. 347(6218):194–98 
102. Lamming DW, Ye L, Katajisto P, Goncalves MD, Saitoh M, et al. 2012. 
Science. 335(6076):1638–43 
103. Saha AK, Xu XJ, Balon TW, Brandon A, Kraegen EW, Ruderman NB. 
2011. Cell Cycle. 10(20):3447–51 
104. Lindgren O, Pacini G, Tura A, Holst JJ, Deacon CF, Ahrén B. 2015. J. 
Clin. Endocrinol. Metab. 100(3):1172–76 
105. Saxton RA, Knockenhauer KE, Wolfson RL, Chantranupong L, Pacold 
ME, et al. 2015. Science 
106. Norheim F, Gjelstad IMF, Hjorth M, Vinknes KJ, Langleite TM, et al. 
2012. Nutrients. 4(12):1898–1944 
	 198	
107. Journel M, Chaumontet C, Darcel N, Fromentin G, Tomé D. 2012. 
Advances in nutrition, pp. 322–29 
108. Kohl S, Behrens M, Dunkel A, Hofmann T, Meyerhof W. 2013. J. 
Agric. Food Chem. 61(1):53–60 
109. Alfa RW, Park S, Skelly K-R, Poffenberger G, Jain N, et al. 2015. Cell 
Metabolism. 21(2):323–33 
110. Jiang Y, Rose AJ, Sijmonsma TP, Bröer A, Pfenninger A, et al. 2015. 
Mol Metab. 4(5):406–17 
111. Crespo CS, Cachero AP, Jiménez LP, Barrios V, Ferreiro EA. 2014. 
Front Endocrinol (Lausanne). 5:58–58 
112. Jordi J, Herzog B, Camargo SMR, Boyle CN, Lutz TA, Verrey F. 2013. 
J. Physiol. (Lond.). 591(Pt 22):5611–21 
113. McCormick MA, Tsai SY, Kennedy BK. 2010. Philosophical 
Transactions of the Royal Society B: Biological Sciences. 
366(1561):17–27 
114. Edwards C, Canfield J, Copes N, Brito A, Rehan M, et al. 2015. BMC 
Genet. 16(1):8 
115. Santos J, Leao C, Sousa MJ. 2012. Oxid Med Cell Longev. 2012:10 
116. Sikalidis AK, Mazor KM, Kang M, Liu H, Stipanuk MH. 2013. J Amino 
Acids. 2013:864757 
117. Cai Z, Zhou Y, Xiao M, Yan L-J, He W. 2015. NDT, pp. 1015–30 
118. Kimball SR, Jefferson LS. 2006. Am. J. Clin. Nutr. 83(2):500S–507S 
119. Bunpo P, Dudley A, Cundiff JK, Cavener DR, Wek RC, Anthony TG. 
2009. J. Biol. Chem. 284(47):32742–49 
120. Rousakis A, Vlassis A, Vlanti A, Patera S, Thireos G, Syntichaki P. 
2013. Aging Cell, pp. 742–2751 
121. Pal S, Ellis V. 2010. BJN, pp. 1241–48 
122. Hoffman JR, Falvo MJ. 2004. Journal of Sports Science and Medicine. 
3:118–30 
123. van Milgen J. 2002. The Journal of Nutrition. 132(10):3195–3202 
124. Chin RM, Fu X, Pai MY, Vergnes L, Hwang H, et al. 2014. Nature. 
510(7505):397–401 
125. D'Antona G, Ragni M, Cardile A, Tedesco L, Dossena M, et al. 2010. 
Cell Metabolism. 12(4):362–72 
126. Poff AM, Ari C, Arnold P, Seyfried TN, D'Agostino DP. 2014. Int. J. 
Cancer. 135(7):1711–20 
127. Gibson AA, Seimon RV, Lee CMY, Ayre J, Franklin J, et al. 2014. 
Obesity Research & Clinical Practice. 8(8):36 
128. Pedroso JAB, Zampieri TT, Donato J. 2015. Nutrients. 7(5):3914–37 
129. Komar B, Schwingshackl L, Hoffmann G. 2015. J Nutr Health Aging. 
19(4):437–46 
130. Jakubowicz D, Froy O. 2013. Journal of Nutritional Biochemistry. 
24:1–5 
131. McCarty MF, Barroso-Aranda J, Contreras F. 2009. Medical 
Hypotheses. 72(2):125–28 
132. Melnik BC, John SM, Schmitz G. 2013. Nutr J. 12:103 
133. Newgard CB. 2012. Cell Metabolism. 15(5):606–14 
134. Poulain M, Herm A, Pes G. 2013. Vienna Yearbook of Population 
Research - JSTOR. 11:87–108 
135. Trichopoulou A, Vasilopoulou E. 2000. Br. J. Nutr. 84 Suppl 2:S205–9 
	 199	
136. Buckland G, Agudo A, Travier N, Huerta JM, Cirera L, et al. 2011. Br. 
J. Nutr. 106(10):1581–91 
137. Crowe FL, Key TJ, Allen NE, Appleby PN, Roddam A, et al. 2009. 
Cancer Epidemiol Biomarkers Prev. 18(5):1333–40 
138. Kalu DN, Masoro EJ, Yu BP, Hardin RR, Hollis BW. 1988. 
Endocrinology. 122(5):1847–54 
139. Zhang X, Beynen AC. 1993. Br. J. Nutr. 70(1):139–46 
140. Bounous G, Gervais F, Amer V, Batist G, Gold P. 1989. Clin Invest 
Med. 12(6):343–49 
141. Shertzer HG, Woods SE, Krishan M, Genter MB, Pearson KJ. 2011. 
The Journal of Nutrition. 141(4):582–87 
142. Coker RH, Miller S, Schutzler S, Deutz N, Wolfe RR. 2012. Nutr J. 
11:105 
143. Noguchi T. 2000. Br. J. Nutr. 84 Suppl 2:S241–44 
144. O'Neill B. 2010. Bioscience Horizons. 3(2):197–212 
145. Geer BW. 1963. J. Exp. Zool. 154(3):353–64 
146. Metaxakis A, Partridge L. 2013. PLoS ONE. 8(9):e74681 
147. Liao C-Y, Rikke BA, Johnson TE, Diaz V, Nelson JF. 2010. Aging Cell. 
9(1):92–95 
148. Ram R, Mehta M, Balmer L, Gatti DM, Morahan G. 2014. Genetics. 
198(1):75–86 
149. Miller DS, Payne PR. 1968. Experimental Gerontology. 3:231–34 
150. Gilani GS, Sepehr E. 2003. The Journal of Nutrition. 133(1):220–25 
151. Sun L, Sadighi Akha AA, Miller RA, Harper JM. 2009. The Journals of 
Gerontology Series A: Biological Sciences and Medical Sciences. 
64A(7):711–22 
152. Ozanne SE, Hales CN. 2004. Nature. 427(6973):411–12 
153. John AM, Bell JM. 1976. The Journal of Nutrition. 106(9):1361–67 
154. Grönke S, Clarke D-F, Broughton S, Andrews TD, Partridge L. 2010. 
PLoS Genet. 6(2):e1000857 
155. Bass TM, Grandison RC, Wong R, Martinez P, Partridge L, Piper 
MDW. 2007. The Journals of Gerontology Series A: Biological 
Sciences and Medical Sciences. 62(10):1071–81 
156. Piper MD, Blanc E, Leitão-Goncalves R, Yang M, He X, et al. 2013. 
Nat Meth 
157. FAO. 2013. FOOD AND AGRICULTURE ORGANIZATION OF THE 
UNITED NATIONS, p. 79 
158. Van Etten CH, Hubba JE, Mallan JM, Smith AK, Blessin CW. 1959. J. 
Agric. Food Chem. 7(2):129–31 
159. Zezulka AY, Galloway DH. 1976. J. Nutr. 106:212–21 
160. Nielsen K, Kondrup J, Elsner P, Juul A, Jensen ES. 1994. Br. J. Nutr. 
72(1):69–81 
161. Acheson KJ, Blondel-Lubrano A, Oguey-Araymon S, Beaumont M, 
Emady-Azar S, et al. 2011. Am. J. Clin. Nutr. 93(3):525–34 
162. Burnet B, Sang JH. 1968. Genetics. 59(2):211–35 
163. Sury MD, Chen J-X, Selbach M. 2010. Mol Cell Proteomics. 
9(10):2173–83 
164. Wiśniewski JR, Rakus D. 2014. J Proteomics. 109:322–31 
165. Wiśniewski JR, Ostasiewicz P, Duś K, Zielińska DF, Gnad F, Mann M. 
2012. Molecular Systems Biology. 8:611 
	 200	
166. Geiger T, Velic A, Macek B, Lundberg E, Kampf C, et al. 2013. 
Molecular & Cellular Proteomics. 12(6):1709–22 
167. Cox J, Mann M. 2008. Nat. Biotechnol. 26(12):1367–72 
168. Cox J, Neuhauser N, Michalski A, Scheltema RA, Olsen JV, Mann M. 
2011. J. Proteome Res. 10(4):1794–1805 
169. Wong R, Piper MDW, Wertheim B, Partridge L. 2009. PLoS ONE. 
4(6):e6063 
170. Cooper DM. 1960. Evolution. 14(1):41–55 
171. Vargas MA, Luo N, Yamaguchi A, Kapahi P. 2010. Curr. Biol. 
20(11):1006–11 
172. Gomes AV, Waddell DS, Siu R, Stein M, Dewey S, et al. 2012. FASEB 
J. 26(7):2986–99 
173. Spindler SR. 2012. AGE. 34(1):111–20 
174. Warner HR, Ingram D, Miller RA, Nadon NL, Richardson AG. 2000. 
Program for testing biological interventions to promote healthy aging. 
175. Haseman JK, Bourbina J, Eustis SL. 1994. Fundam Appl Toxicol. 
23(1):44–52 
176. Claassen V. 1994. Neglected factors in pharmacology and 
neuroscience research, Vol. Volume 12. Amsterdam and New York: 
Elsevier. 2 p. 
177. Hedrich HJ, Bullock GR. 2004. The Laboratory Mouse. London: 
Elsevier. 1 p. 
178. Aletor V, Hamid I, Nieß E, Pfeffer E. 2000. Journal of the Science of 
Food and Agriculture. 80:547–54 
179. Orentreich N, Mataas JR, Defelice A, Zimmerman JA. 1993. The 
Journal of Nutrition, pp. 269–74 
180. Harper AE, Kumta US. 1959. Fed. Proc., pp. 1136–42 
181. Percy DH, Barthold SW. 2007. Pathology of Laboratory Rodents and 
Rabbits. Iowa: Blackwell Publishing. 1 p. Third ed. 
182. Keenan KP, Ballam GC, Soper KA, Laroque P, Coleman JB, Rakesh 
D. 1999. Toxicological Sciences. 52:24–34 
183. Oka K, Sakuarae A, Fujise T, Yoshimatsu H, Sakata T, Nakata M. 
2003. J. Dent. Res. 82(6):491–94 
184. Beamer WG, Shultz KL, Donahue LR, Churchill GA, Sen S, et al. 
2001. Quantitative trait loci for femoral and lumbar vertebral bone 
mineral density in C57BL/6J and C3h/HeJ inbred strains of mice, Vol. 
20. Journal of Bone and Mineral Research. 120000 p. 
185. Halloran BP, Ferguson VL, Simske SJ, Burghardt A, Venton LL, 
Majumdar S. 2002. J Bone Miner Res. 17(6):1044–50 
186. Millward DJ. 2012. BJN. 108 Suppl 2:S3–S21 
187. Young VR, el-Khoury AE. 1995. Proc. Natl. Acad. Sci. 92:300–304 
188. Sofola-Adesakin O, Castillo-Quan J, Rallis C, Tain LS, Bjedov I, et al. 
2014. Frontiers in Aging Neuroscience. 6(190):1–10 
189. Pellett PL, Kaba H. 1972. The Journal of Nutrition. 102(1):61–68 
190. Fuller MF, McWilliam R, Wang TC, Giles LR. 2007. BJN. 62(02):255–
67 
191. Dewey KG, G B, C F, B L, P R. 1996. Eur J Clin Nutr. 50(1):S119–47, 
S147–50 
192. Reeds PJ. 2000. The Journal of Nutrition. 130(7):1835S–40S 
193. Dabrowski K, Zhang Y, Arslan M, Terjesen BF. 2009. Rev Col Cienc 
	 201	
Pec. 20(4):508–11 
194. Fuller MF, Garlick PJ. 1994. Annu. Rev. Nutr. 14:217–41 
195. Pencharz PB, Ball RO. 2003. Annu. Rev. Nutr. 23:101–16 
196. Fürst P, Stehle P. 2004. The Journal of Nutrition. 134:1558s–1565s 
197. Rippon WP. 1959. Br. J. Nutr. 13:243–60 
198. Takruri HR, Humeid MA, Umari MAH. 1990. Journal of the Science of 
Food and Agriculture. 50(3):319–27 
199. Hunt V. 1970. Drosophila Information Services, p. 179 
200. Koehnle TJ, Russell MC, Gietzen DW 
201. Hao S, Sharp JW, Ross-Inta CM, McDaniel BJ, Anthony TG, et al. 
2005. Science. 307(5716):1776–78 
202. Rogers QR, Harper AE. 1965. The Journal of Nutrition. 87(3):267–73 
203. Miller RA, Buehner G, Chang Y, Harper JM, Sigler R, Smith-Wheelock 
M. 2005. Aging Cell. 4(3):119–25 
204. Yu BP. 1994. Proc Soc Exp Biol Med. 205:97–105 
205. Wootton JC. 1994. Current Opinion in Structural Biology. 4(3):413–21 
206. MacLeod EL, Ney DM. 2010. Ann Nestlé [Engl]. 68(2):58–69 
207. Chintapalli VR, Wang J, Dow JAT. 2007. Nat Genet. 39(6):715–20 
208. Breslin T, Edén P, Krogh M. 2004. BMC Bioinformatics. 5:193 
209. Nikoh N, Hosokawa T, Moriyama M, Oshima K, Hattori M, Fukatsu T. 
2014. Proceedings of the National Academy of Sciences. 
111(28):10257–62 
210. Su Q, Xie W, Wang S, Wu Q, Liu B, et al. 2014. PLoS ONE. 
9(2):e89002 
211. Chwalibog A, Sawosz E, Niemiec T, Grodzik M, Thorbek G. 2008. 
Archives of Animal Nutrition. 62(1):82–85 
212. Sang JH, King RC. 1961. J. Exp. Biol. 38:793–809 
213. Chou H-Y, Lin Y-H, Shiu G-L, Tang H-Y, Cheng M-L, et al. 2014. J. 
Biomed. Sci. 21(1):64 
214. Ingolia NT, Lareau LF, Weissman JS. 2011. Cell. 147(4):789–802 
215. Rodrigues MA, Martins NE, Balancé LF, Broom LN, Dias AJS, et al. 
2015. Journal of Insect Physiology. 81:69–80 
216. Taormina G, Mirisola MG. 2014. Biomed Res Int. 2014:308690 
217. Lanet E, Maurange C. 2014. Front Physiol. 5:117 
218. Vernochet C, Kahn CR. 2012. Aging. 4(12):859–60 
219. Elia M. 1992. In Protein-Energy Interactions, eds NS Scrimshaw, B 
Schurch. Lausanne Switzerland: International Dietary Energy 
Consultancy Group (I/D/E/C/G). Proceedings of an I/D/E/C/G 
Workshop held in Waterville Valley, NH, USA ed. 
220. Owen OE, Smalley KJ, D'Alessio DA, Mozzoli MA, Dawson EK. 1998. 
Am. J. Clin. Nutr. 68(1):12–34 
221. Vigne P, Frelin C. 2007. Mechanisms of Ageing and Development. 
128(5-6):401–6 
222. Pant R. 1988. Proc. Indian Acad. Sci. 97(5):379–415 
223. Magwere T, Goodall S, Skepper J, Mair W, Brand MD, Partridge L. 
2006. The Journal of Gerontology. 61A(1):36–47 
224. Zhang Y, Nicholatos J, Dreier JR, Ricoult SJH, Widenmaier SB, et al. 
2014. Nature. 513(7518):440–43 
225. Zahn JM, Poosala S, Owen AB, Ingram DK, Lustig A, et al. 2007. 
PLoS Genet. 3(11):e201 
	 202	
226. Walther DM, Kasturi P, Zheng M, Pinkert S, Vecchi G, et al. 2015. 
Cell. 161(4):919–32 
227. Green EL. 1967. Biology of the Laboratory Mouse. New York, : 
Blakiston Division, McGraw-Hill. 1 p. 2nd ed. 
228. Drickamer LC. 1995. J. Chem. Ecol. 21(10):1481–93 
229. Belmonte L, Coëffier M, Le Pessot F, Miralles-Barrachina O, Hiron M, 
et al. 2007. World J. Gastroenterol. 13(20):2833–40 
230. Kueper J, Beyth S, Liebergall M, Kaplan L, Schroeder JE. 2015. Int J 
Endocrinol. 2015:628740 
231. Kremen NA, Calvert CC, Larsen JA, Baldwin RA, Hahn TP, Fascetti 
AJ. 2013. Journal of Animal Science. 91(3):1270–76 
232. Reeves PG, Nielsen FH, Fahey GC. 1993. AIN-93 purified diets for 
laboratory rodents: final report of the American Institute of Nutrition ad 
hoc writing committee on the reformulation of the AIN-76A rodent diet. 
233. Deshpande PD, Harper AE, Elvehjem CA. 1958. Journal of Biological 
Chemistry. 230(1):327–33 
234. Sklan D, Noy Y. 2005. Poult. Sci. 84(3):412–18 
235. Rose WC. 1937. Science. 86(2231):298–300 
236. Wang S, Tsun Z-Y, Wolfson RL, Shen K, Wyant GA, et al. 2015. 
Science. 347(6218):188–94 
237. Huang X, Hancock DP, Gosby AK, McMahon AC, Solon SMC, et al. 
2013. Obesity. 21(1):85–92 
238. Leto S, Kokkonen GC, Barrows CH. 1976. J Gerontol. 31(2):149–54 
239. Shamoto Nagai M, Maruyama W, Kato Y, Isobe KI, Tanaka M, et al. 
2003. Journal of Neuroscience Research. 74(4):589–97 
240. Rosalba Putti RSVMLL. 2015. Front Physiol. 6: 
241. Ross J, Olson L, Coppotelli G. 2015. International Journal of Molecular 
Sciences 2015, Vol. 16, Pages 22830-22855. 16(8):19458–76 
242. Ayala V, Naudí A, Sanz A, Caro P, Portero-Otín M, et al. 2007. The 
Journals of Gerontology Series A: Biological Sciences and Medical 
Sciences. 62(4):352–60 
243. Miwa S, Jow H, Baty K, Johnson A, Czapiewski R, et al. 2014. Nat 
Commun. 5:3837 
244. Simpson SJ, Raubenheimer D. 2012. Princeton University Press 
245. Hart RW, Neumann DA, Robertson RT. 1995. Dietary restriction: 
implications for the design and interpretation of toxicity and 
carcinogenicity studies. International Life Sciences Institute 
246. Olewine DA, Barrows CH, Shock NW. 1964. J Gerontol. 19:230–33 
247. Sørensen A, Mayntz D, Raubenheimer D, Simpson SJ. 2008. Obesity. 
16(3):566–71 
248. Guo F, Cavener DR. 2007. Cell Metabolism. 5(2):103–14 
249. Rotella CM, Dicembrini I. 2015. World J Methodol. 5(1):1–9 
250. Mahoney LB, Denny CA, Seyfried TN. 2006. Lipids Health Dis. 5:13 
251. Lees EK, Król E, Grant L, Shearer K, Wyse C, et al. 2014. Aging Cell. 
13(5):817–27 
252. Hill RBJ, Prosper J, Hurschfield JS, Kern F Jr. 1968. Experimental and 
molecular pathology, pp. 66–74 
253. Hirschfield JS, Kern F Jr. 1969. J. Clin. Invest. 48(7):1224–29 
254. Magne H, Savary-Auzeloux I, Migné C, Peyron M-A, Combaret L, et 
al. 2013. PLoS ONE. 8(8):e70130 
	 203	
255. Stitt TN, Drujan D, Clarke BA, Panaro F, Timofeyva Y, et al. 2004. 
Molecular Cell. 14:395–403 
256. Mehlem A, Hagberg CE, Muhl L, Eriksson U, Falkevall A. 2013. Nat 
Protoc. 8(6):1149–54 
257. Fontana L, Partridge L, Longo VD. 2010. Science. 328(5976):321–26 
258. Ni YG, Wang N, Cao DJ, Sachan N, Morris DJ, et al. 2007. 
Proceedings of the National Academy of Sciences. 104(51):20517–22 
259. Ulusoy E, Eren B. 2006. Histol. Histopathol. 21(9):925–30 
260. Selman C, Lingard S, Choudhury AI, Batterham RL, Claret M, et al. 
2008. FASEB J. 22(3):807–18 
261. Vajiheh Izadi SS-BLA. 2014. ARYA Atherosclerosis. 10(5):266 
262. Otoda T, Takamura T, Misu H, Ota T, Murata S, et al. 2013. Diabetes. 
62(3):811–24 
263. Drake JC, Bruns DR, Peelor FF, Biela LM, Miller RA, et al. 2015. 
Aging Cell 
264. Heaney RP, Layman DK. 2008. Am. J. Clin. Nutr. 87(5):1567S–1570S 
265. Rokutanda S, Fujita T, Kanatani N, Yoshida CA, Komori H, et al. 2009. 
Dev. Biol. 328(1):78–93 
266. Courtland H-W, Kennedy OD, Wu Y, Gao Y, Sun H, et al. 2013. AGE. 
35(5):1691–1703 
267. Hawkins J, Cifuentes M, Pleshko NL, Ambia-Sobhan H, Shapses SA. 
2010. The Journal of Nutrition. 140(1):31–37 
268. Brochmann Murray EJ, Beamer WG, Duarte ME, Behnam K, Grisanti 
MS, Murray SS. 2001. Metabolism. 50(4):436–42 
269. Brochmann EJ, Duarte ME, Zaidi HA, Murray SS. 2003. Metabolism. 
52(10):1265–73 
270. Villareal DT, Fontana L, Weiss EP, Racette SB, Steger-May K, et al. 
2006. Arch. Intern. Med. 166(22):2502–10 
271. Gat-Yablonski G, Phillip M. 2015. Nutrients. 7(1):517–51 
272. Almquist HJ. 1954. Arch. Biochem. Biophys. 50(2):503 
273. Taylor S, Coburn SP, Townsend DW. 1996. Mathematical Modeling in 
Experimental Nutrition: Vitamins, Proteins, Methods, Vol. 40. 
Academic Press. 1 p. 1st ed. 
274. Min K-J, Tatar M. 2006. Mechanisms of Ageing and Development. 
127(7):643–46 
275. Katewa SD, Demontis F, Kolipinski M, Hubbard A, Gill MS, et al. 2012. 
Cell Metabolism. 16(1):97–103 
276. Kristensen TN, Overgaard J, Loeschcke V, Mayntz D. 2011. Biology 
Letters. 7(2):269–72 
277. Pimentel D, Pimentel M. 2003. Am. J. Clin. Nutr. 78(3 Suppl):660S–
663S 
278. Wolfe RR. 2000. American Journal of Clinical Nutrition. 72(2):551s–
557s 
 
 
 
 
 
 
 
	 204	
Ich	versichere,	dass	ich	die	von	mir	vorgelegte	Dissertation	selbständig,	die	benutzen	Quellen	und	Hilfsmittel	vollständig	angegeben	und	die	Stellen	der	Arbeit	–	einschließlich	Tabellen,	Karten	und	Abbidungen	-,	die	anderen	Werken	im	Wortlaut	oder	dem	Sinn	nach	entnommen	sind,	in	jedem	Einzelfall	als	Entlehnung	kenntlich	gemacht	habe;	dass	diese	Disseartation	noch	keine	anderen	Fakultät	oder	Universität	zur	Prüfung	vorgelegen	hat;	dass	die	–	abgesehen	von	unten	angegebenen	Teilpublikationen	–	noch	nicht	veröffentlicht	worden	ist	sowie,	dass	ich	eine	solche	Veröffentlichung	vor	Abschluss	des	Promotionsverfahrens	nicht	vornehmen	werde.	Die	Bestimmungen	dieser	Promotionsordnung	sind	mir	bekannt.	Die	von	mir	vorgelegte	Dissertation	ist	von	Prof.	Linda	Partridge	betreut	worden.	
 
George A. Soultoukis 
 
 
22.02.16 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	 205	
 
Curriculum	Vitae	
 
PERSONAL INFORMATION 
 
Name: George Soultoukis 
Current residence: 28 Redwitzstraße, Sülz, Cologne  
Email: georgiossoultoukis675@hotmail.com  
Telephone nr.: 0221 370970 655 
Mobile nr.: 01525 917 5541 
Nationality: Hellenic (EU) 
 
 
PUBLICATIONS 
 
ACCEPTED 
 
1. Matthew D W Piper, Eric Blanc, Ricardo Leitão-Gonçalves, Mingyao 
Yang, Xiaoli He, Nancy J Linford, Matthew P Hoddinott, Corinna 
Hopfen, George A Soultoukis, Christine Niemeyer, Fiona Kerr, Scott D 
Pletcher, Carlos Ribeiro, and Linda Partridge. A holidic medium for 
Drosophila melanogaster. Nature Methods 11, 100–105 (2014). 
 
2. George A. Soultoukis and Linda Partridge. Protein, Metabolism and Ageing. Annual 
Reviews of Biochemistry 85, xxx-xxx, (2016), (accepted). 
 
IN PREPARATION 
 
1. George A Soultoukis*, Matthew D Piper*, Eric Blanc, Ilian Athanassov, 
Paula Juricic, Hanna Salmonowicz, Matthew Hoddinott, Carlos Ribeiro, 
Andrea Mesaros, Stephen J Simpson, and Linda Partridge. Exome 
matching of essential amino acids in the diet increases anabolic 
efficiency without limiting lifespan. eLife, (submitted)  
 
2. George A. Soultoukis, Andrea Mesaros, Hanna Salmonowicz, Stanka 
Matic, Chirag Jain, Joana Goncalves, Youssef Hassan, Alain de Bruin, 
and Linda Partridge. Disparate metabolic effects of promoting 
anabolism through dietary exome matching in vertebrates and 
invertebrates. (in preparation) 
*authors contributed equally 
 
RESEARCH EXPERIENCE 
 
Max Planck Institute for Biology of Ageing – (01/02/2012 – till present) 
- Graduate studies: Doctoral student placement at Prof. Linda Partridge 
Department Biological Mechanisms of Ageing. 
	 206	
- Project Title: Elucidating mechanisms of mouse and fly lifespan 
regulation through nutrients in the diet. 
- Special techniques: Mouse and fly dissections, Insulin (ITT) and 
glucose tolerance (GTT) assays, histopathology, statistical and 
bioinformatics analyses (including data analysis and visualisation on 
R), nitrogen balance assays, body composition analysis by TD-NMR, 
blood and hemolymph extraction, defined media preparation, 
Drosophila melanogaster in vivo assays for nutrient intake (PEB assay, 
EDS blue dye assay), fluorescent microscopy, foraging behaviour 
assays (DPI), uric acid and urea assay, enzyme-linked immunosorbent 
assay (ELISA), triacylglyceride (TAG) assay. 
 
Max Planck Institute for Biology of Ageing – (13/06/2011 – 31/01/2012) 
- Scientific research assistant: Pre-doctoral student placement in the 
Department Biological Mechanisms of Ageing. 
- Project Title: Foxo dependence of lifespan extension in a dominant 
negative insulin receptor (dInRDN) mutant fly. 
- Special techniques: rtPCR genotyping, semi-defined media 
preparation, genetic crossing strategies, microscopy, Drosophila 
melanogaster in vivo assays for xenobiotic stress resistance, starvation 
resistance, fecundity, development, and lifespan. 
 
University College London - (04/10/2010 – 25/03/2011) 
- 3rd Year Undergraduate Research Project at the Institute of Neurology, 
National Hospital of Neurology and Neurosurgery. 
- Project Title: ‘Biochemical consequences of methylmalonic acid on 
human neuroblastoma SH-SY5Y cells: inhibition of mitochondrial 
electron transport chain complex I and other effects on mitochondrial 
metabolism’. 
- Special techniques: cell culture and microplating (human 
neuroblastoma SH-SY5Y cells), cell (LDH) and mitochondrial (GSH) 
toxicity assays, fluorimetry, spectrophotometry, WB, light microscopy. 
 
Sanofi-Aventis, Alnwick Research Centre - (03/08/2009 – 17/09/2010) 
- Extramural Industrial Placement at the Metabolism Group of the Global 
Metabolism and Pharmacokinetics Department, Alnwick Research 
Centre.  
- Main Project Title: ‘A metabonomics preclinical study on rats with CNS 
toxicity caused by 5-ethoxymethyl pyridine-2-amine, an impurity in a 
drug substance’.  
- Special techniques: metabolomics, sample preparation (oxidation, 
drying, reconstitution, etc.), RP/HPLC-MS, MS data analysis (PCA, 
PLS-DA, MVDA, UVDA), R programming, data mining, radiolabelled 
sample scintillation analysis (LSC, MSC). 
 
University College London - (01/06/2009 – 31/07/2009) 
- BBSRC Vacation Scholarship at the Institute of Structural and 
Molecular Biology, UCL. 
- Project Title: ‘Structural investigation of the synthesis of alpha-
synuclein (αSyn) on the ribosome by NMR Spectroscopy’. 
	 207	
- Special techniques: plasmid purification, gene isolation (endonuclease 
cleavage and gel electrophoresis) and amplification (PCR), DNA 
quantification, gene insertion in vector, cell transformation and culture 
(E. coli DH5a cells), NMR spectroscopy. 
 
EDUCATION 
 
Doctoral studies: University of Cologne, Graduate School for Biological 
Sciences  
- PhD in Genetics (Start date: Feb 2012, Award date: Jul 2016)  
- Department Biological Mechanisms of Ageing, Max Planck Institute for 
Biology of Ageing, Cologne, Germany. 
- Supervisor: Prof. Linda Partridge, PhD Thesis Title: Elucidating 
mechanisms of mouse and fly lifespan regulation through nutrients in 
the diet 
 
Bachelor studies: University College London  
- BSc, Molecular Biology (Start date: Sep 2007, Award date: Aug 2011)  
- Recommended Degree Class: Upper Second Class Hons. 
 
College education: Kingston University 
- Science Degree Foundation Course (Sep 2006 - June 2007) 
- Kingston College, Kingston University, London, UK. 
- Result: 79% (Passed with distinction), Modules & Marks: Biology 78%, 
Chemistry 81%, Mathematics 78%, Physics 93%, Information & 
Communication Technology 86%. 
 
FUNDING & AWARDS 
 
- 2010 - Winner of the Sanofi-Aventis Alnwick Research Center Student 
‘Poster of the Year' Award. Poster title: ‘A metabonomics preclinical 
study on rats with CNS toxicity caused by 5-ethoxymethyl pyridine-2-
amine’. 
 
- 2009 - €3,000 - BBSRC Vacation Scholarship at the Institute of 
Structural and Molecular Biology, University College London. Project 
Title: ‘Structural investigation of the synthesis of alpha-synuclein 
(αSyn) on the ribosome by NMR Spectroscopy’.  
 
- 2007 - Graduated with Distinction from the Kingston University Science 
Degree Foundation Course. 
 
STUDENTS SUPERVISED 
 
- 2014 - 2015 - Hanna Salmonowicz (26/01-13/07/2015 – Master 
Thesis*) 
(21/04-30/06/2014 & 01/10-23/01/2015 – Undergraduate*) 
	 208	
- 2014 - 2015 - Nina Grisard (01/07/2014-31/03/2015 – Undergraduate*) 
 
*University of Cologne 
ONLINE CONTRIBUTIONS 
 
Interview for news release: ‘A standardized chemical diet for flies allows to 
reduce conflicting results across labs and might thus speed up science’ 
http://www.age.mpg.de/news-events/news/singleview-
news/?no_cache=1&tx_ttnews%5Btt_news%5D=132&cHash=c8dd85530ce2f
62d79f150a434563b27 
 
RELEVANT QUALIFICATIONS & TRAINING  
 
- Felasa B Course (Theoretical and practical mouse handling course 
with qualification awarded) - 06/2012 (5 days) - Berlin, Germany 
- FRAME: Experimental design and statistical analysis of biomedical 
experiments (Workshop on minimizing animal use in basic research 
experiments) - 07/12 (3 days) - University of Nijmegen, Netherlands 
- Mouse pathology workshop (Theoretical and practical training) - 
05/2013 (1 day) - Utrecht University, Dutch Molecular Pathology 
Center, Netherlands 
- National and European research funding for young researchers (MPI 
Age – CECAD Information Event) – 10/2013 (1 day) - MPI Age, Robert 
Koch Strasse, Cologne Germany 
- Data visualization workshop (Science Craft training seminar) - 11/2014 
(3 days) - University of Cologne, Germany 
- Statistical literacy workshop (Science Craft theoretical and practical 
workshop) - 03/2015 (3 days) - University of Cologne, Germany 
- Effective writing for biomedical professionals (Oxford University 
scientific writing workshop) – 11/2015 (2 days) – Oxford, UK 
 
PRESENTATIONS & POSTERS 
 
- George Soultoukis, Matthew Piper, and Linda Partridge (2012) 4th 
International Symposium Crossroads in Biology,	Cologne, Germany, 9-
10/02/2012. Title: ‘Elucidating dietary effects on Drosophila physiology 
using a holidic medium’. Poster. 
- George Soultoukis, Matthew Piper, and Linda Partridge (2012) 
Eurosymposium on Healthy Ageing, Brussels, Belgium, 12-14/12/2012. 
Title: ‘Elucidating the effects of dietary amino acids on Drosophila life 
history traits using a holidic medium’. Poster. 
 
REFEREES 
 
Name: Prof. Linda Partridge 
Connection: PhD supervisor 
	 209	
Address: Department Biological Mechanisms of Ageing, Max Planck 
Institute for Biology of Ageing, Joseph-Stelzmann-Str. 9b, D-50931, 
Cologne, Germany 
Contact No.: +49 221 37970 600  
Email: Partridge@age.mpg.de 
 
Name: Prof. Aleksandra Trifunovic,  
Connection: PhD thesis committee member 
Address: Cologne Cluster of Excellence in Cellular Stress Responses 
in Aging, Joseph-Stelzmann-Str. 26, D-50931, Cologne, Germany 
Contact No.: +49 221 478 842 91 
Email: aleksandra.trifunovic@uk-koeln.de 
 
Name: Dr Lisa Cabrita,  
Connection: Lecturer, Tutor, and Vacation Scholarship Supervisor  
Address: Darwin Building, Department of Structural and Molecular 
Biology - University College London - Gower Street - London - WC1E 
6BT 
Contact No.: +44 20 7679 2375 
Email: l.cabrita@ucl.ac.uk 
 
 
 	
 
